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Après stimulation antigénique, les  lymphocytes T CD8+ naïves subissent plusieurs 
modifications, comme l’expression des molécules de surface. Chez l’homme, l’association 
du CCR7, CD45RA, CD27 et CD28 est fréquemment  utilisée pour discriminer de façon 
reproductible des sous-populations de cellules T CD8+ fonctionnellement différentes. 
Néanmoins, la description de ces populations reste incomplète, puisque plusieurs études 
ont utilisé des associations différentes et limitées de molécules de surface. En 
conséquence, certaines sous-populations de cellules T CD8+ n’ont pas encore été 
établies, en particulier dans les compartiments CCR7–CD45RA+ et CCR7–CD45R0+. De 
plus, les voies de différenciation de ces sous-populations ainsi que leurs rôles respectifs 
ne sont pas encore définis. 
L’objet  de ce travail était de définir une corrélation précise et prévisible entre un 
phénotype de surface donné et des propriétés fonctionnelles des cellules T CD8+.  Nous 
avons associé les niveaux d’expression de CCR7, CD45RA, CD27 et CD28 pour 
subdiviser les cellules T CD8+ en quatorze sous-types cellulaires différents. Ces 
populations ont été isolées et l’expression génique de 18 gènes a été étudiée 
simultanément sur des cellules uniques, par une nouvelle méthode de RT-PCR multiplex 
que nous avons développée. Nos résultats démontrent que les différentes populations 
présentent des profils d’expression génique caractéristiques et distincts, reproductibles 
entre différents donneurs. L’expression de CD45RA est nécessaire pour identifier les 
cellules naïves, mais ne discrimine pas les différentes populations de cellules qui ont déjà 
rencontré l’antigène. Par contre, les profils d’expression génique des cellules T CD8+ 
CCR7– montrent une importante corrélation avec les niveaux d’expression de CD27 ainsi 
qu’avec la co-expression CD27/CD28. Une hiérarchie d’activation a été établie de la façon 
suivante : naïve < CD27high < CD27+CD28+ < CD28+CD27– < CD27+CD28– < CD27–CD28–. 
De plus, nous montrons que les cellules CD45RA+ et CD45RA– appartenant à ces sous-
populations ont des profiles d’expression génique identiques, au niveau qualitative et 
quantitative. Par ailleurs, nous avons identifié des sous-populations mineures avec des 
caractéristiques d’activation récente parmi les compartiments CD45RA+ et CD45RA–. Ces 
résultats suggèrent que la différentiation des cellules naïves T CD8+ en cellules effectrices 
n’oblige pas à une perte d’expression de CD45RA. Nous avons, donc, décrit des 
nouvelles populations T CD8+ et établis une corrélation entre le phénotype de surface et 




Following antigenic challenge, naïve CD8+ T lymphocytes undergo several 
changes, including the expression of cell-surface molecules. In humans, the 
association of CCR7, CD45RA, CD27 and CD28 is widely used to discriminate a 
reproducible set of functionally different subpopulations of CD8+ T cells. However, 
the prevailing data concerning the description of these subsets remains 
fragmentary, since a multitude of studies used a different and limited set of surface 
markers. Hence, some CD8+ T-cell subsets are still not clearly established, 
especially within the CCR7–CD45RA+ and CCR7–CD45R0+ compartments, and 
the correspondent differential roles and lineage relationships remain undisclosed. 
The present study aims to define a predictable and precise correlation 
between particular cell surface markers and CD8+ T-cell functional properties. We 
associated CCR7, CD45RA, CD27 and CD28 expression levels to subdivide CD8+ 
T cells into fourteen different cell types. These populations were further isolated 
and gene expression of 18 genes was assessed, simultaneously, in single-cells by 
a novel multiplex RT-PCR method we developed. Our results demonstrate that the 
different subpopulations display distinct and characteristic gene co-expression 
patterns, reproducible between donors. CD45RA expression is required to define 
the naïve subset, but does not discriminate functionally different populations of 
primed cells. In contrast, gene expression profiles of CCR7-CD8+ T cells correlate 
significantly to CD27 expression levels and CD27/CD28 co-expression, and a 
hierarchy of activation stages could be established as follows: naïve < CD27high < 
CD27+CD28+ < CD28+CD27– < CD27+CD28– < CD27–CD28–. Surprisingly, we 
found that CD45RA+ and CD45RA– cells of each of these subsets had the same 
gene expression patterns at both qualitative and quantitative level. Importantly, we 
identified minor subsets displaying characteristics of recent activation that could be 
found in both CD45RA+ and CD45RA– compartments. These findings strongly 
suggest that differentiation of naïve CD8+ T cells into effectors does not 
necessarily imply CD45RA downregulation. Furthermore, they describe novel 
CD8+ T cell subsets and establish a correlation between surface phenotype and 
























1. The immune system: an overview 
 
Every living being is continuously threatened by environmental aggressions, 
including other organisms. These threats have acted as selective pressures 
among evolution driving species to evolve several defensive mechanisms that 
allow them to escape and survive such dangers. In response to invading 
pathogens, eukaryotes have evolved an elaborate protective apparatus generally 
known as the immune system. The word “immune” comes from the Latin immunis, 
meaning “exempt”. In this way, an organism that is immune to a specific infecting 
agent is able to remain free from infection by that agent.  
The immune system functions in two distinct lines of defense: the innate 
immunity and the adaptive (or acquired) immunity. Types of immune response 
classified as “innate” are present already in almost all metazoans and depend on 
germ line-encoded receptors that recognize highly conserved pathogen-
associated molecular patterns. These responses are extremely fast and constitute 
the earlier line of action of the immune system. In addition to innate immunity, 
jawed vertebrates have evolved an adaptive immune system that provides highly 
specific immune responses to particular pathogens. In contrast to the immediate 
induction of defense mechanisms from innate immunity, adaptive immune 
responses can take several days to mount. However, acquired immunity can 
confer in many cases lifelong protection to re-infection with the same pathogen, a 
phenomenon also known as immunological memory (Pancer and Cooper, 2006). 
Innate immunity action is based on the recognition and killing of invading 
agents by phagocytes, a class of white blood cells (or leukocytes) specialized in 
the ingestion and digestion of unwanted materials. This cell type includes 
neutrophils and macrophages, which are the major players of the innate immunity. 
Other cells, called dendritic cells, are highly specialized in capturing antigen and 
present it to cells of the adaptive immune system. Cells of the innate immunity 
have a relatively short life-span and are thought to proliferate only in the 
generative hematopoietic tissues. Phagocytes express a large panel of surface 
receptors, such as integrins, scavenger receptors, Toll-like receptors, and others, 
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that recognize microbial conserved components and through which they can be 
activated to become effector cells. 
If the innate immune defenses are by-passed, evaded or overwhelmed, an 
adaptive immune response normally ensues. Adaptive immunity is mediated by a 
very important class of leukocytes with potential for self-renewal and clonal 
expansion that carries on the surface specific recognition molecules, the antigen 
receptors. Such cells are called lymphocytes and fall into two major categories: B 
lymphocytes (or B cells) and T lymphocytes (or T cells). B lymphocytes are the 
major players of humoral immunity, and T cells are responsible for cell-mediated 
immunity, but often they work in concert, and also with other types of cells, to 
accomplish an effective immune response. 
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2. Lymphocyte ontogeny and diversity 
 
All the cellular components of immune system develop from a population of 
multipotent and self-renewing hematopoietic progenitors, the hematopoietic stem 
cells (HSCs), which can be found in the adult bone marrow. HSCs differentiate into 
two main lineages: myeloid, which originates erythrocytes, megakaryocytes, 
granulocytes and monocytes, and lymphoid, which generates B, T and natural 
killer (NK) cells (Laiosa et al., 2006). 
Adult mammalian B lymphocytes develop in the bone marrow in a sequence 
of discrete stages that can be identified by the differential expression of several 
surface markers and are associated to the progressive rearrangement of the 
immunoglobulin (Ig) loci. These events lead to the formation of a highly specific B 
cell receptor (BCR) which is expressed on the surface of mature B cells. Once 
activated, B lymphocytes differentiate into plasma cells, which are highly 
specialized in antibody production and secretion. The antibodies, which indeed 
correspond to a secreted form of the BCR, specifically bind the antigen that led to 
B cell activation. This can result in neutralization or opsonization that leads to 
pathogen destruction by phagocytes or complement. 
 T-cell precursors also originate from adult bone marrow-derived cells. 
Although it is not yet clearly established where T-cell commitment occurs, T-cell 
precursors eventually migrate at a very early stage to the thymus, where the 
receptor gene rearrangements and T-cell maturation can occur. Similarly to B 
lymphocytes, T-cell differentiation is a stepwise process towards the generation of 
T-cell receptor (TCR) expressing cells. 
Unlike B cells, T lymphocytes recognize non-soluble antigens presented by 
highly polymorphic cell surface molecules generally known as major 
histocompatibility complex (MHC). T cells are said to be MHC restricted because 
they specifically recognize antigenic peptides presented by particular MHC alleles. 
MHC restriction is achieved during thymic T-cell development by positive selection 
of T lymphocytes recognizing self MHC-peptide complexes. In addition, a process 
of negative selection also takes place during T-cell maturation, leading to the 
deletion of lymphocytes with strong affinity to self peptides bound to self MHC 
molecules. Together, these two selection processes confer T lymphocytes the 
capacity of discrimination between “nonself” and “self”. 
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NK cells are also generated from the differentiation of common lymphoid 
progenitors. Unlike B and T lymphocytes, NK cells do not express clonally 
distributed receptors for antigen. For this reason, they are considered to belong to 
the innate immune system. However, they express a panoply of receptors, 
including inhibitory receptors specific for polymorphic MHC molecules. Such 
receptors enable NK cells to mediate “missing self recognition”, the capacity to 
attack self cells that extinguish expression of MHC class I molecules, such as viral 
infected or tumor cells. NK cells can thus recognize and exert strong cytolytic 
activity against cells with abnormal MHC expression, and also produce cytokines 
and chemokines that stimulate other immune functions.  
 
2.1. A glance on T-cell development 
 
The rearrangement status of TCR genes, together with the expression of 
TCR, the co-receptors CD4 and CD8 and other molecules on the cell surface, 
allow the discrimination of successive stages of T-cell differentiation in the thymus. 
Recombination events assemble the TCR coding sequence, which includes the 
variable (V), diversity (D), joining (J) and constant (C) gene segments that locate 
discontinuously in the genome. The program of T lymphocyte development can 
drive thymocytes into two distinct lines of differentiation: the γδ lineage, in which 
lymphocytes bear antigen receptors formed by a γδ heterodimer, and the αβ 
lineage in which the generated receptors consist of αβ heterodimers. For simplicity 
and because the aim of this manuscript does not cover the lymphocyte 
development issue, differentiation of γδ T-cells was omitted and only αβ T-cell 
development is described. 
In brief, TCR β-chain DJ rearrangements occur first, followed by VDJ 
recombination in a stage where thymocytes are triple-negative for CD3, CD4 and 
CD8 and are CD44low CD25+. A further productive rearrangement with a C gene 
segment allows the expression of low levels of the TCR β-chain at the surface, 
together with the invariant pre-α (pTα) molecule, a surrogate α-chain, and the CD3 
complex. In this stage, CD4–CD8– thymocytes have lost the expression of CD25. 
The expression of this pre-TCR signals the developing thymocyte to cease further 
rearrangements in the TCR-β locus (allelic exclusion) and to proliferate (β 
selection). After the proliferative burst, thymocytes acquire the expression of both 
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CD4 and CD8 co-receptors and rearrangements on the TCR α-chain locus begin. 
Rearrangements of the α-chain gene can occur continuously in both 
chromosomes even after the formation of a cell-surface receptor, which can 
generate in some cells more than one type of α-chain. These recombination 
events are ceased when CD4+ CD8+ double-positive cells undergo positive 
selection. This process favors the survival of thymocytes whose receptors 
recognize peptides bound to self MHC molecules and therefore occurs only after 
the expression at the cell surface of a productive αβ TCR. At this point, the type of 
co-receptor that will be expressed by mature T lymphocytes is also selected. 
Hence, TCRs recognizing peptides presented by MHC class II molecules lead to 
selection of the CD4 co-receptor, whereas lymphocytes whose TCRs recognize 
peptides presented by MHC class I molecules will develop into CD8-expressing 
cells. Positive selection therefore ensures that mature T-lymphocytes have antigen 
receptors capable of responding to peptides presented by self MHC molecules, 
selects the appropriate co-receptor and determines the functional commitment to 
the class of MHC molecule recognized. Finally, an additional process of negative 
selection leads to apoptosis of T cells bearing antigen receptors with high affinity 
to self peptides, thereby preventing the maturation of potentially self-reactive 
lymphocytes (Spits, 2002). 
 
2.2. Diversity of T-cell repertoire 
 
 TCR diversification occurs primarily in the thymus by stochastic 
recombination of VDJ gene segments. Diversity is further increased by imprecise 
joining of the recombinant segments, by random addition of non-germline 
nucleotides by DNA-repair machinery and through pairing of diverse TCR α and β 
chains, or γ and δ chains. In addition, diversity can be still enhanced in cells 
expressing more than one type of TCR due to the lack of TCR α-chain allelic 
exclusion, which results in the pairing of more than one TCR α-chain with the 
same type of β-chain. Whether these “secondary” TCRs have an effective function 
with self MHC molecules is not clear. The diversity of αβ-TCRs collectively 
originated by these events was estimated to be higher than 1×1015. Nevertheless, 
during intrathymic lymphocyte differentiation positive and negative selection 
significantly limit and shape the diversity of the generated repertoire by the loss or 
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enrichment of certain TCR specificities. The theoretical diversity of the peripheral 
TCR repertoire generated by this system was nevertheless estimated to be higher 
than 1×1013 – more than the number of T lymphocytes existing in a mouse (1-
2×108) or in humans (1×1012) (Nikolich-Zugich et al., 2004). Moreover, some 
lymphocytes express the same TCR due to homeostatic proliferation of naïve T 
cells and/or homeostatic and antigen-driven expansion of effector and memory 
populations. The potential achievable repertoire is therefore several orders of 
magnitude larger than the one that can be expressed in an individual. This extra 
variability is probably the basis of the differences observed in the expressed TCR 
repertoire of genetically identical or different individuals. 
 Surprisingly, estimates of the real diversity of TCR repertoire in mice and 
humans indicate that it may be much lower than the number of T lymphocytes 
these organisms can comprise. In humans, the actual number of different αβ-
TCRs was calculated to be about 2,5×107 and in mice 2×106 (Nikolich-Zugich et 
al., 2004). If these estimates are correct, the restriction of diversity in humans is 
much more important as compared to mice, which can be due to the longer 
longevity of humans, the need of higher clone sizes in this species, the fact that 
mice are genetically manipulated animals that are maintained in protected 
environments, etc. 
 In addition to the previously described mechanisms that generate TCR 
diversification, the spectrum of specificities of a given TCR is still increased by 
crossreactivity with several ligands, as TCRs can vary in the degree of 
specificity/promiscuity of peptide-MHC recognition. 
In summary, several mechanisms ensure the diversification of T-lymphocyte 
specificities. Because T-cell function relies on the ability to recognize the antigen 
presented by other cells; because the antigen universe is tremendously vast; and, 
finally, because the precise antigens derived from invading pathogens are 
unpredictable, the generation of a repertoire of T lymphocytes capable of 
responding to a broad range of antigens is fundamental for an efficient protection 




3. T lymphocytes: key players on adaptive immunity 
 
T lymphocytes are specialized in detecting and destroying pathogens that 
replicate inside the cells, such as some bacteria and other intracellular parasites, 
as well as viruses. Furthermore, T lymphocytes play a fundamental role in the 
immune surveillance against tumors. 
T cells fall into two main classes depending on the type of co-receptor 
molecule expressed. Lymphocytes expressing CD8 specifically bind peptides 
presented by MHC class I molecules, which derive from proteins synthesized and 
degraded in the cytosol. In turn, CD4+ T lymphocytes recognize peptides derived 
from proteins degraded in endocytic vesicles, which are presented by MHC class II 
molecules. These two types of T cells play distinct roles upon activation: CD4+ T 
cells differentiate into cells capable of delivering different types of signals to other 
cells, such as B lymphocytes and macrophages, and CD8+ T  lymphocytes acquire 
the ability of killing other cells, i.e., become cytotoxic. As both CD4+ and CD8+ T 
cells recognize foreign peptides presented by the MHC proteins of the target cells, 
T-cell function relies mainly on direct interactions between T lymphocytes and the 
cells presenting the antigen. In addition, T lymphocytes can also product cytokines 
that may have stimulatory or inhibitory effects in different types of cells and 
contribute, directly or indirectly, to pathogen clearance. 
 
3.1. Structure and function of the TCR 
 
T cells bear on their surface thousands of antigen receptor molecules that 
recognize specific antigen determinants presented by MHC molecules (Figure 1). 
TCRs are made up of two membrane anchored polypeptide chains, either α and β 
in αβ T cells or  γ and δ in γδ T cells (Garcia and Adams, 2005). Although they do 
not follow exactly the same differentiation processes, both αβ T cells and γδ T cells 
develop mostly in the thymus. In mice and humans, γδ T cells represent 1-5% of 
circulating T lymphocytes, but in epithelial tissues most cells express γδ receptors. 
The receptors of some of these epithelial γδ T cells show very restricted variability. 
In contrast, γδ T cells found in the blood, peripheral lymphoid organs or certain 
epithelial tissues as the gut, display highly diverse TCRs. Unlike αβ T cells, 
lymphocytes bearing a γδ TCR are not MHC restricted. They are implicated in 
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immunoregulation processes and tumor surveillance, as well as in some particular 
primary immune responses and wound healing. However, T cells that generally 
are responsible for antigen-specific cellular immunity are of the αβ type 
(Pennington et al., 2005). For this reason, this revision will focus only on αβ T cells 
and the generic terms TCR and T cell will always refer to the αβ T cells. 
During early T-cell development in 
the thymus, in a stage that precedes the 
rearrangement of the TCR α chain locus, 
thymocytes express a third type of TCR, 
in which the β chain pairs with a pTα 
chain. This pTα chain serves as 
surrogate for the TCR α chain and is 
actively involved in signaling via the pre-
TCR (Call and Wucherpfennig, 2005). 
Both α and β TCR polypeptides 
contain one constant and one variable 
regions. The antigen recognition site of 
the TCR is located in the variable 
domain and is formed by six loops 
named complementarity determining regions (CDRs). Each TCR chain contributes 
with three loops: CDR1, CDR2 and CDR3. The sequences for CDR1 and 2 are 
encoded by the V gene segments, but the outstanding TCR diversity relies on 
CDR3, which is created by the combinatorial and junctional processes between 
the V, D and J gene segments. In fact, the TCRα chain has a large number of J 
gene segments that, together with the diversity conferred by the D segments of the 
TCR β chain, accounts for the almost unlimited variability of the TCRs (Arden, 
1998). 
 
3.2. The CD3 complex 
 
The functionally complete TCR comprises also the CD3 invariant chains, 
which associate non-covalently with the variable α and β chains of the TCR (Call 
and Wucherpfennig, 2005). The CD3 complex subunits include the γ, δ, ε and ζ 
chains, with all but CD3ζ being structurally related (Figure 2). Indeed, CD3γ, CD3δ 












Figure 1. Structure of the T-cell 




and CD3ε are encoded in adjacent genes, while ζ chains are encoded elsewhere 
in the genome. The CD3γ, CD3δ and CD3ε proteins contain an Ig-like extracellular 
domain, a transmembrane region and a cytoplasmic tail that contains one single 
immunoreceptor tyrosine-based activation motif (ITAM). In turn, CD3ζ is largely 
intracytoplasmic, having only a short extracellular portion, and own 3 ITAMs in its 
cytoplasmic domain. 
Although the precise stoichiometry of the components that constitute a 
minimal TCR complex remains controversial, it is generally accepted that each αβ 
heterodimer associates with one CD3εγ heterodimer, one CD3εδ heterodimer and 
one CD3ζζ homodimer. In this way, each TCR would contain 10 ITAMs. 
Apparently the assemblage of TCR and CD3 chains depends largely on the 
interaction of the transmembrane domains, where the positively charged residues 
of the TCR interact with the negatively residues of the CD3 subunits (Arnett et al., 
2004; Call and Wucherpfennig, 2005; Rudolph et al., 2006).  
When the αβ heterodimer recognizes a specific peptide presented by the 
MHC complex, a cascade of signaling events are initiated via the ITAMs. The TCR 
αβ chains, however, have no functional relevant cytoplasmic domains and thus are 
not able to signal to the cell that antigen has bound. Therefore, while the αβ 
heterodimer recognizes and binds antigen, the CD3 complex is fundamental to 
transmit information from the external environment into the intracellular 
compartment, in form of signal transduction (Samelson, 2002). 
The CD3 subunits are also required for normal surface expression of the 
TCR αβ heterodimer in mature T lymphocytes. The expression of TCR-CD3 
complex is regulated in such a way that the absence of CD3 subunits results in 
defective or null TCR expression (Ashwell and Klusner, 1990). Moreover, 
deficiencies in the genes coding for the different CD3 subunits, which also 
associated with the pre-TCR, induce a blockade on thymocyte development before 
the CD4+CD8+ stage and impair the TCRα gene rearrangement. These evidences 
indicate that CD3 components have a role in the T cell differentiation (de Saint 
Basile et al., 2004; Fischer et al., 2005). 
In summary, the TCR consists of two functionally distinct types of 
components: two genetically variable chains, which account for the recognition 
and binding to the antigen/MHC complex, and the invariant chains of the CD3 




















3.3. The T cell co-receptors CD4 and CD8 
 
T-cell co-receptors, CD4 and CD8, are cell surface glycoproteins expressed 
by distinct subsets of mature T lymphocytes (Figure 3). Hence, lymphocytes are 
referred to as CD4+ or CD8+, depending on the type of co-receptor they express.  
During antigen recognition, the co-receptors associate with the TCR and 
bind the lateral face of MHC molecules. While CD4 associates with a constant 
domain of the MHC class II molecule, CD8 binds to invariant parts of the MHC 
class I molecule. Both co-receptors interact with MHC molecules in a domain that 
is distant from the TCR binding site, enabling the simultaneous association of CD4 
and TCR, or CD8 and TCR, to the same peptide-MHC complex. Binding of CD4 or 
CD8 to the same peptide-MHC complex than the TCR is believed to be required 
for T cell activation and is on the basis of the classification of CD4 and CD8 as co-
receptors (Janeway, 1992). 
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Figure 3. Structure of CD4 and CD8 molecules. 
CD4 is a single polypeptide chain molecule, made 
of four external immunoglobulin-related domains. 
Domains 1 and 2 (D1 and D2) have a unique 
strand topology, similarly to domains 3 and 4 (D3 
and D4), which are joined to the first domains by a 
flexible hinge. The CD8 molecule is a disulfide-
linked heterodimer of two polypeptides, α and β. 
Both chains contain an immunoglobulin-like 
amino-terminal domain linked to the membrane by 
an extended polypeptide region containing 
several O-linked sugars, which helps to maintain 
this stretch of polypeptide in an extended 
conformation and to protect it from cleavage by 
proteases. CD8α chains can also form 
homodimers, although these are not seen when 




One of the major functions of CD4 and CD8 is to increase the avidity of the 
interaction between TCR and MHC complex (Hampl et al., 1997; Luescher et al., 
1995). Furthermore, the cytoplasmic domains of CD4 and CD8 molecules interact 
strongly with components involved in the signaling cascade initiated upon antigen 
recognition, in particular the protein tyrosine kinase Lck (Veillette et al., 1988). 
Hence, the simultaneous binding of the co-receptors and the TCR to the same 
MHC:peptide complex brings Lck into close proximity to its targets, which 
associate with the cytoplasmic domains of the TCR complex. This enhances the 
tyrosine phosphorylation and further recruitment and activation of downstream 
signaling effector molecules (Germain, 2001).  
In summary, mature T cells that recognize antigen in the context of MHC 
class I molecules express CD8, whereas T cells restricted by MHC class II 
express CD4. Aggregation of the appropriate co-receptor with the TCR enhances 
enormously the sensitivity of a T cell to the antigen presented by MHC molecules. 
In addition, optimal signaling trough the TCR occurs only when it clusters with the 











3.3. T-cell receptor signaling 
 
3.3.1. Signaling events initiated upon antigen recognition 
 
The ITAMs are tyrosine-containing motifs that serve as sites of association 
with protein tyrosine kinases (PTKs) and other phosphotyrosine-binding moieties 
involved in receptor signaling. Upon antigen binding, the co-receptors CD4 or CD8 
are clustered with the TCR complex. Consequently, the receptor-associated PTKs 
are brought together and act on each other and on the receptor cytoplasmic tails 
to initiate the signaling process. 
The phosphorylation of the tyrosine residues of the ITAMs is the first 
intracellular signal indicating that specific antigen has been encountered. Two 
members of the Src family of PTKs mediate ITAM phosphorylation: Lck and Fyn. 
Lck interacts constitutively with the cytoplasmic domain of the co-receptor 
molecules CD4 and CD8 and is the predominant enzyme involved in ITAM 
phosphorylation (Rudd et al., 1989; Veillette et al., 1988). Fyn binds to the 
cytoplasmic domain of ζ and CD3ε chains upon receptor clustering. Both Fyn and 
Lck phosphorylate specific ITAMs on the accessory chains of the TCR complex 
(Samelson, 2002).  
The activity of Src-family kinases (SFKs) is regulated by the 
phosphorylation status of two regulatory tyrosine residues, one activating and the 
other inhibitory, on the enzyme active site. In thymocytes and T cells both tyrosine 
residues are usually not phosphorylated. In this state, the SFKs are ready to be 
activated and are said to be in a “primed” state. During the receptor clustering that 
follows antigen recognition, the SFKs are brought in close proximity and 
transphosphorylation events can occur, leading to the activation of SFKs via their 
activating tyrosine. In contrast, phosphorylation of the inhibitory tyrosine induces 
SFK to adopt a closed conformation that renders the enzyme inactive (Palacios 
and Weiss, 2004). Lck and Fyn can, thus, be simultaneously present in the cell in 
three different states: in an open and non-activated conformation (primed); in an 
open and activated conformation (phosphorylated in the activating tyrosine); and in 
a closed and inactivated conformation (phosphorylated in the inhibitory tyrosine). 
These forms can exist in an equilibrium that might be shifted by CD4 or CD8 co-








The PTK Csk (C-terminal Src kinase) is a key element in controlling the 
activity of SFKs due to its ability to phosphorylate their inhibitory tyrosine. In 
resting cells, Csk constitutively associates to transmembrane proteins. Membrane 
anchoring favors Csk proximity to SFKs that, in this way, are maintained in an 
inactive state by phosphorylation of the inhibitory tyrosine. Upon TCR ligation, Csk 
is released from its membrane anchor into the cytosol, which likely contributes for 




The transmembrane tyrosine phosphatase CD45, also known as leukocyte 
common antigen, has the opposite effect of Csk. This phosphatase specifically 
dephosphorylates the inhibitory tyrosine residue in the C-terminus of SFKs and it 
is considered to be a critical positive regulator of Lck and Fyn in T cells (Hermiston 
et al., 2003). Hence, the balance between the action of Csk and CD45 is one of 
the ways in which the activity of SFKs is regulated. 
All hematopoietic cells, with the exception of erythrocytes, express CD45 
proteins. In lymphocytes, expression of CD45 is so abundant that can reach 10% 
of their surface area (Dahlke et al., 2004). 
Structurally, the CD45 is a transmembrane protein with an extracellular 
region, a single transmembrane domain and a cytoplasmic tail. Only the 
cytoplasmic region, which contains two tandem tyrosine phosphatase domains, is 
required for enzymatic activity (Trowbridge and Thomas, 1994).  
CD45 exists as distinct isoforms generated by alternative splicing of the 
exons 4, 5 and 6 that encode part of the N-terminal extracellular domain. At least 
eight isoforms can be theoretically generated that are distinguished on the basis of 
antibody recognition. In this way, the isoforms containing the product of exon 4, 5 
or 6 are named CD45RA, CD45RB or CD45RC, respectively. The isoform 
generated by the complete splicing out of the three exons is called CD45R0. The 
amino-terminal region encoded by the exons 3 to 8 contains several O-linked 
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carbohydrates attachment sites. Therefore, the variable use of exons 4, 5 and 6 
changes the size, shape and overall charge of the extracellular domain 
(Trowbridge and Thomas, 1994). Alternative splicing of CD45 occurs during T-cell 
development and peripheral activation. The pattern of isoform expression is highly 
conserved amongst vertebrates, suggesting functional importance in vivo 
(Okumura et al., 1996). 
The natural ligand for CD45 has not yet been identified and the 
mechanisms involved in the regulation of CD45 activity are only beginning to be 
understood. The high regulation of isoform expression and the abundance of 
CD45 on the cell surface suggest a mechanism for regulating CD45 activity based 
on the spontaneous and isoform-differential homodimerization. Artificial 
dimerization of chimeric CD45 molecules inhibits the phosphatase function 
apparently by blocking the catalytic domain on the paired enzymes (Desai et al., 
1993; Majeti et al., 1998). Disruption of this regulatory mechanism leads to 
autoimmunity and lymphoproliferation in mice (Majeti et al., 2000). The 
extracellular domains of the different CD45 isoforms, which exhibit different 
numbers of O-glycosylation modifications, have a major influence in the 
homodimerization and, consequently, the activation status of the protein (Xu and 
Weiss, 2002). For instance, smaller molecular isoforms, which are less O-
glycosylated, dimerize more efficiently than larger isoforms. 
In human cord blood almost all CD8+ T cells express the high molecular 
weight (m.w.) isoform CD45RA (Hamann et al., 1997). With increasing age, CD8+ 
T cells express also the CD45R0 isoform. Actually, T cell activation induces a shift 
from high to low CD45 m.w. isoforms (Akbar et al., 1988). Consequently, the 
expression of CD45RA is down-regulated while CD45R0 expression is up-
regulated. In addition, expression of CD45RA appears to be re-acquired later in 
the immune response, with the concomitant loss of CD45R0 (Champagne et al., 
2001). These changes in cell-surface phenotype are one of the ways to distinguish 
naïve from antigen experienced cells, effector and memory, and will be discussed 
in more detail later in this manuscript. 
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3.3.2. TCR signaling final destination: the nucleus 
 
TCR activation following antigen recognition leads to phosphorylation of 
ITAMs. In the phosphorylated state, ITAMs can recruit the zeta-associated kinase 
(ZAP-70), which binds to the ITAMs in the ζ chain via its tandem SH2 (Src 
homology domain 2) domains. Recruitment of ZAP-70 allows its phosphorylation 
and enzymatic activation by either Lck or Fyn.  Active ZAP-70 then phosphorylates 
the membrane adapter protein LAT (linker of activation in T cells).  LAT contains 
multiple tyrosines that, once phosphorylated, serve as SH2-domain-binding 
regions. The cytoplasmic adapter SLP-76 (SH2 domain containing leukocyte 
phosphoprotein of 76 kDa) binds to phosphorylated LAT, and together these 
proteins act as sites for the recruitment of additional adapters and key enzymes 
involved in further downstream signaling events in T cells (Germain, 2001). 
Two main types of proteins containing SH2 domains participate in the signal 
cascade initiated by TCR triggering. The first one is phospholipase C-γ  (PLC-γ), 
which initiates two of the main signaling pathways leading to the nucleus. The 
second is Ras, a small G protein that initiates the third and major pathway, which 
consists in a cascade of protein kinases that leads directly to the phosphorylation 




PLC-γ is recruited to the cell membrane by its SH2 domains, where it is 
activated by phosphorylation of a tyrosine residue. In the active state, PLC-γ 
cleaves a molecule of the phospholipid membrane, the phosphatidylinositol 
bisphosphate (PIP2), into inositol trisphosphate (IP3) and diacylglycerol (DAG, 
Figure 4). One single molecule of PLC-γ is able to generate many molecules of 
DAG and IP3. Therefore, this and similar enzymatic steps contribute importantly to 
amplify and sustain the signal initiated by TCR ligation. Noteworthy, production of 
DAG and IP3 by activated PLC-γ is not exclusive from the TCR-signaling cascade, 
being rather a common step in signaling pathways of several types of receptors. 
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After cleavage of PIP2, diffusion of IP3 induces the release of Ca
2+ from 
intracellular storage sites in the endoplasmic reticulum (ER) into the cytosol. 
Intracellular free Ca2+ levels increase drastically, triggering the opening of calcium 
channels in the plasma membrane, which let in more Ca2+ into the cell, thus 
sustaining the signal. High levels of free Ca2+ induce activation of the Ca2+-binding 
protein calmodulin, which can associate to and regulate the activity of several 
other proteins, propagating the signal onwards along pathways that also 
eventually converge to the nucleus. 
 
The other product of PIP2 cleavage, DAG, remains linked to the plasma 
membrane and contributes to the activation of the protein kinase C (PKC). This 
serine/threonine kinase is believed to be important in initiating one of the main 
signaling pathways leading to the nucleus. PKC is additionally activated by the 
raise of Ca2+ concentration due to IP3 action. In this way, both products of the 




Like the other small G proteins, Ras can be present in the cell in two 
different forms, depending on whether it is binding GTP or GDP. When bound to 
GTP, Ras is in the active state. Since this form has an intrinsic GTPase activity, 
Ras can turn itself off by removing a phosphate group of GTP. The GDP-bound 
form of Ras is therefore inactive and is the predominant form found in the cell. 
Activation of small G proteins requires a guanine-nucleotide exchange 




Figure 4. Cleavage of PIP2 into DAG and IP3, an intermediate step in the signaling cascade 
initiated upon TCR stimulation. 
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the antigen receptor complex by adaptor proteins to which GEFs also bind, making 
therefore possible the activation of Ras. 
Activated small G proteins trigger a cascade of protein kinases named 
mitogen-activated protein kinases (MAP kinases). Localization and activity of MAP 
kinases depends on their phosphorylation status: non-phosphorylated MAP 
kinases are inactive and stay in the cytoplasm, but once phosphorylated become 
active and translocate into the nucleus. 
MAP kinases pathway has three major enzymatic levels. The first enzyme 
in the cascade is a serine/threonine kinase, generally called MAP kinase kinase 
kinase (MAPKKK or MAPK3), which is activated by the GTP-bound form of Ras. In 
the active form, MAPKKK phosphorylates the next downstream enzyme, the MAP 
kinase kinase (MAPKK or MAPK2). This class of proteins has the ability to 
phosphorylate MAP kinases, the last level enzymes, on both a tyrosine and a 
threonine residue, which induces MAP kinase activation. 
MAP kinases directly phosphorylate and activate transcription factors, a 
class of proteins that bind specific sites on DNA and regulate gene transcription. 
Transcription factors activated through MAP kinase pathway in consequence of 
antigen recognition usually regulate the expression of genes involved in 





Part II. T-cell immune responses 
 
The most remarkable feature of the acquired immune system is the capacity 
to generate immunological memory, i.e., a faster, stronger and more effective 
response against an antigen that has already been cleared in a prior immune 
response.  
In the course of a primary immune response, antigen presented by 
professional antigen-presenting cells (APCs) will drive specific naïve T-cell to 
proliferate and further differentiate. Several different outcomes are possible. In the 
case of CD4+ T lymphocytes, differentiation will induce the polarization of 
lymphocytes toward a T helper 1 (TH1) or TH2 phenotype, originating cells highly 
specialized in cytokine secretion (INFγ or IL-4, respectively). TH1 CD4
+ T 
lymphocytes are the main macrophage activators, potentiating inflammatory 
immune responses, whereas TH2 CD4
+ T cells activate B lymphocytes and 
promote immune responses predominantly mediated by antibodies. In the other 
hand, CD8+ T lymphocytes differentiation leads to the formation of cytotoxic T cells 
(CTL) that kill infected target cells. Upon differentiation T lymphocytes can also 
acquire regulatory properties, which enable them to modulate immune responses. 
In any case, cells generated upon differentiation are ready to respond quickly and 
efficiently upon encounter with the specific antigen and, thus, can be considered 
as “effector cells”. 
In the sequence of naïve priming and differentiation, another type of cells 
can further be generated, which have less stringent requirements for activation 
than naïve cells, are able to proliferate and acquire effector functions in a reduced 
lag-time, and have increased survival capacity. As these cells can survive for 
years in the organism, they were termed “memory cells”. 
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1. Primary immune responses 
 
1.1. APCs interact with naïve T cells in the secondary lymphoid organs  
 
The effective onset of adaptive immune responses requires that naïve 
antigen-specific lymphocytes, being inherently rare throughout the body, rapidly 
encounter foreign antigens. This problem has been elegantly solved in evolution 
through the development of secondary lymphoid tissues as intersections in the 
migratory pathways of antigen-presenting dendritic cells (DCs) and antigen-
specific lymphocytes. T-cell immune responses are therefore initiated in secondary 
lymphoid organs, where peptide-loaded APCs can encounter T cells bearing a 
specific TCR for the antigens they have uptaken in the periphery. Pathogens 
infecting peripheral tissues are captured by DCs that will be trapped in the lymph 
nodes directly downstream the site of infection. Nonetheless, antigen presentation 
can take place in other sites, such as the spleen, if infection takes place in the 
blood, or Peyer’s patches and tonsils, when pathogens invade mucosal surfaces. 
The secondary lymphoid organs are highly organized structures where B, T 
and antigen presenting cells can interact and initiate immune responses. Naïve T 
lymphocytes are continuously circulating from one lymphoid organ to another, via 
blood and lymph, until they encounter antigen. While migrating and prior to contact 
with specific antigen, naïve T cells are metabolically quiescent and have a 
prolonged lifespan, which depends on the successive contact with self-
peptide/MHC complexes and a cytokine, interleukin-7. Recognition of these 
ligands presumably delivers low-level signals, which keep T cells sufficiently 
metabolically active to avoid passive death (Sprent and Surh, 2002; Tanchot et al., 
1997). 
The migratory properties of naïve T cells do not enable them to enter the 
peripheral tissues. Therefore, naïve T lymphocytes can only recognize specific 
antigen and initiate immune responses in the secondary lymphoid organs (Sprent 
and Surh, 2002) (Figure 5). 
To get in lymph nodes and Peyer’s patches, but not in the spleen, T cells 
must cross the walls of the high endothelial venules (HEV). This event requires the 
interaction of molecules present in the plasma membrane of lymphocytes, such as 
selectins and integrins, and their corresponding ligands expressed by the cells of 
the vascular endothelium. Of particular interest are the L-selectin (also known as 
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CD62L) and the chemokine receptor CCR7 expressed on the surface of T cells. 
Interaction of L-selectin and the vascular addressins mediates T-cell rolling on the 
endothelium, which enables the interaction between CCR7 and its ligands, SLC 
and ELC (standing for, respectively, secondary lymphoid-organ chemokine, also 
known as CCL21, or Epstein–Barr virus-induced molecule 1 ligand chemokine, 
also known as CCL19). SLC and ELC are also expressed by stromal cells within 
the T cell areas in the lymphoid tissue and thus target T cells into these sites 
(Cyster, 1999; Zlotnik et al., 1999). Mice lacking CCR7 (through targeted gene 
deletion) or that have insufficient CCL19 or CCL21 (through naturally occurring 
mutation) have structurally disorganized lymph-node T-cell zones and are deficient 
in T-cell dependent immunity (Muller et al., 2003a). Interaction with ELC or SLC 
differs fundamentally in the ability to induce the internalization of CCR7, which 
occurs when this receptor interacts with ELC, but not SLC. Based on this finding, it 
was proposed that T lymphocytes enter lymphoid tissues mainly in response to 
Figure 5. Trafficking of cells of the immune system through the lymph node. 
Adapted from Charo et al., 2006.  
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SLC produced by HEVs. In this way, lymphocytes would retain full chemotatic 
responsiveness to ELC and SLC produced at similar levels in T-cell zones, 
therefore maintaining the ability to migrate into those areas (Bardi et al., 2001).  
When T lymphocytes reach the T cell-zones on the secondary lymphoid 
tissues they establish contact with APCs, in particular DCs, and scrutinize the 
peptides presented by MHC class I and II molecules on its surface. 
Typically, DCs are dispersed in nonlymphoid tissues as resident cells in a 
resting, immature state. Immature DCs are very efficient in capturing antigen, but 
are not capable of efficiently present antigens and activate T cells. This capacity 
only emerges after a complex developmental process called “DC maturation”. The 
antigen uptake associated to other signals, like the cytokine and chemokine 
microenvironment generated by local inflammation, drives immature DCs to 
undergo phenotypic and functional changes that culminate in the complete 
transition from an “antigen-capturing” cell to an “antigen-presenting” cell 
specialization. These modifications include changes in morphology, such as 
formation of dendritic projections, upregulation of co-stimulatory receptors (like B7-
1, B7-2, CD40 and CD58) and an overall increase in the levels of MHC class I and 
class II molecules on the surface. Another important property that accompanies 
maturation is the acquisition of high cellular motility and up-regulation of 
chemokine receptors, such as CCR7 (Mantovani, 1999). After antigen uptake DCs 
leave the inflamed tissues, enter the lymph stream and migrate to the secondary 
lymphoid organs. Here they are driven by gradients of CCL19 and CCL21 to the T-
cell zones where contact with T cells takes place and the DC maturation process 
is completed (Trombetta and Mellman, 2005). 
Interaction with T cells should start soon after DCs reach the T-cell zone 
because DCs are relatively short-lived cells, especially after activation, with a half-
life as low as 1–2 days upon arrival in the lymph node (Ingulli et al., 1997; Kamath 
et al., 2002). Yet recent in situ imaging studies suggest that individual T–DC 
couplings may last 37 h or longer (Stoll et al., 2002). Longevity and abundance of 
DCs in the site of T-cell priming influence the capacity to prime and the strength of 
the activating signals delivered to T cells (Josien et al., 2000; Wong et al., 1997). 
Evidence that enhanced DC survival potentiates T-cell activation has been 
demonstrated by studies of TRANCE, a TNF family member expressed on T cells, 
which can trigger its receptor, also known as RANK, on DCs enhancing their 
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viability (Anderson et al., 1997; Wong et al., 1997). A role for CD40L in regulation 
of DC survival has also been demonstrated (Quezada et al., 2004). 
The naïve T lymphocytes that do not encounter specific antigen leave the 
secondary lymphoid tissue by the efferent lymphatics and proceed circulation in 
the bloodstream and through the other secondary lymphoid organs. In contrast, if 
a specific peptide has been presented by the APC, T cells interrupt circulation to 
initiate a sequence of events that leads to the generation of effector cells. This can 
take several days and encompass two distinct processes: proliferation and 
differentiation. In the end, T cells can leave the lymphoid tissue also by the 
efferent lymphatics and re-enter the circulation to migrate to the sites of infection 
or, instead, stay within the lymph node to help B lymphocytes. 
 
 
1.2. Requirements for T-cell activation 
 
T-cell activation is a complex, multistep process involving a multitude of 
molecules. When T lymphocytes recognize the specific peptide on the surface of 
an APC, several protein-protein interactions are elicited in addition to the specific 
interaction between the TCR and the MHC-peptide complexes. As mentioned 
above, the co-receptors CD4 or CD8 are recruited to their binding sites on MHC 
class II or MHC class I, respectively, thereby lowering the threshold for T-cell 
activation. Moreover, interaction between co-stimulatory receptors, the most 
important of which is CD28, and their cognate ligands on the APC also occur. 
These co-stimulatory interactions are fundamental for effective lymphocyte 
activation and also enhance the immune response (Lenschow et al., 1996). 
Finally, it should be stressed out that for all these interactions to be possible, a 
stable adhesive junction must be formed between the T cell and the APC. 
Adhesion molecules like CD2, ICAM-3 or LFA-1, present on lymphocytes plasma 
membrane, play an important role in the efficient binding to APCs by interaction 
with molecules on their surface. 
After antigen recognition, the avidity of LFA-1 for ICAM-1 (standing for 
intercellular adhesion molecule-1), an integrin expressed on the surface of the 
APC, increases rapidly (Dustin and Springer, 1989). This leads to the formation of 
an adhesion complex between the T cell and the APC characterized by a specific 
pattern of receptor segregation with a central cluster of TCRs and one of its 
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downstream signaling effectors, protein kinase C-θ (PKC-θ), surrounded by a ring 
of integrin family adhesion molecules. This complex is known as immunological 
synapse (Grakoui et al., 1999) or supramolecular activation cluster (SMAC) 
(Monks et al., 1998), and facilitates and sustains TCR engagement and signaling 
(Bachmann et al., 1997). Large molecules such as CD45, also interact with the 
APC but are excluded from the SMAC (Huppa and Davis, 2003). 
In addition to the signal generated by TCR engagement, a second signal is 
often required to achieve full activation of T lymphocytes. This second signal is 
provided by ligation of molecules displayed on the lymphocyte surface and is 
complementary to TCR activation. For this reason, it is called co-stimulation and 
the molecules involved are known as co-stimulatory receptors. 
The immune system has evolved in such a way that only APCs display the 
molecules capable of delivering co-stimulatory signals to lymphocytes. This is 
particularly important to avoid activation of self-reactive T cells that have escaped 
thymic negative selection and might recognize specific peptides displayed by MHC 
class I molecules of tissue cells. Hence, the need for co-stimulation constitutes 
also a strategy of discrimination between self and non-self. Indeed, lymphocytes 
receiving a TCR-mediated signal 1 in the absence of an additional, accessory 
molecule-mediated signal 2 become functionally tolerant (for a review, see Baxter 
and Hodgkin, 2002). This is generally known as the “two-signal theory” of 
lymphocyte activation and supports that signal 2 is important not only for complete 
T cell activation but also to prevent induction of unresponsiveness. 
The major co-stimulatory pathway involves the binding of CD28 to its 
ligands, CD80 or CD86 (also known as B7-1 or B7-2, respectively). Co-stimulation 
by anti-CD28 antibody enhances T cell activation by decreasing the time of 
commitment, amplifying TCR signaling and protecting T cells from death (Iezzi et 
al., 1998; Lenschow et al., 1996; Viola et al., 1999). In addition to CD28, other 
molecules expressed by lymphocytes can mediate co-stimulation, such as several 
members of the tumor necrosis factor receptor (TNFR) family, like CD27 (Watts, 
2005). The biology and function of CD27 and CD28, as well as their role in 





1.3. Co-stimulation may be also required for full activation of T cells 
 
Optimal T cell activation is believed to require two signals: ligation of TCR to 
MHC-peptide complex (signal 1) and co-stimulation (signal 2). Several reports 
have described activation of CD8 cells without the need for co-stimulation, but this 
requires high dose or persistent antigen exposure and the use of TCR transgenic 
mice (Kundig et al., 1996; Luxembourg et al., 1998; Manning et al., 1997; Wang et 
al., 2000). In contrast, only in the presence of co-stimulation can low 
concentrations of antigen induce high CD69 expression, proliferation, and high IL-
2 production. A critical role for co-stimulation in activation of CD8+ CTL was also 
reported (Gajewski et al., 1996; Krummel et al., 1999). 
Co-stimulation enhances T-cell activation in two distinct ways: by promoting 
a more efficient engagement of TCR or, alternatively, by providing additional 
signals to induce cell division, augment cell survival or trigger effector functions, 
such as cytokine secretion or cytotoxicity. Multiple membrane receptors were 
identified as being co-stimulatory. These include receptors belonging to the 
immunoglobulin superfamily, such as CD28, or members of the TNFR family, such 
as CD27. Signaling through these receptors can engage molecules common to the 
TCR signaling cascade, thus improving quantitatively the signal initiated by the 
recognition of specific antigen. Alternatively, co-stimulation can involve the 
activation of signaling intermediate molecules distinct from those engaged by 
TCR, which can selectively induce particular cellular mechanisms. Importantly, 
expression of co-stimulatory receptors by lymphocytes varies along the T-cell 
immune response and also in consequence of the cytokine environment. This 
probably reflects the need of distinct signals at different stages of the immune 
response, the spectrum of co-receptors defining the type of alternative functions 
that might be promoted (reviewed by Acuto and Michel, 2003; Croft, 2003). 
 
 1.3.1 CD28 
 
 CD28 is an integral membrane protein homodimer that contains in the 
extracellular region one immunoglobulin-like domain. In humans, CD28 is 
expressed by ~90% of CD4+ and by ~50% of CD8+ T cells (Acuto and Michel, 
2003). CD28 binds to B7-1 (CD80) and B7-2 (CD86), two structurally homologous 
proteins, expressed on activated APCs, such as DCs, macrophages and activated 
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B cells. B7-1 and B7-2 also belong to the immunoglobulin superfamily and might 
exist as dimers and monomers, respectively (Figure 6). Mice deficient for either 
CD80 or CD86 show that they have partially overlapping functions (McAdam et al., 
2000). Differences in expression kinetics between CD80 and CD86 might explain 
the functional differences that have been observed. CD86 expression is induced 
on APCs early in the immune response and, thus, might be required for initiating 
immune responses. CD80, in contrast, is expressed later and is thought to deliver 
to T cells a more powerful signal, which might be crucial for regulating immune 
responses, perhaps by interacting preferentially with the inhibitory CD28 analogue, 
cytotoxic T lymphocyte antigen 4 (CTLA4) (Acuto and Michel, 2003; Margulies, 
2003). 
 
The main contribution of CD28-mediated signaling is to enhance IL-2 
production (Lucas et al., 1995; Reichert et al., 2001) and IL-2Rα expression 
(McAdam et al., 1998; Shahinian et al., 1993), and accelerate entry into and 
progression through the cell cycle (Bonnevier and Mueller, 2002). However, IL-2, 
as well as other common cytokine receptor γ-chain-dependent cytokines, do not 
have an important role in antigen-driven T-cell proliferation in vivo (Kundig et al., 
1993; Lantz et al., 2000) and in vitro, CD28-enhanced cell-cycle progression is 
partly IL-2 independent (Appleman et al., 2000). 
Co-stimulation via CD28 was shown to be required for CD8+ T cell 
activation in vesicular stomatitis virus and vaccinia virus infections, as well as in 
infection with Listeria monocytogenes (McAdam et al., 2000; Mittrucker et al., 
2001). However, CD28 co-stimulation is assumed to not be necessary for CD8 T-
cell priming following lymphocytic choriomeningitis virus (LCMV) infection (Suresh 
et al., 2001). Therefore, the role of CD28 co-stimulation in protective immunity 
Figure 6. Schematic 
structure of CD28 
and B7-1 and B7-2. 
Adapted from 
Margulies et al., 
2003. 
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differs for different pathogens, probably reflecting disparities in the activation of 
innate inflammatory responses. Alternatively, the lack of co-stimulation might be 
compensated by a very strong signal delivered trough the TCR, which probably 
relates to the abundance of specific T cells and/or the affinity of the TCR to 
particular epitopes, or by an additional helper effect. The non-cytolytic nature of 
LCMV, for instance, might allow the delivery of a uniquely strong and prolonged 
signal 1. In addition, a recent study has reported that CD28 co-stimulatory signals 
might be fundamental for CTL priming in the absence of CD4+ T-cell help (Voigt et 
al., 2006). 
Ablation of CD28 signaling by gene knockout of the receptor or both 
ligands, or by treatment with antagonists of CD28 has several distinct 
consequences, including reduced T-cell proliferation in vitro and in vivo, severe 
inhibition of germinal-centre formation and immunoglobulin isotype-class 
switching, reduced T helper-cell differentiation, induction of TH2-type cytokine 
expression and compromised cytotoxic CD8+ T-cell responses (for a revision see 
Acuto and Michel, 2003). Since CD28 stimulation occurs early in the immune 
response by APCs that are probably stimulating the TCR in parallel, in situations 
of particular low TCR occupancy, CD28 is unique in providing a potent synergistic 
signal to naive cells to effectively activate transcription factors such as nuclear NF-
κB, NFAT and AP1, which control cell proliferation, death and differentiation (Acuto 
and Michel, 2003). In addition, co-stimulation through CD28 up-regulates the 
expression of cytokines, including, IL-2, interferon-γ and IL-4 (McAdam et al., 
1998); chemokines, e.g., macrophage inflammatory protein-1α (Herold et al., 
1997); receptors for cytokines and chemokines, e.g., the IL-2 receptor, IL-12 
receptor and CXC chemokine receptor 5 (CXCR5) (Park et al., 2001; Shahinian et 
al., 1993; Walker et al., 2000); and receptors such as CD40L, CTLA-4 or inducible 
co-stimulatory molecule (ICOS), that will bind their ligands on APCs (Sharpe and 
Freeman, 2002).These events ensure the delivery of a second wave of signals 
(hours or days after the initial T-cell-APC encounter) in secondary lymphoid 
organs and/or after the migration to tissues, and are crucial for effector T-cell 





CD27 is a protein evolutionarily conserved between mice and man that is 
generally expressed in homodimers of 55 kDa on lymphocytes membrane 
(Camerini et al., 1991; Gravestein et al., 1993; van Lier et al., 1987). A soluble 
form of CD27 (sCD27), likely generated by proteolytic cleavage of the surface 
molecule, can also be found in activated T lymphocytes (Borst et al., 1989; 
Hintzen et al., 1991a; Loenen et al., 1992). 
CD27 has a constitutive expression on NK cells, antigen experienced B 
cells and naïve CD4 and CD8 T cells (reviewed by Croft, 2003; Watts, 2005). 
Similarly to CD28, expression of CD27 varies along the T-cell immune response 
and between distinct T-cell subsets (discussed later). 
CD70, also known as CD27 ligand (CD27L), is a TNF family member and 
the natural ligand of CD27 (Bowman et al., 1994; Goodwin et al., 1993; Hintzen et 
al., 1994). In contrast to CD27, which is constitutively expressed on resting T cells, 
NK cells and memory B cells, CD70 expression is only transiently induced upon 
activation of T cells, B cells and NK cells and on mature DCs (Bertram et al., 2004; 
Kashii et al., 1999; Tesselaar et al., 1997; Tesselaar et al., 2003b; Watts, 2005). 
The expression patterns of CD27 and CD70 in humans and mice are quite similar, 
with the exception of a higher frequency of primed B cells expressing CD27 in 
humans (Borst et al., 2005). 
CD70 expression is primarily controlled by antigen receptor and Toll-like 
receptor stimulation, but it can also be induced by anti-CD40 and GM-CSF. 
Following influenza viral infection, CD70 can be detected on T and B cells in 
draining lymph nodes (LNs) of mice. It can also be found in lung infiltrating T cells, 
but most of the protein is retained intracellularly, suggesting that CD70 expression 
at the surface is tightly regulated (Tesselaar et al., 2003b). In fact, CD70 over-
expression leads to a lethal immunodeficiency attributed to chronic stimulation, 
which may explain the need of a tight physiological regulation of this molecule 
(Tesselaar et al., 2003a). 
Interaction between CD27 and CD70 on T cells enhances TCR-induced 
expansion and promotes the generation of effector T cells with cytolytic function 
and IFN-γ-secreting capacity, as discussed below. The expression pattern of CD27 
and CD70 suggest several different landscapes of interaction: (i) in the T-cell 
priming phase, during the interaction between T cells and DCs; (ii) in the 
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expansion phase, through T-T cell interactions; and (iii) in the effector phase, 
between CD27 expressed on T cells and CD70 on DCs and B cells, which express 







Considering that co-stimulation refers to the need of a second signal in 
addition to those received through the TCR to achieve full T-cell activation and 
survival, CD27 can be considered a co-stimulatory molecule as its engagement 
enhances proliferation of CD4+ and CD8+ T cells, as well as cytokine production 
and survival.  In vitro studies revealed that unlike CD28, stimulation via CD27 does 
not induce strong production of IL-2 by T-cells in murine cells. However, it elicits 
TNF-α production at comparable levels to CD28, promotes development of 
cytotoxic T lymphocyte (CTL) effectors and enhances T-cell survival (Brown et al., 
1995; Hintzen et al., 1995; Hendriks et al., 2000; Ochsenbein et al., 2004).  
Figure 7. CD27-CD70 interactions in different phases of the immune response. 
Adapted from Borst et al., 2005. 
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Transgenic mice constitutively expressing CD70 show at 4 weeks of age 
increased numbers of CD4+ and CD8+ T cells displaying an effector phenotype. 
Nonetheless, these mice present a reduced number of mature B-cells due to a 
high CD27-dependent IFN-γ production by T-cells (Arens et al., 2001). The 
increment on IFN-γ production in CD70-Tg mice is not a mere consequence of a 
higher number of effector cells, but it is also due to increased IFN-γ production on 
a per cell basis. Consequently, mice over-expressing CD70 have enhanced CD8 
T-cell responses to influenza virus, as well as improved tumor rejection (Arens et 
al., 2004). On the other hand, such a constant delivery of co-stimulation signals 
seems to exhaust the immune system, as these mice die between 6-8 months of 
age from Pneumocystis carinii infection, a hallmark of T-cell immunodeficiency 
(Tesselaar et al., 2003a). This lethal immunodeficiency is ascribed to an antigen-
dependent conversion of the naïve T-cell pool into effector cells over time, thereby 
leading to the depletion of the naïve T-cell repertoire. This finding is in line with the 
tight regulation of CD70 expression observed in vivo. In fact, analysis of lung 
tissue and LN-derived cells of mice infected with influenza showed that CD70 
expression can be found in lung-infiltrating T cells, but not on B cells or CD11c+ 
DCs. Furthermore, it can be expressed on B and T cells recovered from LNs as 
well. In contrast, CD70 expression was virtually absent from lymphocytes of the 
LNs and lung of uninfected mice. Interestingly, confocal microscopy revealed that 
CD70 expression on the LN-derived cells was largely cytoplasmic, particularly on 
B cells. In addition, flow cytometry studies showed that plasma membrane 
expression of CD70 was detected only in a small fraction of CD3+ T-cells and this 
fraction was maximal on the peak of the response. These data indicate that CD70 
is induced in T and B cells upon in vivo activation, but is to a large extent retained 
intracellularly by transcriptional and post-translational mechanisms not disclosed 
yet (Tesselaar et al., 2003b). 
In CD27-deficient mice, reduced numbers of CD4+ and CD8+ effector T cells 
were found in the lung after primary and secondary infection with influenza virus 
(Hendriks et al., 2000). These observations imply that CD27/CD70 interaction 
regulates the size of the expanded T-cell pool in vivo. However, CD27 does not 
affect cell division of T cells, as no difference is found between the 
carboxyfluorescein diacetate succinimidyl ester (CFSE) profiles of wild-type and 
CD27 KO cells. Unlike CD28, that increases IL-2 production thus enhancing entry 
in cell cycle, CD27 rather appears to promote T-cell expansion by allowing 
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activated T cells to survive throughout successive rounds of division, especially at 
the site of infection. This is achieved by promoting the generation of a specific T-
cell pool on the LNs and, possibly, by the induction of lymphocyte migration to the 
site of infection and/or their survival at this site (Hendriks et al., 2003). 
The relative contributions of CD27 and CD28 co-stimulatory signals for 
cellular accumulation depend on the organ and on the type of response. Hence, 
during primary response to influenza virus in mice, generation of virus-specific 
CD8 T-cell pool in the draining LNs is highly dependent on the collective, partially 
non-redundant contribution of both CD27 and CD28. In the lungs, however, the 
absence of CD28 can be greatly compensated by CD27 as T-cell response at this 
site remains partially intact if CD27 signaling is available. Conversely, the 
secondary response in the lungs is more dependent on CD28 than primary 
response, while in LNs it remains relatively similar. In the spleen, the response is 
regulated in a slightly different way. In the primary response, lack of CD28, but not 
CD27, impairs at a great extent the accumulation of virus specific CD8 T cells, 
whereas upon secondary challenge memory responses were severely reduced by 
either CD27 or CD28 depletion. This evidence indicates that the role of CD27 in 
the spleen is much more significant in secondary responses (Hendriks et al., 
2003). 
Additionally, the fact that engagement of CD27 not only induces loss of its 
membrane expression but also the induction of effector functions corroborates the 




1.4. Strength of TCR signaling encompasses multiple components and 
can contribute for clonal selection 
 
The strength of antigenic stimulation is a complex parameter that 
encompasses several factors: first, the number of APCs, the density of peptide-
MHC complexes on their surface and the TCR avidity for the MHC-peptide 
complex, which together establish the antigen dose and determine the rate of TCR 
triggering; second, the density of co-stimulatory molecules, which determine the 
degree of signal amplification; and, finally, the duration of the APC-T cell 
interaction, which defines the extent of the signaling process (Lanzavecchia and 
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Sallusto, 2002). Collectively, these factors can make signal strength vary in 
several orders of magnitude, stimulating lymphocytes over a broad spectrum of 
conditions. Moreover, they can balance one another; for instance, a high level of 
co-stimulation might compensate a short-time APC-T cell contact, or a prolonged 
TCR stimulation might compensate for a low level of antigen. 
 The threshold of activation is not the same for all populations of T cells. This 
results from the different coupling status of the signaling machinery (Lanzavecchia 
and Sallusto, 2000). In naïve T cells, the components of the signaling apparatus 
are delocalized from the TCR and co-receptors. Upon antigen recognition, the 
kinases and adaptor proteins that mediate the signaling cascade initiated by TCR 
triggering are redistributed and associate preferentially with the proteins located on 
the membrane (Bachmann et al., 1999b). For this reason naïve T cells can take up 
to 20 hours of stimulation to be able to progress in the cell cycle. Co-stimulation 
can help to decrease the threshold of activation of naïve cells (Iezzi et al., 1998; 
Viola et al., 1999). Primed T lymphocytes, on the contrary, have the signaling 
machinery fully coupled and can be activated when stimulated for only 30 minutes 
or less, even in the absence of co-stimulation (Iezzi et al., 1998). In addition, 
memory cells are in a more advanced G1 phase of the cell cycle than naïve 
lymphocytes, expressing higher levels of active complexes of cyclin D and cyclin 
dependent kinase-6, a molecular complex crucial for progression through G1 and 
S phases of the cell cycle. The presence of high amounts of these molecular 
complexes in the cytoplasm is believed to confer to memory T cells a rapid cell 
cycle progression after re-stimulation and a lower threshold of activation than 
naïve cells (Veiga-Fernandes and Rocha, 2004). 
The capacity of each of the numerous clones activated in a primary immune 
response to achieve effective stimulation is strictly dependent on TCR affinity for 
antigen and on the capacity to compete with other cells, of the same or of other 
clones, for limiting resources, such as APCs, antigen and also cytokines. As these 
variables are important components determining the overall signal strength, cells 
expressing TCRs with different affinities receive dissimilar levels of stimulation and 
will likely have different activation thresholds. Interestingly, there is evidence that 
competition for antigen between T-cell clones occurs in human populations of T 
cells. A recent study reports that intrinsic properties of TCR avidity for antigen co-
segregate with distinct CD8+ T-cell clonotypes in the context of EBV infection 
(Price et al., 2005). Indeed, while dominant clonotypes exhibit high levels of TCR 
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avidity directly ex vivo, as well as more sensitive functional response profiles, 
subdominant clonotypes show the inverse behavior. This suggests that TCR-
dependent mechanisms could determine the optimization of the response during 
antigen-driven CD8+ T-cell expansion in chronic infection. Although the 
relationship between antigen avidity and functional sensitivity is nonlinear, such 
progressive evolution toward high avidity CD8+ T-cell usage amongst peripheral T-
cell repertoire is potentially advantageous in terms of improved effector function 
and control of viral replication (Alexander-Miller et al., 1996; Derby et al., 2001; 
Sedlik et al., 2000). In addition, another study concluded that an affinity threshold 
mechanism should operate during the peripheral selection and expansion of 
antigen-specific CD4+ T-cell populations to limit the competitive advantage of 
clonotypes with the highest avidity and prevent monopolization of the response 
(Malherbe et al., 2004). Such mechanisms would be of fundamental value to 
restrain proliferation of self-reactive T-cell clones with excessively high avidity that 
had escaped thymic selection. 
 
 
1.5. Signal strength determines T-cell fate 
 
The duration and strength of TCR stimulation are two important parameters 
that determine the cell fate. Interaction between one particular TCR and a MHC-
complex lasts only for few seconds and can trigger some effector functions, such 
as killer T-cell execution of target cells. However, the stabilizing effect of the 
immunological synapse allows T lymphocytes to stay in contact with the APC for 
several hours. This favors the interaction of multiple TCRs on the same 
lymphocyte with one single MHC-complex, sustaining the signaling necessary to 
induce and maintain some more complex functions, like proliferation (Timmerman 
et al., 1996). High levels of activation, however, can be deleterious in the way that 
T cells can be driven to undergo a process called activation-induced cell death 
(AICD) (Alexander-Miller et al., 1996; Lenardo et al., 1999). This process can be 
circumvented to some extent by up-regulation of the anti-apoptotic factor Bcl-XL, 
achieved by co-stimulation (Boise et al., 1995). 
After priming, T lymphocytes are committed to proliferate, generating large 
numbers of antigen-specific cells. Following the clonal-expansion phase, a large-
scale, programmed apoptotic episode occurs, resulting in a substantial reduction 
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in the number of antigen-specific T cells (Badovinac et al., 2002). The survival 
capacity – or “fitness” – of the lymphocyte sub-population that have escaped death 
results from the balance between resistance to cell death and responsiveness to 
homeostatic cytokines, like interleukin-7 and interleukin-15 (IL-7 and IL-15, 
respectively). T-cell survival is an important aspect that determines the extent of 
cell accumulation and, thus, the effectiveness of the immune response. Activation 
of T lymphocytes induces a marked raise in metabolic activity and mitochondrial 
volume, which are sustained by TCR and cytokine signaling that promote nutrient 
uptake and up-regulation of anti-apoptotic factors, such as Bcl-XL. On antigen 
withdrawal, loss of signaling through TCR and cytokine receptors reduces nutrient 
uptake and elicits expression of pro-apoptotic molecules. Therefore, in the course 
of the immune response antigen withdraw renders lymphocytes more susceptible 
to cell death and, in order to maintain their high metabolic activity in the absence 
of antigen, survival signals become strongly required (Plas et al., 2002).  IL-7 and 
IL-15, two constitutively expressed cytokines which sustain T-cell homeostasis, 
can be the source of such signals (Ma et al., 2006). Lymphocyte survival will, thus, 
depend on the expression of the corresponding receptors, together with the 
expression of anti-apoptotic factors. Interleukin 2 (IL-2), interestingly, is a cytokine 
expressed mainly on the antigen-driven phase and might play an opposite role to 
IL-15 in the control of memory T lymphocyte homeostasis (Ku et al., 2000). 
Lymphocyte fitness was reported to be strongly dependent on signal 
strength. Experiments in vitro and in vivo have demonstrated that a weak TCR 
stimulation leads to defective proliferation in response to homeostatic cytokines 
and cell death by neglect, whereas a stronger stimulation enhances T-cell survival 
and cytokine responsiveness. Two mechanisms implicated in lymphocyte survival 
were identified: (1) up-regulation of Bcl-XL and (2) expression of the IL-15Rα and 
γc chains, both improved in strongly stimulated T cells (Gett et al., 2003). 
Another fundamental consequence of lymphocyte activation is acquisition of 
effector functions, a phenomenon also called differentiation. Interestingly, 
differentiation of lymphocytes might also be strongly dependent on signal strength. 
In vitro stimulation of naïve CD4+ T cells with a weak stimulus can induce 
proliferation, but not further differentiation. Upon in vivo transfer these cells 
migrate to lymph nodes, proliferate and acquire effector functions. In contrast, 
naïve CD4+ T cells that have been stimulated with a stronger stimulus in the 
presence of IL-12 or IL-4, which drive T cell polarization towards a TH1 or TH2 
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phenotype, respectively, upon in vivo transfer are excluded from lymph nodes and 
migrate directly to peripheral tissues to execute effector functions. In vitro 
experiments with naïve CD8+ T cells have put in evidence that differentiation of 
these cells, similarly to CD4+, is also dependent on signal strength, as CD8+ T 
cells primed by a weak stimulus are committed to proliferation, but cells fail to up-
regulate anti-apoptotic molecules and the receptors for homeostatic cytokines. 
Accordingly, when transferred to a syngeneic host these cells do not survive (Gett 
et al., 2003). Moreover, CD8+ T cells given a sub-optimal stimulation fail to 
mediate cytotoxicity in vivo, a phenomenon that can not be overcome by 
transgenic expression of anti-apoptotic molecules (van Stipdonk et al., 2003).  
Collectively, these evidences point to the strength of the signals delivered 
by TCR and cytokine receptors as being fundamental factors that define T-cell 
fate. This led to the formulation of a theory for lymphocyte differentiation generally 
known as «progressive differentiation model», which will be discussed in further 
detail later in this manuscript.  
 
1.6. Lymphocyte differentiation and the pivotal role of cytokines 
 
Differentiation of T lymphocytes following antigen stimulation is a process 
that relies on transcriptional programs controlling the cell cycle, response to 
cytokines, migratory properties, effector function and survival capacity. Signals 
provided by the TCR and cytokine receptors synergize to induce specific 
transcription factors that mediate chromatin remodeling events, leading to the 
expression of specific target genes. According to the progressive differentiation 
model (described in detail in section 3.2), while some transcriptional programs 
would be activated at low levels of stimulation, others would require a higher 
strength of stimulation and further signaling through cytokine receptors. 
Cytokines play a crucial role in lymphocyte differentiation. These molecules 
are generally cell-secreted proteins that affect the properties or behavior of other 
cells upon recognition by a specific receptor. Some cytokines produced by T cells 
are also called interleukins (IL), some of which were already mentioned. The 
recognition of pathogens can induce DCs, macrophages, T cells and other players 
in the immune response to produce cytokines. The overall balance of the 
cytokines produced is, thus, determined by the differential interaction of pathogens 
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1.6.1. CD4+ T lymphocyte commitment into TH1 or TH2 cell types 
 
The polarization of CD4+ T lymphocytes towards a TH1 or a TH2 phenotype, 
for instance, is a phenomenon profoundly influenced by cytokines present 
throughout the initial proliferative phase of T-cell activation. TH1 and TH2 subsets 
develop from common T-cell precursors, rather than from distinct lineages (Abbas 
et al., 1996). These precursors are mature, naive CD4+ T lymphocytes that 
generally secrete IL-2 upon initial encounter with antigen. IL-2 is, thus, the earliest 
cytokine to be secreted during CD4 T helper polarization. IL-12 and IFN-γ, mainly 
produced by APCs in response to virus and some intracellular bacteria, as well as 
by activated T cells, drive CD4+ T lymphocytes to develop into a TH1 phenotype. 
IL-18 can also influence TH1 development by increasing IFN-γ production and 
proliferation of TH1 clones. An important impact on inducing CD4
+ T-cell 
proliferation was recently reported for IFN-γ (Whitmire et al., 2005a), which 
contrasts with other published data indicating a suppressive role for this cytokine 
in T-cell responses (Badovinac et al., 2000; Dalton et al., 2000; Refaeli et al., 
2002). The signature cytokine of TH1 subset is IFN-γ, but these cells secrete also 
large amounts of IL-2 and TNF-α and TNF-β. As a consequence of the cytokines 
they produce, TH1 lymphocytes are extremely efficient in eliminating intracellular 
pathogens, like Leishmania, via macrophage activation. In result, TH1-dominant 
immune responses are often associated with inflammation and tissue injury, the 
typical inflammatory reaction being delayed-type hypersensitivity (DTH) 
responses. Conversely, development of TH2 CD4
+ T cells is promoted by IL-4 and 
IL-6. The TH2 CD4
+ T subset secretes the cytokines IL-4, IL-5, IL-10 and IL-13, 
which accomplish for humoral immunity to helminthic parasites and are 
responsible for immune responses to persistent antigens, like allergens. In 
particular, IL-4 is the main inducer of B-cell switching to IgE production and is 
therefore a key initiator of IgE-dependent, mast-cell-mediated reactions; IL-5 is the 
principal eosinophil-activating cytokine, and mice deficient for IL-5 or its receptor 
show marked defects in eosinophil responses to helminthes; IL-4 and IL-13 
antagonize the macrophage-activating action of IFN-γ; IL-10 suppresses numerous 
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macrophage responses; and transforming growth factor β (TGF-β), a cytokine 
produced by some TH2 cells and many other cell types, is anti-proliferative and 
inhibits leukocyte activation; finally, TH2 cells are excellent helpers for B 
lymphocytes, as they stimulate the production of high levels of IgM and non-
complement-fixing IgG isotypes, such as IgG1 in mice, or its homologue, IgG4 in 
humans (Abbas et al., 1996; Glimcher and Murphy, 2000; Mosmann and Sad, 
1996; O'Garra, 1998). 
In addition to the above described subsets of CD4+ T lymphocytes, 
individual cells that do not exhibit a cytokine-secreted pattern that fits into the TH1 
or TH2 classification can often be found, especially in humans. These cells secrete 
a complex and heterogeneous set of cytokines with various combinations of IL-2, 
IL-4, IL-5 and IFN-γ, and sometimes IL-10 and TGF-β, which can accomplish for 
important functions but are not characteristic of either subset. Such mixed 
cytokine-producing cells have been classified as TH0 (Abbas et al., 1996). 
The TH1 and TH2 secreted cytokines endow the corresponding CD4
+ T 
subsets with the capacity of cross-regulate each other’s activity and development. 
For instance, IFN-γ produced by TH1 cells amplifies TH1 development and 
prevents proliferation of TH2 cells, whereas IL-4 and IL-10 inhibit the generation of 
TH1 cells. Therefore, the balance between TH1 and TH2 secreted cytokines 
determines the extent of polarization and the type of the prevalent immune 
response. Accordingly, when a T-cell immune response begins to develop along 
one pathway, namely TH1 or TH2, it tends to become progressively polarized in 
that direction. Furthermore, a regulatory function for TH2 subset has been 
proposed, in which these cells, owing to the anti-inflammatory cytokines they 
secrete, would help to limit the injurious consequences of TH1-mediated protective 
immunity. This hypothesis is based on the fact that, during in vitro T-cell activation, 
TH1 precede the development of TH2 responses (Croft and Swain, 1995) and 
predicts that TH1 responses would develop predominantly in early time points, 
when antigen concentration is not too high and the major APCs are DCs and 
macrophages, which secrete large amounts of IL-12, while TH2 committed 
lymphocytes would appear later in the response, when antigen doses become 
higher and antigen can be presented by APCs that do not produce IL-12, thus 
favoring TH2 polarization (Abbas et al., 1996). 
Expression of cytokines in CD4+ T helper cells is transient; after primary 
activation cytokines are expressed for several days (Assenmacher et al., 1998) 
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and, in later stages of the response, expression of cytokines is memorized. In 
result, upon re-stimulation, polarized CD4 T cells recall the expression of cytokines 
they had been instructed to express earlier (Murphy et al., 1996). One of the 
reasons that explains cytokine memory is the somatic epigenetic imprinting of the 
corresponding genes (Agarwal and Rao, 1998; Bird et al., 1998; Bix and Locksley, 
1998). Indeed, the cytokine genes that have been previously expressed in 
differentiated CD4+ T cells remain accessible, rendering possible their later 
expression after recall stimulation, whereas others remain silenced (Rengarajan et 
al., 2000). 
At the molecular level, differentiation of CD4+ T cells is orchestrated by up-
regulation of specific transcription factors. Two key transcription factors are 
involved in helper T-cell polarization: T-bet, which induces TH1 lineage 
development, and GATA3, which drives polarization towards a TH2 phenotype 
(Szabo et al., 2000; Zheng and Flavell, 1997). T-bet initiates TH1 lineage 
development from naive unpolarized cells both by activating TH1 genetic programs 
and by repressing the opposing TH2 programs. GATA3, in turn, activates the 
expression of TH2 prototypic genes, such as IL-4, IL-5, IL-6, IL-10 and IL-13, but 
does not abort the program for TH1 cytokine gene expression, as IFN-γ gene 
expression remains unaltered. Therefore, it is likely that other factors implicated in 
TH1 cytokine expression, like Stat-4, ERM, class II MHC transactivator (CIITA) or 
Hlx, are lost during TH2 polarization, just as gata-3 expression is lost in TH1 cells. 
In addition to GATA3, other transcription factors involved in TH2 differentiation 
were identified, including Stat-6, c-Maf, NF-IL6, NF-AT and AP-1. The precise 
contribution of each of these molecules, however, remains to be elucidated 
(Murphy et al., 2000; Szabo et al., 2000; Zheng and Flavell, 1997). 
 Expression of T-bet and GATA3 is up-regulated not only by the action of 
polarizing cytokines, but also by signaling through the TCR (Iezzi et al., 1999; 
Richter et al., 1999). Indeed, it had already been reported that the extent of T 
helper polarization can be influenced by the strength of TCR stimulation, as well 
as by the level of co-stimulation. In general, low antigen concentrations and 
conditions of low co-stimulation tend preferentially to induce TH1 responses, 
whereas high doses of antigen and co-stimulation potentiate TH2 development (for 
a review, see Abbas et al., 1996; Glimcher and Murphy, 2000). One possible 
explanation is that high levels of antigen lead to repeated TCR stimulation, thus 
increasing IL-4 production and TH2 development, or induce a state of 
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immunological unresponsiveness, which in general shuts off TH1 responses (De 
Wit et al., 1992). In the same line of reasoning, another possibility is that high co-
stimulation would promote TH2 responses by increasing the magnitude of the initial 
T-cell activation which, again, boosts IL-4 production and favors the IL-4-
dependent autocrine pathway of TH2 differentiation. TH1 polarization, in the other 
hand, relies on IL-12 secreted by APCs in parallel with some level of co-
stimulation (Murphy et al., 1994), but is less influenced by the magnitude of the 
TCR signaling. Interestingly, despite high levels of co-stimulation by APCs 
enhance TH2 development, fully differentiated TH2 cells respond to antigen without 
co-stimulation, whereas TH1 cells still require co-stimulation in order to become 
activated (McKnight et al., 1994; Seder et al., 1994). Finally, it has also been 
proposed that at high signal strength conditions T-cell polarization may possibly be 
accomplished even in the absence of cytokines (Lanzavecchia and Sallusto, 
2002). 
Lastly, it should be stressed out that the complete activation of naïve T cells 
is accompanied by profound changes in the homing behavior of these cells. 
Lymphocytes can modify their migration properties due to changes in the cell-
surface molecules, such as chemokine receptors and adhesion molecules 
(Bonecchi et al., 1998; Sallusto et al., 1998; Siveke and Hamann, 1998). Hence, 
while some lymphocytes keep the potential to home to the lymph nodes (by 
maintaining the expression of CCR7 and L-selectin), where they might be re-
stimulated by antigen and/or by survival-promoting cytokines, others acquire the 
capacity to migrate to inflamed peripheral tissues where they can finish their 
differentiation process or exert immediate effector functions. Interestingly, effector 
cells can be found in non-lymphoid tissues for prolonged period of time in a non-
dividing state (Reinhardt et al., 2001). However, whether these cells are long-lived 
or replaced over time remains to be clarified.  
 
 
1.6.2. CD8+ T lymphocytes differentiate into cytotoxic T cells 
 
TCR recognition of peptide–MHC class I complex on naïve CD8+ T cells, in 
conjunction with co-stimulatory and helper signals, invoke the typical events of an 
immune response that eventually culminate in the generation of memory: cellular 
activation, clonal expansion, differentiation into effector cytotoxic T lymphocytes 
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(CTLs) and contraction. CD4+ T-cell help is not always essential for CTL 
differentiation in primary immune responses, since activation of naïve CD8+ T cells 
can be often achieved when lymphocytes are activated in vivo by viruses, peptide-
pulsed DCs or tumor cells in the absence of CD4+ T cells (Dalyot-Herman et al., 
2000; Marzo et al., 2000; Marzo et al., 2004). These CD4+ T cell-independent CTL 
responses concern only the primary immune responses and occur especially in 
non-limiting conditions, such as high antigen-specific precursor frequency, high 
TCR affinity for antigen or a strong innate immune response. Conversely, in 
limiting conditions CTL responses are strongly dependent on CD4+ T-cell help and 
also on co-stimulation via CD28 (Zhan et al., 2000). 
Originally, help for the primary CD8+ T-cell response was thought to be 
mediated by cytokines secreted by CD4+ T helper cells, such as IL-2, which 
promotes CD8+ T cell proliferation in vivo (Keene and Forman, 1982). Later, CD4+ 
T-cell help has been shown to involve CD40–CD40L interactions between APCs 
and CD4+ T cells, leading to the APC activation required for the priming of naïve 
CD8+ T cells (Bennett et al., 1998; Ridge et al., 1998; Schoenberger et al., 1998). 
CD40L is a cell-surface molecule transiently expressed by recently activated CD4+ 
T cells which is involved in their activation and development of effector functions 
(Banchereau et al., 1994). More recently, a further interaction has been 
demonstrated between CD8+ and CD4+ T cells via CD40-CD40L (Bourgeois et al., 
2002a). In particular, it has been shown that mRNA coding for CD40 increases in 
T cells shortly after activation and CD40 protein expression is transiently induced 
at the surface of CD8+ specific T cells during the first days of the response. 
Moreover, when antigen specific CD8+ T lymphocytes, but not DCs, lack CD40 
defects in proliferation and cytokine production capacity were also observed, 
indicating CD4+ T cells can possibly deliver the helper signal via CD40L directly to 
CD8+ T cells expressing CD40 (Bourgeois et al., 2002a).  
Notably, CD4+ T-cell help was reported to be not essential for the initial 
activation, expansion and development of effector functions of naïve CD8+ T 
lymphocytes. However, memory CD8+ T cells generated in the absence of CD4+ 
T-cell help exhibit poor proliferative capacity and cytokine production upon in vitro 
re-stimulation (Bourgeois et al., 2002a; Janssen et al., 2003). The requirement for 
CD4+ T cells is apparently transitory, as in vivo depletion three days following 
priming have no deleterious effect on the generation of functionally competent 
memory CD8+ T cells (Janssen et al., 2003). Moreover, unaffected memory CD8+ 
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T cell responses can be generated in the absence of CD4+ T cells if help was 
provided during the primary response (Bourgeois et al., 2002b; Shedlock and 
Shen, 2003; Sun and Bevan, 2003). Together, these evidences indicate that CD4+ 
T cell help is fundamental for effective secondary responses, but it is only required 
during the initial stages of activation. Thus, imprinting for memory potentiality 
would be attributed during priming and would have a distinct nature from the 
signals that dictate the genesis of competent cytotoxic effector cells. 
The transition from naïve to effector and memory CD8+ T-cell populations is 
accompanied by marked and heritable changes in gene expression (Kaech et al., 
2002). Likewise CD4+ T cells, after priming the naive CD8+ T-cell precursors 
undergo genetic remodeling events that result in the expression of genes 
fundamental to CD8+ effector T-cell function, including genes that encode 
cytokines and chemokines, as well as genes associated with cytolysis. IFN-γ and 
TNF-α are the main cytokines induced following CD8+ T-cell activation but the 
hallmark of activated CD8+ T lymphocytes is the expression of cytolytic molecules, 
such as perforin, granzymes or Fas ligand (FasL).  
IFN-γ production by cytotoxic CD8+ T lymphocytes is a pivotal mechanism in 
the combat to viral infections. IFN-γ is a direct inhibitor of viral replication and 
facilitates antigen processing of viral peptides by inducing expression of MHC 
class I molecules, TAP (standing for transporter associated with antigen 
processing) transporter proteins and components of the proteasome, a protease 
complex responsible for degradation of cytosolic proteins, such as viral proteins, 
and the generation of peptides that can be presented at the cell surface by MHC 
class I molecules. 
Unlike naïve cells, which produce little IFN-γ, effector CD8+ T cells secrete 
large amounts of IFN-γ immediately after activation. The transition from naïve to 
effector CD8+ T-cell stage is controlled, at least in part, by the transcription factor 
T-bet. Expression of T-bet is induced early after T-cell priming by signaling through 
the TCR and also the IFN-γ receptor (IFN-γR). Similarly to CD4+ T cells and NK 
cells, which both require T-bet for control of IFN-γ production, expression of IFN-γ 
by antigen-specific CD8+ T lymphocytes is also dependent on expression of T-bet 
(Sullivan et al., 2003; Szabo et al., 2002). Moreover, in the absence of T-bet, CD8+ 
T cells fail to acquire a normal profile of effector cell-surface markers, such as 
downregulation of CD62L, an event associated with differentiation and activation. 
Curiously, these changes are masked if the T cells are activated in an antigen 
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non-specific manner (Sullivan et al., 2003), which suggests that the strength of the 
signal transduced by the TCR might play an important role. Finally, T-bet is also 
implicated in the development of cytotoxic effector functions, as T-bet deficient 
mice exhibit defective in vivo killing when compared to wild-type mice and fail to 
mount a protective response against LCMV infection (Sullivan et al., 2003). 
Nevertheless, the cell killing capacity was not completely abrogated in the 
absence of T-bet, demonstrating that other factors might have a role in this setting.  
There are also evidences indicating that, in the absence of T-bet, an intrinsic 
defective generation of viral-specific effector CD8+ T cells might occur (Glimcher et 
al., 2004; Juedes et al., 2004). 
The T-box transcription factor eomesodermin (Eomes), a paralogous of T-
bet, was recently identified as having a complementary action to T-bet in the 
development of cytolytic effector function and in the long term renewal of memory 
CD8+ T cells (Intlekofer et al., 2005; Pearce et al., 2003).  Eomes was originally 
known by its important role in development, for the determination of mesodermal-
cell fate in vertebrates. More recently, it was demonstrated that Eomes is 
expressed at low levels in naïve CD8+ T cells and that mRNA levels are markedly 
increased upon activation. As homozygous Eomes deficient mice die early in 
embryogenesis, the relative contributions of Eomes and T-bet in CD8+ T 
lymphocyte effector differentiation and function was evaluated using transfectant 
retroviruses that encode a dominant negative form of T-bet (DN T-bet) or Eomes 
(DN Eomes) and mice with compound mutations of T-bet and Eomes genes. In the 
absence of both T-bet and Eomes, IFN-γ production was shown to be severely 
compromised. Moreover, introduction of DN Eomes or DN T-bet (which targets 
both T-bet and Eomes) into CD8+ T cells from wild-type mice led to a greater 
defect in granzyme B induction than did gene deletion of T-bet alone, suggesting 
that Eomes might mediate an alternative, complementary pathway to T-bet for the 
induction of cytotoxic genes (Pearce et al., 2003). Indeed, inhibition of Eomes in 
activated lymphocytes lead to a substantial defect in killing capacity in vitro. In 
addition, haplo-insufficiency of Eomes (Eomes+/–) results in reduced levels of 
perforin mRNA, but IFN-γ transcripts are only minimally affected, which might be 
due to the partial knock-down and/or to the presence of normal levels of T-bet in 
these cells. Ectopic expression of Eomes by T-bet deficient CD8+ T cells can 
restore IFN-γ production, indicating that the regulation of IFN-γ  transcription might 
be under the control of both Eomes and T-bet. Additionally, Eomes over-
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expression in CD4+ TH2 polarized cells, a cell lineage normally devoided of 
cytolytic function, was shown to be sufficient to induce IFN-γ and cytotoxic gene 
expression (perforin and granzyme B). Furthermore, expression of Eomes 
correlates with the expression of the mRNA for the lytic molecules perforin and 
granzyme B in activated NK cells and CD8+ T cells. Together, these evidences 
indicate that Eomes not only controls IFN-γ production, but also appears to be 
fundamental for the expression of perforin and granzyme B by effector cells 
(Glimcher et al., 2004; Pearce et al., 2003). 
In addition to regulate cytotoxic programming, Eomes and T-bet seem to be 
cooperatively responsible for the responsiveness of primed cells to IL-15 by 
inducing expression of CD122, the receptor that confers the ability to respond to 
IL-15. Both T-box factors are necessary and sufficient to induce expression of 
CD122 in naïve cells that are differentiating into effector cells and also for 
maintaining high levels of CD122 expression in mature memory cells. 
Furthermore, loss of T-bet in Eomes haplo-insufficient mice renders the peripheral 
lymphoid organs devoided of IL-15-dependent lineages, a phenotype alike to IL-15 
deficiency (Intlekofer et al., 2005). However, the defect in cytotoxic function in 
compound T-box factor mutants is not shared by IL-15 pathway mutants, 
indicating that IL-15 responsiveness and effector function may be programmed in 
parallel by Eomes and T-bet. 
In conclusion, Eomes seems to complement the role of T-bet in governing 
cellular immunity by providing redundancy and, possibly, cooperativity in the 
induction of effector genes of T cells, as well as in the ability of memory cells to 
undergo IL-15-driven proliferative renewal. It would be interesting to investigate 
whether other memory related cellular events, such as signal transduction, survival 
and apoptosis, cell cycle regulation, etc, are also under the control of Eomes and 
T-bet. Moreover, the precise mechanisms by which these T-box factors control 




2. CD8+ T-cell mediated cytotoxicity 
 
 The main function of CD8+ T lymphocytes is the killing of infected cells. 
Lymphocyte-mediated cytotoxicity uses two alternative mechanisms to induce 
target cell death (Russell and Ley, 2002). The first one is a pathway initiated by 
FADD (Fas-associated via death domain) upon engagement of a target cell 
receptor by CTLs. Evidences from gene knock-out studies indicate Fas as the 
most physiologically important initiator of FADD pathway, although other receptors 
of the TNF receptor family, such as TNFR1 and TRAILR, can also mediate cell 
death by activation of this pathway (Kischkel et al., 2000; Sprick et al., 2000). The 
second killer mechanism is the localized exocytosis of cytolytic granules 
containing perforin and granzymes. Perforin is a protein that can polymerize to 
form membrane pores, which potentiates the traffic of granzyme proteins into the 
target cells where they subsequently initiate cell death through various 
mechanisms, including activation of caspase-independent mitochondrial and 
nuclear cell-death pathways, disruption of the plasma membrane and damaging of 
the DNA. The granule-exocytosis pathway encompasses several alternative 
mechanisms that depend on the spectrum of granzymes induced upon activation. 
This is, indeed, the crucial pathway for mediating cellular cytotoxicity against 
intracellular pathogens and tumors, although undoubtedly FADD-activating 
receptors and the secretion of cytokines are also important (Balkow et al., 2001; 
Muller et al., 2003b). 
 Both FADD and perforin/granzymes pathways require previous activation of 
the naïve CTL precursors in order to be induced. The same signals that instruct 
the lymphocyte to proliferate and become activated also induce de novo synthesis 
of Fas ligand (FasL) and cytotoxic granules. These armed CTLs can act very 
rapidly upon encountering specific antigen on other cells. Once formed, the 
granules can be reoriented and released within minutes of TCR stimulation into 
the region of contact between the target cell and the CTL, in the vicinity of the TCR 
activation cluster. Whether the architecture of the immune synapse has a 
physiological function in the reorientation and exocytosis of the cytotoxic granules 
remains poorly defined (O'Keefe and Gajewski, 2005). Activity of FasL has a much 
slower kinetics, since very little amounts of the molecule can be stored in the 
cytoplasm, even in activated cells, and induction of new ligand demands 1-2 hours 
of TCR stimulation. On the other hand, FasL has a long half-life (2-3 hours) on the 
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cell surface, which enables the effector cell to maintain cytotoxic activity even after 
TCR stimulation has ceased. In consequence, all the cells that express Fas in the 
surrounding area can be promiscuously killed, even those that do not express the 
antigen recognized by the TCR – a phenomenon known as bystander killing. 
Hence, the target killing via Fas can be much more promiscuous than cytotoxicity 
mediated by perforin and granzymes, once the vectorial release of granules to the 
contact site between the killer and target cells ensures exquisite specificity to the 
perforin-initiated killer pathway (Russell and Ley, 2002). 
 
2.1. FADD pathway 
 
Mechanisms of CD8+ T-cell mediated cytotoxicity induce cell death by 
activating apoptotic pathways on the target cells. These pathways basically consist 
of proteolytic cascades and commonly involve the activation of a particular type of 
protease cascade, the caspase cascade. These enzymes have a cysteine residue 
in the active site and mediate a specific cleavage at aspartic acid residues. The 
substrates of the various caspases are ultimately responsible for the 
morphological (cytoskeletal, nuclear membrane breakdown) and biochemical 
(DNA laddering) changes associated with apoptosis. 
In the case of Fas, interaction with the ligand recruits FADD to the 
cytoplasmic domain of the receptor. FADD interacts with caspase-8 through the 
corresponding death effector domains, which somehow induces caspase-8 
activation by cleavage of an inhibitory pro-domain. The active caspase is able to 
process downstream pro-caspases, as well as its own pro-caspase precursor. 
Caspase activation proceeds in a hierarchical manner throughout a series of 
proteolytic cleavage events of specific targets that culminates in activation of 
effector caspase-3, caspase-6 and caspase-7. It is finally the action of these 
molecules that leads to the proteolytic cleavage of the various cellular substrates 
responsible for the particular DNA fragmentation that characterizes apoptosis 
(Dempsey et al., 2003). 
Activation of the caspase cascade is referred to as type 1 apoptosis. An 
alternative type of apoptosis, called type 2 apoptosis, involves loss of organelle 
function. Signaling initiated by FADD, together with activity of Bcl-2 family proteins, 
plays a major role in regulating mitochondrial dysfunction on this second type of 
apoptosis. Bcl-2 and Bcl-XL are anti-apoptotic molecules that sequester pro-
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apoptotic proteins containing the homology motif BH3 (from Bcl-2 homology 
domain), such as Bak. The oligomerization of Bak at the surface of the outer 
mitochondrial membrane is thought to form intramembranous pore complexes that 
allow the release of cytochrome c to the cytosol. This process is, in turn, 
dependent on the proteolytic processing of Bid by activated caspase-8. The 
cleavage of Bid releases the potent pro-apoptotic truncated protein tBid that 
localizes at the outer mitochondrial membrane and drives the assembly of Bak 
proteins. The release of cytochrome c induces the oligomerization of apoptotic 
protease activating factor-1 (Apaf-1), a protein that interacts with caspase-9 and 
promotes, in the presence of ATP, the generation of a functional apoptosome. The 
apoptosome complex can cleave and activate procaspase-3 and, from this point 
on, the subsequent apoptotic events follow the same pathway as the one initiated 
by caspase-8. Thus, regulation of cytochrome c release by the receptor Fas is a 
balance between the activation of Bid and the inhibition of Bcl-2 related molecules 
(Dempsey et al., 2003). 
In contrast to Fas, TNFR1 (the main receptor for TNF-α) only signals for cell 
death in certain circumstances, like when protein synthesis is blocked. In this 
case, TNFR1 associates with TRADD which can interact with the death domain of 
FADD, thereby initiating the caspase-8 activation pathway. Nonetheless, TNFR1 
engagement is more likely to induce the activation of inflammatory genes. In this 
situation TRADD recruits TRAF1, TRAF2 and RIP, leading to the activation of the 
NFκB and JNK signaling pathways which initiate inflammatory responses and 
protect the cell from apoptosis (Dempsey et al., 2003). 
The relative contribution of FADD and granule exocytosis pathways for the 
control of intracellular infections, the main function of immune responses mediated 
by CD8+ T cells, has been analyzed using genetically deficient animals (reviewed 
by Russell and Ley, 2002). Indeed, each pathway assumes a different importance 
depending on the type of infection. Perforin is, in general, more important than the 
Fas pathway for clearance of pathogens, and abrogation of both mechanisms 
usually results in uncontrolled infection as, for instance, with neurotropic murine 
hepatitis virus. In this infection, perforin deficiency significantly delays viral 
clearance from the central nervous system, but absence of Fas has no effect, 
unless perforin is also absent. Interestingly, complete clearance of this infection 
requires IFN-γ. One possible explanation is that IFN-γ might up-regulate the 
expression of MHC class I or Fas on oligodendrites, thus increasing their 
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sensitivity to CTLs. Another example is infection with murine cytomegalovirus, 
which is absolutely dependent on perforin, but not Fas, for complete virus 
clearance during acute infection. However, apoptosis mediated by Fas is important 
in limiting chronic inflammatory disease. 
 
2.2. Perforin/granzymes pathway 
 
Antigen recognition by the TCR on CD8+ T lymphocytes activates 
transcriptional mechanisms that eventually lead to the production of cytotoxic 
granules and their constituent proteins. Concretely, cytotoxic granules are 
specialized lysosomes composed of perforin, granzymes and other lysosomal 
proteins, such as cathepsins, granulysin and calreticulin, which begin to be 
synthesized within one day after T-cell activation then become resident in the 
cytoplasm. Specific signals generated upon activation endow the secretory 
machinery of effector lymphocytes to direct the lytic granules to the site of contact 
with the target cell. Here, the granule fuses with the plasma cell membrane, and its 
contents are secreted into the tight intracellular junction formed between the two 
cells (Trambas and Griffiths, 2003). 
 
 




Perforin is a pore-forming protein that polymerizes on the plasma 
membrane in a Ca2+-dependent manner. Originally, this phenomenon was 
considered to induce direct damage to the plasma membrane, causing cell lysis 
identically to the complement. Nevertheless, it has been shown that perforin-
induced membrane damage is not sufficient to cause apoptosis (Duke et al., 
1989). Granzymes or other granule components are required to act in cooperation 
with perforin to transduce the apoptotic signal. Homo-polymerization of perforin on 
the surface of the target cell forms transmembrane pore structures that can act as 
a channel. These perforin channels were thought to act as a gateway for delivery 
of granzymes into the cytosol of the target cell, thus implying that productive 
cytotoxicity depends on the simultaneous expression and exocytosis of perforin 
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and granzymes. However, this idea has been questioned since the size of this 
pore is probably too small to permit large molecules like granzymes to enter target 
cells (Lieberman, 2003). Apparently, the size of the pore formed in the plasma 
membrane largely depends on the amount of perforin molecules available. The 
effective concentration of perforin present in the contact region between the CTL 
and their targets is, however, not known. Nevertheless, despite the precise 
mechanism of how perforin delivers granzymes is still undisclosed, perforin is 
unquestionably required for CTL-mediated cytolysis via the granule exocytosis 
pathway since the gene knock-out results in severe immunodeficiency against 
virus and tumors (Kagi et al., 1994). An alternative hypothesis to explain granzyme 
entry suggests that perforin-induced pore formation generates a signal for the 
target cell to repair the damage by endocytosing the perforin and surrounding 
plasma cell membrane; granzymes in the vicinity of the lesion would be also 
endocytozed and ultimately delivered to the target cell cytoplasm and nucleus, 
where they initiate the apoptotic events (Podack, 1999). 
 
Granzymes, cathepsins and calreticulin 
 
Granzymes are serine proteases with high specificity for substrate. One can 
find two clusters of granzyme genes in the genome of mice and men: the tryptase 
granzymes A and K gene cluster and the granzymes B, C, D, E, F, G and H gene 
cluster. Additionally, a third gene cluster was identified in humans, encoding 
granzyme M along with neutrophil serine proteases (Lieberman, 2003). As 
granzymes are positively charged proteins, they are non-covalently bound by 
charge, together with perforin, to the acidic granule proteoglycan serglycin. Inside 
of the granule, the acidic pH maintains granzymes in an inactive state, preventing 
damage of the lymphocyte itself by its own granule enzymes. Moreover, at least 
some granzymes (e.g. granzyme B) are synthesized in an inactive pro-enzyme 
form. Only after proteolytic cleavage of the inhibitory domain by cathepsin C (also 
known as dipeptidyl peptidase I), another component of the cytotoxic granules, 
these granzymes become active. In addition, calreticulin, a Ca2+-dependent 
chaperone protein that binds to perforin, is also present in the granules. This 
chaperone is thought to prevent perforin assembly in the granules, thus avoiding 
the exit of granzymes to the cytosol, which would led to autolysis of the CTL. 
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Another lysosomal protein present inside the cytotoxic granules is cathepsin 
B. This protein is thought to protect the CTL after exocytosis from its own cytotoxic 
molecules secreted into the synapse, by cleavage and inactivation of perforin 




A further granule component protein called granulysin has been identified in 
human, but not rodent, CTLs and NK cells. Similarly to perforin and the 
granzymes, granulysin is synthesized upon T-cell activation and localizes in the 
same cytotoxic granule compartment (Krensky and Clayberger, 2005). Granulysin 
is an effective antimicrobial agent related with virulence factors of amoebae, which 
has the ability to kill both intracellular and extracellular bacteria, as well as 
mycobacteria and fungi, by increasing their membrane permeability. Granulysin 
was also shown to display cytotoxic activity against mammalian tumors in vitro 
(Gamen et al., 1998). The homology with pore forming proteins suggests that 
granulysin might use this strategy to induce damage in the target cell membrane. 
In this way, granulysin could provide a backup strategy for perforin-membrane 
disruption in humans. However, there is no experimental evidence supporting this 
idea. Granulysin can induce mitochondrial depolarization and the release of 
cytochrome c as well. Nevertheless, granulysin-induced mitochondrial damage 
does not cause procaspase 9 activation via the classical apoptosome, but it still 
manages to activate caspase 3. Evidences suggest that granulysin-mediated cell 
death might require the presence of mitochondria in the target cell, as red blood 
cells are not lysed by granulysin, but reticulocytes are sensitive (Li et al., 2005). 
Moreover, it has recently been shown that granulysin also acts as a 
chemoattractant for monocytes, CD4+ and CD8+ memory (CD45RO+), but not 
naïve (CD45RA+) T cells, NK cells, and mature, but not immature, monocyte-
derived DCs. Furthermore, granulysin also induces the production of chemokines, 
including MCP-1 and RANTES, and cytokines, such as IFN-γ by monocytes. Thus, 
in addition to eliminating pathogens and tumor cells, granulysin helps to recruit 
immune cells to the sites of inflammation (Deng et al., 2005). Since a murine 
orthologue of this molecule has not yet been identified, the importance of 
granulysin for CTL function in vivo is still not completely understood. However, 
since most of the perforin-independent cytotoxic activity of CTLs in perforin 
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2.2.2. The universe of granzymes 
 
Target cell apoptosis induced by CTLs can be accomplished by both 
caspase dependent and independent pathways, depending on the acting 
granzyme set. For instance, granzyme A, C and granulysin trigger the caspase-
independent pathway of cell death, but granzyme B can induce both the caspase-




Granzyme B cleaves proteins preferentially after an aspartic acid residue, a 
common feature to caspases. Indeed, a vast number of procaspases can be 
cleaved and activated by granzyme B, such as procaspase-3, for instance. 
Cleavage of procaspases generally activates the downstream proteolytic cascade 
that culminates in the death of the target cell. Granzyme B was reported to 
activate other non-caspases substrates as well. The most important are Bid, which 
induces mitochondrial dysfunction (see above) and ICAD, the inhibitor of a 
nuclease known as caspase-activated DNAse (CAD) (Thomas et al., 2000). CAD 
is a nuclear protein that is retained in its inactive form by association with ICAD 
(inhibitor of CAD).  Cleavage of ICAD in result of caspase-3 or granzyme B activity 
facilitates the assembly of CAD into its active form, which mediates 
oligonucleosomal fragmentation of DNA and, ultimately, leads to cell death (Sharif-
Askari et al., 2001). 
Granzyme B induces rapid DNA fragmentation of target cells, as 
demonstrated in granzyme B deficient mice whose CTLs are unable to induce 
rapid target cell DNA fragmentation in vitro (Heusel et al., 1994). Using mice 
deficient for granzyme B, granzyme A or both  granzymes A and B, it has also 
been demonstrated that granzyme B plays an important role in vivo, in providing 






Granzyme A is the most abundant protease in the cytotoxic granules. Unlike 
granzyme B, it is also a component of the lytic granules of NK cells. Expression of 
granzyme A is activated approximately three to five days after naïve T cell priming 
and, in contrast to granzyme B and perforin, granzyme A continues to be 
expressed long after T-cell activation. By a poorly understood mechanism, upon 
delivery into the target cell along with perforin both granzymes A and B rapidly 
accumulate in the nucleus, where they can activate pathways of nuclear damage 
(Lieberman, 2003). 
Cellular death mediated by granzyme A is completely independent of 
caspases. However, it elicits cellular events common to those induced by the 
caspase pathway, such as chromatin condensation, nuclear fragmentation, 
externalization of phosphatidyl serine in the cell membrane and loss of 
mitochondrial transmembrane potential. DNA damage in the granzyme A pathway 
is provoked by single-stranded nicks that originate large DNA fragments. The 
enzyme that mediates these events is called NM23-H1 and is inhibited by a 
protein, SET, that is a direct substrate of granzyme A and belongs to a recently 
described multiprotein complex.  The SET complex is ubiquitously expressed and 
contains three granzyme A substrates: the nucleosome-assembly protein SET; the 
DNA bending high-motility group protein 2, HMG2; and the base excision repair 
(BER) enzyme apurinic/apirimidinic endonuclease 1, APE1 (Beresford et al., 
2001). The cleavage of either of these proteins by granzyme A destroys all of their 
known functions. When granzyme A enters the target cells, the SET complex 
translocates to the nucleus in few minutes (Fan et al., 2003a). Cleavage of SET 
unleashes the inhibition of NM23-H1, which then begins DNA nicking. The SET 
complex is, therefore, fundamental for granzyme A-mediated DNA breakdown. 
The relevance of NM23-H1 and SET in this setting was demonstrated by 
overexpression of NM23-H1 and silence of SET, which both increase DNA 
damage and cell death, and by further experiments in which diminished cell death 
was observed in targets with silenced NM23-H1 or enhanced SET expression 
(Fan et al., 2003a). To date, the normal physiological function of the SET complex 
was not completely demonstrated, but the functions of its different components 
strongly suggest a role in the regulation of chromatin structure, integrity and gene 
expression. Oxidative stress and granzyme A loading into the target cell induces 
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rapid translocation of the SET complex from the endoplasmic reticulum, to which is 
generally associated, into the nucleus. This raised the hypothesis that SET 
complex proteins are involved in the repair response to oxidative damage (Fan et 
al., 2003b). Indeed, granzyme A activity was recently shown to induce loss of 
mitochondrial transmembrane potential in a Bid and caspase independent ways 
(Martinvalet et al., 2005). The mitochondrial attack is apparently direct, does not 
require the SET proteins and is insensitive to Bcl-2 over-expression and caspase 
inhibition. 
In addition, granzyme A cleavage of APE1, a multifunctional repair protein, 
reinforces the apoptosis process initiated with activation of NM23-H1 by 
preventing cell recovery via repair (Fan et al., 2003b). 
Granzyme A displays two further activities that contribute to target cell 
death. The first one is the disruption on the nuclear envelope and chromatin 
integrity by the cleavage of lamins. These filament proteins constitute the main 
structural components of the inner nuclear envelope and provide anchor sites for 
chromatin and the nuclear pore complexes. Lamin cleavage is also elicited by 
caspases, which suggests that disruption of the nuclear lamina might be a 
requisite for inducing apoptosis by any means (Zhang et al., 2001a). The second 
additional granzyme A activity is degradation of the linker histone H1, which 
anchors the DNA around the core histones (Zhang et al., 2001b). Removal of H1 
histones opens up the chromatin and enhances DNA fragmentation by nucleases, 
which might account for the synergy action of granzymes A and B in the induction 




Granzymes of unknown function are referred as “orphans”. Apart from 
granzyme A and B, the granules also contain the granzymes H and K in humans 
and C, D, E, F, G, K and M in mice. Orphan granzymes are less expressed in 
CTLs than granzyme A and B. In mice, however, granzymes C, D, F and K have 
an important expression in NK cells, which might be related to specialized roles in 
the induction of target cell death in specific physiologic situations (Lieberman, 
2003). Granzyme C has been reported to induce rapid cell death by a distinct 
pathway from that induced by either granzymes A or B (Johnson et al., 2003). Cell 
death associated events induced by granzyme C include cell-membrane damage, 
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single-strand DNA nicking, mitochondrial swelling, depolarization and release of 
cytochrome c, which occurs via an apparently caspase-independent mechanism. 
In addition, recent studies using mice with deficient expression of granzymes C 
and F reports that these enzymes might be implicated in the control of the 
gammaherpesviruses in vivo (Loh et al., 2004; Revell et al., 2005). For granzymes 
H and M, substrate specificity has been determined to be chymotrypsin-like, 
although specific protein substrates have not been identified, nor has a pro-
apoptotic role yet been identified for granzyme H (Lieberman, 2003). Granzyme M 
is not expressed by conventional CD4+ and CD8+ T cells, but it is preferentially 
expressed by cells participating in innate immune responses, like NK cells and γδ 
T cells (Sayers et al., 2001). Recently granzyme M has been reported to induce 
perforin-mediated cell death by a unique mechanism not involving DNA 
fragmentation, caspase activation or mitochondrial involvement (Kelly et al., 2004) 
Additionally, a regulatory function was proposed to granzyme M, which was shown 
to cleave and inactivate the proteinase inhibitor 9, an endogenous inhibitor of 
granzyme B (Mahrus et al., 2004). 
It is possible that multiple granzymes activating distinctly different pathways 
to cell death provide alternative ways to induce apoptosis of target cells. This 
could be of great value if pathogens develop strategies to elude immune 
surveillance that directly inhibit specific granzymes. In addition, the fact that mice 
have evolved a more extended set of granzymes possibly reflects an evolutionary 
backup for protection from a more diverse set of microbial pathogens than that 
encountered by humans (it seems unlikely that selection pressure was provided by 
tumors, given the short reproductive cycle of mice). 
 




The TGFB1 (herein simply called TGF-β) is a pleiotropic regulatory cytokine 
involved in multiple biological processes in diverse cell types (reviewed by Li et al., 
2006). In the immune system, the central role of TGF-β is believed to be the 
maintenance of tolerance via the regulation of lymphocyte proliferation, 
differentiation, and survival. The differentiation state of target cells and the 
presence of additional regulatory signals, including co-stimulatory molecules and 
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inflammatory cytokines, influence TGF-β regulation of T cell activity (Cerwenka 
and Swain, 1999; Kehrl et al., 1986). In consequence, depending on the context 
TGF-β can induce distinct outcomes on the immune response and even play 
opposing roles. Accordingly, under some circumstances, TGF-β have a pro-
inflammatory action by promoting monocyte maturation into DCs (Geissmann et 
al., 1998; Jaksits et al., 1999; Strobl et al., 1996; Zhang et al., 1999) or by 
recruiting monocytes to the site of injury or inflammation via multiple mechanisms: 
it can act as a chemoattractant for monocytes (Wahl et al., 1987); it induces 
adhesion molecules, including LFA-1 and the fibronectin receptor on monocytes 
(Bauvois et al., 1992; Wahl et al., 1993), enabling their attachment to extracellular 
matrix; and it induces matrix metalloproteinases, which can dissolve vascular 
membranes and facilitate monocyte transmigration (Wahl et al., 1993). In addition, 
TGF-β can induce the expression of pro-inflammatory molecules on monocytes, 
like IL-1 and IL-6, thus potentiating inflammation (Turner et al., 1990; Wahl et al., 
1987). On the other hand, under different conditions TGF-β might also have an 
anti-inflammatory action by preventing the development of TH2 cells through 
inhibition of expression of GATA-3 (Gorelik et al., 2000; Heath et al., 2000). 
Interestingly, despite TGF-β inhibits naïve T cell proliferation, it has minimal effect 
on activated T cells (Cottrez and Groux, 2001). It is possible that TGF-β inhibition 
of naïve T cell activation in the absence of co-stimulation attenuates T cell 
responses to self-antigens under steady state, whereas reversal of TGF-β 
inhibition by strong co-stimulatory signals, which are often associated with 
infection, limits the suppressive activity of TGF-β during a normal immune 
response (Li et al., 2006). 
In addition to proliferation, TGF-β can also inhibit CD8+ T cell differentiation 
by preventing the expression of multiple effector molecules of CTLs. Early studies 
showed that CD8+ T cells activated in the presence of TGF-β do not acquire 
typical CTL functions, which is likely due to TGF-β inhibition of perforin expression 
in activated CD8+ T cells (Ranges et al., 1987). TGF-β inhibition of perforin 
expression was observed upon activation of resting T cells, implying perforin as a 
direct TGF-β target (Smyth et al., 1991). Co-stimulation through 4-1BB, a TNFR 
family member co-stimulatory receptor, was shown to reverse TGF-β inhibition of 
CTL differentiation, which is further enhanced by IL-12 but reduced by IL-4 (Kim et 
al., 2005). Therefore, TGF-β inhibition of CD8+ T cell differentiation is modulated 
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by co-stimulatory receptor and cytokine signaling pathways. TGF-β also inhibits 
FasL expression in T cell lines (Genestier et al., 1999), thereby affecting the death 
receptor cytotoxic pathway of CD8+ T lymphocytes. Further, TGF-β greatly 
attenuates IFN-γ expression in CD8+ and also in TH1 CD4
+ T lymphocytes, which 
relates with reduced T-bet expression (Ahmadzadeh and Rosenberg, 2005; Bonig 
et al., 1999). More recently, studies in the mouse suggested inhibitory effect of 
TGF-β on the expression of perforin, granzyme A and B, FasL and IFN-γ by CD8+ 
T lymphocytes occurs at the transcription level (Thomas and Massague, 2005). 
In the immune system, TGF-β can be produced by all the lymphoid cells 
and also by DCs, macrophages, mast cells and granulocytes. The function of 
TGF-β is mediated through a membrane receptor that can be formed by two or 
three subunits named TGF-β receptor (TGF-βR) 1, 2 and 3 (Li et al., 2006). TGFβ-
R2 can bind free ligand, whereas TGFβ-R1 can only recognize ligand that is 
already bound with TGFβ-R2 and formation of a ligand-induced complex involving 
both TGFβ-R1 and TGFβ-R2 is required for signaling. In contrast, TGFβ-R3 lacks 
a cytoplasmic domain and appears to function mainly in the concentration and 
presentation of TGF-β to TGFβ-R1 and TGFβ-R2. Signaling by these receptors 
occurs via Smad-dependent and Smad-independent pathways (for a review, see 
Massague, 1998). Figure 8 summarizes the main outcomes of TGF-β signaling 




2.3.2. Chemokines: a matter of attraction 
 
Chemokines are small and generally secreted molecules that play a major 
role in cellular trafficking and orchestration of lymphoid tissue architecture. Once 
released, they tend to remain concentrated locally, forming stable gradients that 
Figure 8. TGF-β regulation of 
immune responses. Adapted 
from (Li et al., 2006). 
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guide the cells expressing the correspondent receptors throughout these 
gradients. Thanks to this mechanism, it is possible that rare antigen-specific T and 
B lymphocytes encounter antigen, as well as several distinct types of cells interact 
with each other. Leukocyte traffic therefore represents a key element in the 
regulation of the immune response. By displaying a different panel of chemokine 
receptors at the surface, the cells gain selective access to different types of 
tissues. Hence, the selectivity and flexibility necessary to regulate cell traffic under 
homeostatic and inflammatory conditions is provided by a differential tissue 
distribution of chemokines and a regulated expression of chemokine receptors on 
different leukocyte subsets (Sallusto and Lanzavecchia, 2000). 
Chemokines and chemokine receptors are involved in the two distinct steps 
of leukocyte migration. The first is extravasation from the blood into lymph nodes, 
Peyer’s patches, and inflamed tissues, a phenomenon also dependent on 
selectins and integrins. The second step controlled by chemokines and chemokine 
receptors is the migration to and positioning of leukocytes within secondary 
lymphoid organs and tissues (Sallusto et al., 2000).  
Chemokines are classified into “lymphoid” and “inflammatory” based on the 
nature of the stimuli that induce their production and the site where it occurs 
(Sallusto et al., 2000). Lymphoid chemokines are produced within lymphoid 
tissues and are involved in maintaining homeostatic leukocyte traffic and cell 
compartmentalization within these organs. Inflammatory chemokines are produced 
by several cell types, including endothelial, epithelial, stromal and leukocytes, in 
response to a spectrum of inflammatory stimuli such as LPS, IL-1, and TNF-a. 
RANTES (acronym for regulated upon activation, normally T-expressed, and 
presumably secreted) and macrophage inflammatory proteins (MIP)-1 α and β are 
included in this subset.  
In accordance to their differential functions in the immune system, TH1 and 
TH2 CD4
+ T cells express a different panel of chemokine receptors. Lymphocytes 
that have differentiated towards a TH1 phenotype express preferentially CCR5, 
CXCR3, and CCR1, whereas in TH2 cells CCR3, CCR4, CCR8 and an orphan 
chemoattractant receptor, CRTH2 are the main chemokine receptors. CCR5 and 
CXCR3 are expressed also at lower levels on TH2 cells (Sallusto et al., 2000). 
Similarly to the previously described TH1/ TH2 feedback regulation, the 
cytokines produced by TH1 cells, namely IFN-γ, up-regulate TH1-attracting 
chemokines, such as RANTES, and antagonize TH2-attracting chemokines. 
 69 
Conversely, IL-4 and IL-13 produced by TH2 cells stimulate the expression of TH2-
chemokines, like eotaxin, and down-modulate the expression of chemokines 
induced by TH1 cells. TNF-α, a cytokine associated with both type 1 and type 2 
responses, co-stimulates production of both type 1 and type 2 chemokines. 
In respect to CD8+ T lymphocytes, expression of CXCR3, CCR4, CCR5 and 
CCR7 can be found in different subsets. The later receptor is particularly important 
for T cells to gain access to secondary lymphoid tissues and is expressed by naïve 
and a subpopulation of memory cells known as “central memory” (discussed 
below). Conversely, CCR5 confers to lymphocytes the ability to migrate for the 
peripheral inflamed tissues and its expression is up-regulated following activation 
(for a review, see Sallusto et al., 2000) A recent work reports a further function for 
CCR5 in enabling naïve CD8+ T cells to be directed to the sites where activated 
CD4+ T cells interact with professional APCs (Castellino et al., 2006). Upregulation 
of CCR5 constitutes therefore a pivotal step in the orchestration of the lymphocyte 
interactions, facilitating the encounter of CD8 with activated CD4+ T cells capable 
of delivering the appropriate helper signals necessary for the generation of 
memory CD8+ T lymphocytes. 
 
RANTES, MIP-1α and MIP-1β 
 
The chemokine RANTES is a potent chemoattractant and activator of 
several classes of leukocytes, including T cells. The principal roles of this 
inflammatory chemokine, inferred from early in vitro studies, are exerting selective 
chemoattractant effects on monocytes and T cells (especially from the CD45R0+ 
subset) and induction of transient changes in intracellular free calcium 
concentration in granulocytes and T cells (Kuna et al., 1992; Rot et al., 1992; 
Schall et al., 1990). In particular, RANTES induced calcium mobilization in T cells 
is biphasic, the initial, transient peak being predominantly associated with 
chemotaxis and the second, sustained one being associated with a spectrum of 
cellular responses characteristic of TCR activation, such as calcium channel 
opening, IL-2 receptor expression, cytokine release and T-cell proliferation (Bacon 
et al., 1995). These effects are directly related with the concentration of RANTES 
(reviewed by Appay and Rowland-Jones, 2001). At nanomolar concentrations, 
RANTES interact with a specific receptor (CCR1, CCR3, CCR4 or CCR5) to 
induce a transient calcium influx, which results in receptor polarization and cell 
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migration; however, at micromolar concentrations RANTES forms multimeric self-
aggregates that potentially crosslink multiple cell-surface signaling molecules, 
including CD3, which induced a prolonged calcium influx and leads to a 
generalized cell activation state. Whether high concentrations necessary for 
RANTES aggregation can be found in vivo is not known. In addition, RANTES 
promotes cell adhesion of T lymphocytes by up-regulating the expression of a 
variety of cell-surface adhesion molecules, such as CD44, CD50 and CD28 
(Szabo et al., 1997). Finally, an important anti-viral effect is also attributed to 
RANTES, as several viruses have developed a panel of evasion mechanisms to 
escape its effects (Appay and Rowland-Jones, 2001). The function of RANTES on 
anti-viral immunity might be related with the fact that it co-localizes with perforin 
and granzymes in the cytolytic granules of antigen-specific cells, being released 
along with those cytotoxic mediators following activation with the antigen (Wagner 
et al., 1998). 
Activated CD8+ T lymphocytes expressing CD45R0 are apparently the main 
source of RANTES in the immune system, as well as MIP-1α (Conlon et al., 1995).  
RANTES expression in T cells might be partially induced by TCR engagement and 
in endothelial cells the combined effects of IFN-γ and TNF-α have an enhancer 
effect on RANTES production at the mRNA and protein level (Dairaghi et al., 1998;  
Marfaing-Koka et al., 1995). Interestingly, RANTES mRNA is up-regulated late 
during T-cell activation (between days 3 and 5) and its expression is maintained in 
terminally differentiated T-cell lines (Schall et al., 1988). In the mouse system, 
expression of RANTES by memory CD8+ T cells was reported to be controlled at 
posttranscriptional level, by a TCR-dependent mechanism. High levels of fully 
matured transcripts coding for RANTES remain silenced in the cytoplasm and 
protein synthesis occurs only after TCR stimulation, independently of CD28 
(Swanson et al., 2002). 
 
MIP-1α and MIP-1β are two related chemokines mainly produced by 
activated macrophages, but also by other activated immunocompetent cells such 
as lymphocytes, neutrophils, DCs, mast cells and NK cells, and whose main 
function is to attract other proinflammatory cells to sites of inflammation. In 
addition, these chemokines, as well as RANTES, can potently inhibit the 
macrophage uptake of HIV-1 via CCR5 ligation (Cocchi et al., 1995; Horuk, 1999). 
Production of MIP-1α and MIP-1β is induced by various proinflammatory stimuli, 
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including LPS, viral infection, TNF-α, IFN-γ and others, and down-regulated anti-
inflammatory signals (like IL-4 and IL-10, for instance). Binding of MIP-1α and 
MIP-1β to their receptors, CCR5 or CCR1, elicits wide range of target cell 
functions including chemotaxis, degranulation and phagocytosis. In addition, as 
discussed above, as ligands of CCR5 these chemokines are likely involved in the 




3. Secondary T-cell immune responses 
 
 
CD8+ T-cell responses to specific pathogens are composed of distinct 
phases with different time-scales. The first phase occurs for a time-scale of few 
weeks and corresponds basically to the primary response after exposure to the 
pathogen, in which antigen-specific clones rapidly expand (by < 4-5 log), 
originating a population of effector cells. Subsequently, there is a massive 
contraction (by < 1-2 log) of the effector population which is programmed and 
independent of the magnitude of the initial expansion, antigen dose or duration of 
infection (Badovinac et al., 2002). The second phase involves the maintenance for 
a long time-scale (many years) of the small pathogen-specific population that 
escapes the contraction episode in the absence of re-exposure to the pathogen. 
Because these cells might potentially account for the control of a further infection 
upon re-challenge with the same pathogen, they are commonly named “memory 
cells”. The third phase consists of an increase in the number of this type of cells 
after re-exposure to the pathogen, which then provides protection. Exactly how 
protection is achieved is an item not completely understood. 
 
3.1 Memory T-cell responses are different from primary responses 
 
Memory T lymphocytes are distinct from the naïve counterparts in several 
ways, including surface markers, tissue distribution, activation status, kinetics of 
proliferation and differentiation, and requirements for survival. 
 
 
3.1.1. Memory cell subsets have particular turnover and activation 
properties  
 
 Antigen-experienced T lymphocytes can be subdivided in two major 
subsets, according to their rate of turnover in vivo and expression of activation 
markers. 
The first T lymphocyte subset is characterized by a relatively slow turnover 
(Geginat et al., 2003; Zimmerman et al., 1996), the absence of activation markers 
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and a similar pattern of distribution amongst lymphoid tissues to naive T cells 
(Sallusto et al., 1999b). Such non-polarized antigen-experienced lymphocytes 
were termed “central memory” T cells (TCM) and commonly express CCR7 and 
CD62L, which, likewise naïve T cells, enables their entry in the lymph nodes and 
Peyer’s Patches via high endothelial venules. Although dividing only sporadically, 
resting memory cells are less inert than the naïve lymphocytes because they 
express higher levels of RNA as compared to naïve cells, which suggests that 
many of these cells are in at the late G1 phase of cell cycle (Veiga-Fernandes et 
al., 2000). TCM have also a higher sensitivity to antigenic stimulation than naïve 
cells, are less dependent on co-stimulation, and up-regulate CD40L to a greater 
extent. Following TCR triggering, TCM produce mainly IL-2, but after proliferation 
they efficiently differentiate into effector cells that loose CCR7 expression and 
produce large amounts of IFN-γ or IL-4, in the case of CD4+ T cells, or cytotoxic 
mediators, in the case of CD8+ T cells (Sallusto et al., 2004). 
Other type of memory cells differ from the former described subset due to a 
clearly more activated state which closely resemble effector cells. For this reason, 
these cells were named “effector memory” T cells (TEM). This cell subset has a 
rapid turnover and is characterized by rapid effector function. Hence, CD8+ TEM 
carry large amounts of perforin, and both CD4+ and CD8+ TEM cells produce 
effector cytokines within hours following antigenic stimulation (Sallusto et al., 2004; 
Sallusto et al., 1999b). Human TEM are memory cells that have lost the constitutive 
expression of CCR7, are heterogeneous for CD62L expression and display 
characteristic sets of chemokine receptors and adhesion molecules that are 
required for homing to inflamed tissues (Sallusto et al., 1999b). Such activated 
memory cells are therefore found in the blood and spleen, but are largely excluded 
from lymph nodes due to the absence of lymph node homing receptors, CD62L 
and CCR7. Nevertheless, these cells do enter lymph nodes in small numbers via 
afferent lymphatic vessels (Yawalkar et al., 2000). 
The relative proportions of TCM and TEM in the human blood vary within the 
CD4+ and CD8+ T-cell compartments: TCM is predominant within the CD4
+ and TEM 
within the CD8+. The exact relationship between TCM and TEM cells in humans 
remains unclear. In particular, whether TCM and TEM subsets represent two distinct 
populations derived from different precursors during the primary immune response 
or, alternatively, TEM differentiate from TCM after the primary response, is still a 
matter of debate. The same expanded clones could be found in both TCM and TEM 
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subsets within the influenza-specific CD8+ memory T-cell pool for a period up to 
nine months, indicating that the same clonotypes can be present in both subsets in 
a stable way (Baron et al., 2003). However, in another study, the distribution of 
EBV-specific CD8+ T lymphocytes for lytic versus latent epitopes was shown to be 
different amongst TCM and TEM subsets and dependent on the stage (acute versus 
chronic) of infection (Hislop et al., 2002). Hence, lytic epitope responses were 
dominant in the acute phase of infection, while latent epitope specificities were 
barely detected, and both had a uniform TEM phenotype. In contrast, in the chronic 
stage of infection, where lytic epitope specificities were less abundant but in 
general still detected, and latent epitope specific cells were more frequent as 
compared to acute phase of infection, latent epitope responses show a greater 
tendency to acquire a TCM phenotype, while lytic epitope specific cells remain 
preferentially in the TEM compartment and show a propensity to express CD45RA, 
a phenomenon that will be discussed in further detail later in this manuscript. 
 
 
3.1.2. Memory cells provide quantitatively and qualitatively enhanced 
protection  
 
After the primary immune response, a fraction of activated T lymphocytes 
persist as circulating memory cells, which are able to give a quantitatively 
enhanced and qualitatively different response upon secondary challenge. First of 
all, despite the dramatic decline of T-cell number during the contraction phase, the 
precursor frequency of antigen-specific memory cells is far higher than for naïve T 
lymphocytes (Ahmed and Gray, 1996; Lin et al., 2000; Whitmire and Ahmed, 
2000). An increased precursor frequency of antigen-specific cells is one of the 
reasons why secondary immune responses are accelerated upon re-exposure to 
antigen, in relation to primary immune responses. However, the significantly 
improved efficiency of secondary immune responses is also due to other important 
properties inherent to memory cells. In the case of TCM lymphocytes, these include 
a shorter lag time for entering cell cycle, synthesizing cytokines, differentiating into 
CTL, and migrating to nonlymphoid tissues as compared to naïve cells (Cho et al., 
1999; Garcia et al., 1999; Iezzi et al., 2001; Kedl and Mescher, 1998; Rogers et 
al., 2000; Veiga-Fernandes et al., 2000). In addition, TCM cells are also less 
dependent on co-stimulation than naive T cells. In contrast, TEM cells exert 
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immediate effector function and cytokine synthesis in vivo without prior activation, 
following re-exposure with the specific antigen (Hogan et al., 2001; Lanzavecchia 
and Sallusto, 2000).  
The functional properties of TCM and TEM subsets are, thus, coordinated with 
their migratory routes: TEM cells are believed to patrol the nonlymphoid tissues, 
providing immediate protection upon encounter with antigen, whereas TCM cells, 
residing mainly within the secondary lymphoid organs, are reactivated by antigen 
in the draining lymph nodes where they activate APCs and undergo extensive 
clonal expansion, generating new waves of effector cells before migrating to 
nonlymphoid tissues. Despite the lag time associated to the reactivation of TCM, it 
is well established that both TCM and TEM are more sensitive than naïve cells to 
TCR stimulation and provide an improved immune response upon a second 
encounter with antigen (Lanzavecchia and Sallusto, 2000). In summary, due to 
their inherent differential functional properties, TCM and TEM subsets may play 
complementary protective roles on the immune response, depending on the nature 




3.1.3. Memory cells have distinct survival requirements  
 
In the absence of perturbation, the steady state number and diversity of T 
cells in the peripheral lymphoid compartment is controlled through generation, 
death, survival and turnover. These mechanisms are largely regulated through 
competition for extrinsic limiting resources, including contact with self peptide-
MHC complexes and cytokines such as IL-7 and IL-15 (Grossman et al., 2004; 
Tanchot et al., 1997). While both naïve CD4+ and CD8+ T cells require interaction 
with self peptide-MHC, as well as IL-7 for survival, memory cells can be 
maintained in the apparent complete absence of specific antigen (Garcia et al., 
1999; Tanchot et al., 1997; Veiga-Fernandes et al., 2000). Experiments of 
adoptive transfer of memory cells into MHC-/- hosts have shown that both CD4+ 
and CD8+ memory cells can survive for long periods without TCR stimulation (Hu 
et al., 2001; Murali-Krishna et al., 1999; Swain et al., 1999). Whether long-term 
survival in MHC-/- hosts applies to both TCM and TEM remains to be determined. 
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Although interaction with peptide-MHC is not vital for keeping memory cells 
alive, it is extremely important to maintain memory cell functional quality (Kassiotis 
et al., 2002). In addition, cytokines, in particular the pro-survival cytokines IL-7 and 
IL-15 constitutively produced by DCs and stromal cells in the lymphoid tissues, 
were shown to be very important in maintaining T-cell memory homeostasis 




 The specific role of IL-15 is to support proliferation of the CD8+ memory T-
cell population (Becker et al., 2002; Goldrath et al., 2002; Schluns et al., 2002; Tan 
et al., 2002). In accordance, CD122 (IL-2Rβ), a component of the receptor for IL-
15 (and IL-2), is selectively expressed in cells with a memory phenotype. 
Treatment with anti-CD122 monoclonal antibody considerably reduces normal 
turnover of memory cells in vivo, presumably because of a blockade of T cell 
contact with IL-15 (Ku et al., 2000). In the absence of IL-15 signals, antigen-
specific memory CD8+ T cells gradually decrease (Becker et al., 2002). This effect 
can be compensated by IL-7, but in the absence of both cytokines memory CD8+ 
T-cell homeostatic proliferation is completely abrogated (Becker et al., 2002). 
Nevertheless, naïve T cells also express the receptor for IL-7 and, thus, compete 
with memory CD8+ T cells for this cytokine. As naïve T lymphocytes largely 
outnumber memory CD8+ T cells, the compensatory effect that IL-7 might have for 
the absence of IL-15 is always extremely limited. Further, these evidences strongly 
suggest that regulation of the naive and memory pools is interdependent and the 





As mentioned above, multiple lines of evidence indicate that signals 
delivered by IL-7 are important for maintaining memory CD8+ T cells. The receptor 
for IL-7 (IL-7R) is composed of two chains: the IL-7Rα chain (CD127) and the 
common cytokine γ chain (γc, CD132), which is also part of the receptor for IL-2 
and IL-15 (Ma et al., 2006). The α chain of the receptor for IL-7, which is uniformly 
expressed by naïve cells, is down-regulated following activation but is further re-
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expressed on a subset of activated CD8+ T cells that progress to become memory 
CD8+ T cells. These evidences suggest that IL-7 may transmit the same survival 
signals to memory CD8+ T cells as it does to naive cells (Goldrath et al., 2002; 
Schluns et al., 2000). Consistent with this idea is the finding that memory cells 
survive poorly after adoptive transfer into IL-7-/- recipient hosts (Schluns et al., 
2000). A significant finding that might provide an explanation for this phenomenon 
was that IL-7 binding to its receptor increases expression of genes that promote 
lymphocyte survival and reduces expression of genes that induce lymphocyte 
apoptosis and cell cycle arrest (Khaled and Durum, 2003; Rathmell et al., 2001). 
Furthermore, expression of IL-7Rα parallels Bcl-2 expression, which is up-
regulated upon treatment with IL-7. Therefore, IL-7 and Bcl-2 apparently work in 
concert to regulate the survival of resting T cells (Akashi et al., 1997; Maraskovsky 
et al., 1997). 
In the case of memory CD4+ T cells, cytokine dependence is more 
controversial since some evidences indicate that memory CD4+ T cells are 
capable of homeostatic proliferation and antigen responses in the absence of 
signaling through γc receptors (Lantz et al., 2000; Tan et al., 2002), while other 
studies show that memory CD4+ T cells require IL-7 signals in order to maintain 
basal proliferation and survival (Kondrack et al., 2003; Lenz et al., 2004; Seddon 
et al., 2003). Interestingly, in contrast to the persistent CD8+ memory T-cell pool, 
the number of antigen-specific CD4+ memory T cells declines steadily over time, 
suggesting that CD4+ memory T cells might not be actively maintained (Homann et 
al., 2001). Therefore, identifying the factors that regulate CD4+ memory T-cell 
homeostasis requires further investigation. 
Interestingly, IL-7 binding to its receptor transiently down-regulates IL-7Rα 
on resting T cells (Park et al., 2004). This observation suggests the intervention of 
a feedback control mechanism in which T cells that have recently received an IL-7 
signal, by down-regulating expression of the receptor, will not compete with those 
that have yet to encounter IL-7. In this way, size of the peripheral T-cell 






Unlike IL-15 and IL-7, IL-2 has been reported to have an inhibitory role on 
memory CD8+ T-cell turnover (Dai et al., 2000; Ku et al., 2000). Since IL-2 is 
thought to play a supportive role in the activation of T cells (reviewed by Ma et al., 
2006), the finding that it might also have a restrictive effect on lymphocyte 
proliferation is intriguing.  One possibility is that IL-2 stimulates a suppressive 
population of IL-2-dependent regulatory CD4+ T cells (Annacker et al., 2000; 
Sakaguchi, 2000; Suzuki et al., 1999). Hence, the balance in the relative 
concentrations of IL-15 and IL-2 could represent a key mechanism for controlling 
memory CD8+ T-cell homeostasis. 
 
3.1.4. Cell surface molecules associated to memory phenotypes 
 
Antigen-experienced T cells express a spectrum of cell-surface molecules 
related to several functions, such as cell adhesion, migration, co-stimulation, 
survival, and others. Some of these surface markers are common to unprimed T 
lymphocytes, e.g., expression of CCR7 or CD27, and therefore can not be used to 
identify any specific subset per se (Hamann et al., 1997; Sallusto et al., 1999b). In 
contrast, low levels of CD62L or expression of CD45R0 in humans are exclusive of 
primed cells (Sprent and Surh, 2002). In addition, association of the expression 
profiles of several markers can be used to identify distinct sub-populations of 
antigen-experienced cells, such as the so called “central memory” 





A cell-surface molecule widely used to distinguish human naïve and primed 
T lymphocyte subsets is the leukocyte universal integrin CD45. In human cord 
blood almost all T cells express the CD45RA isoform, whereas cells expressing 
CD45R0 arise and accumulate progressively along life time of the individuals, 
reaching generally 40–60% of the total repertoire in the adult (Hayward et al., 
1989). In vitro activation of CD45RA+ T cells induces up-regulation of CD45R0 
with concomitant loss of expression of CD45RA (Akbar et al., 1988). In addition, 
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the switching for CD45R0 phenotype is coincident with the acquisition of the ability 
to provide help for antibody production by B cells and, further, when compared 
with the CD45RA+ counterparts, CD45R0+ T cells seem to have a lower threshold 
of activation (Byrne et al., 1988; Clement et al., 1988). Collectively, these 
evidences led to the assumption that the CD45RA+ population corresponds to un-
primed, naïve cells, while memory and/or effector cells are comprised within the 
CD45R0+ T-cell compartment (Dutton et al., 1998). If for CD4+ T cells there are no 
evidences to date arguing against this presumption, it became clear that for CD8+ 
T lymphocytes it was an oversimplification. Actually, nearly all CD4+ and CD8+ 
single-positive T cells from the cord blood and thymus express low levels of the 
integrin LFA-1 (Okumura et al., 1993). This lymphocyte ubiquitous cell-surface 
antigen, consisting of a heterodimer between the CD11a and CD18 molecules, 
plays an important role on binding to antigen presenting cells and is significantly 
up-regulated following lymphocyte activation. In the CD4+ T cells of the adult 
peripheral blood, a high level of LFA-1 is found uniquely in the CD45R0+ subset, 
as CD45RA+ T-cells are homogeneously LFA-1low. In contrast, despite the 
circulating CD45R0+ CD8+ T cells are also LFA-1high, the CD45RA+ compartment 
has a subpopulation that expresses high levels of LFA-1, in addition to the LFA-
1low subset (Okumura et al., 1993). 
With the emergence of the tetrameric MHC-peptide complex technology, 
identification of antigen-specific T lymphocytes became possible. Studies using 
MHC tetramers associated with immunogenic peptides from human infecting 
viruses, such as EBV, HIV and CMV, showed that the viral-specific CD8-T cell 
clones are distributed amongst the CD45RA+ and CD45R0+ LFA-1high subsets 
(Callan et al., 1998; Faint et al., 2001; Wills et al., 1999). The CD45RA+ LFA-1high  
CD8+ T subpopulation therefore comprises antigen-experienced cells. This 
conclusion was corroborated by the intracellular staining of these cells for effector 
molecules like perforin and IFN-γ (up to 85% and 93% of cells, respectively, were 
positive for those markers), as well as by the profile of expression of other cell-
surface activation-related molecules, such as loss of CD62L and expression of 
CD57 (Faint et al., 2001; Vargas et al., 2001). In conclusion, expression of the 
CD45RA isoform can accurately be used to identify human naïve CD4+ T 
lymphocytes, but for CD8+ T cells CD45RA does not absolutely discriminate 
between naïve and antigen-experienced cells. Instead, an additional activation 
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marker is required, such as LFA-1, in order to differentiate the naïve (LFA-1low) 
from the antigen-experienced (LFA-1high) CD45RA-expressing cells. 
Some markers used to define memory cells were reported to be partially 
reversible on late memory cells (Walker et al., 1995; Wills et al., 1999; Zimmerman 
et al., 1996). This is the case, for instance, of CD62L and CD45RA, which are 
expressed at very low levels in some subsets of antigen-experienced cells, but 
whose expression can be found in other primed lymphocyte subsets. 
Nevertheless, it is unclear whether this reversion is real, or reflects preferential 
survival of cells that failed to lose these markers during the primary responses 
(Pihlgren et al., 1996; Wills et al., 1999). This ambiguity also applies to CCR7 
expression in human central memory population (Sallusto et al., 1999b), since up 
to date it has not yet been clearly demonstrated if this population can directly 
result from activation of naïve T cells, where CCR7 expression is never lost or, 
instead, derives from effector memory cells that have reacquired CCR7 
expression, or both. 
 Finally, other cell-surface molecules, such as CD28 and CD27, are thought 
to be irreversibly lost during the differentiation process in which initial naïve T-cell 
precursors are converted into fully mature effector and memory T cells. These 




In the adult human peripheral blood it can be found a CD8+ T-cell 
population that have lost surface expression of CD28. This population expands 
under conditions of chronic activation of the immune system, such as viral 
infections, autoimmune diseases, bone marrow transplantation or tumors, and also 
in the normal process of ageing. CD8+ T lymphocytes specific for viral peptides of 
EBV, HIV and CMV were detected within the CD28- compartment and cells with 
this phenotype express perforin at considerable levels (Appay et al., 2002; 
Borthwick et al., 2000; Posnett et al., 1999). CD28- CD8+ T cells are nevertheless 
absent from the thymus and only very low frequencies have been detected in cord 
blood. Therefore, these cells clearly constitute an antigen-experienced subset. In 
accordance, they are morphologically large, granular lymphocytes that express, 
amongst other cell-surface activation associated molecules, CD57 and high levels 
of LFA-1 (Azuma et al., 1993). In addition, CD28- CD8+ T cells produce high levels 
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of IFN-γ in vivo and mediate potent cytolytic activity in vitro, but display poor 
proliferative capacity and significantly shorter telomeres when compared to the 
CD28+ subset, which suggests a history of increased cell divisions (Batliwalla et 
al., 2000). Long-lived TCR oligoclonal Vβ expansions can also be found in vivo 
within the CD28- population. Furthermore, evidences from in vitro studies indicate 
that firstly, CD28+ CD8+ T cells relatively prone to apoptosis, which is consistent 
with the high proliferation rate observed in this population; secondly, CD28- CD8+ 
T cells originate from CD28+ CD8+ precursor cells; and lastly, CD28- CD8+ T cells 
are relatively resistant to apoptosis when compared with their CD28+ CD8+ 
precursors. Therefore, CD8+ T lymphocytes that escape apoptosis might mature 
into CD28- CD8+ perforin-expressing effector cells (Posnett et al., 1999). Finally, 
several factors were shown to influence the loss of CD28 on CD8+ T lymphocytes 
in vitro, such as proliferation and the presence of type I interferons (IFN-α and 
IFN-β), a type of cytokines that are produced during viral infections and indirectly 
promote the clonal expansion of CTLs in vivo (Borthwick et al., 2000). Taken 
altogether, these evidences suggest that CD28- CD8+ T lymphocytes are terminal 
differentiated cells that have evolved by several rounds of division from CD28+ 




As described previously, CD27 has a constitutive expression on NK cells, 
antigen experienced B cells and naïve CD4+ and CD8+ T cells (reviewed by Croft, 
2003; Watts, 2005). CD27 is transiently upregulated after T-cell activation in vitro, 
the peak expression level occurring between 24 and 72 hours, which suggests 
CD27 is important early in the response (de Jong et al., 1991; Gravestein et al., 
1993). Furthermore, activation induces the production of the soluble form of CD27, 
which can be found in the supernatant of activated lymphocyte cultures and in the 
body fluids of healthy individuals as well (Hintzen et al., 1991b; Hol et al., 1993). A 
recent report describes that surface expression of CD27 can also be transiently 
downregulated by days 5 to 9 after stimulation in cultures of viral-specific human 
CD8+ T-cell clones (Ochsenbein et al., 2004), but in vivo evidence of such 
phenomenon was never found. Later in the response, expression of CD27 can be 
irreversibly lost, likely after CD8+ T cells had undergone several rounds of division 
(Hamann et al., 1999; Rufer et al., 2003; Ochsenbein et al., 2004). Conversely, in 
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CD4+ T-cells CD27 expression can apparently be down-regulated without 
substantial cellular division (Baars et al., 1995). 
Adoptive transfer of an autologous HIV-specific CD8+ T-cell clone expanded 
in vitro and followed in vivo for more than 3 months revealed a propensity for 
CD27– cells to disappear, while CD27+ infused cells persisted at large numbers at 
day 104 post-transfer. Since a stable reversion from a CD27– to a CD27+ state 
was never observed in vitro, and because CD27+ cells exhibit increased 
proliferation and resistance to apoptosis in vitro than CD27– cells, it was suggested 
that CD27 expression could confer a survival advantage to T cells in vivo 
(Ochsenbein et al., 2004). However, it can not be excluded that the clinical 
settings generated by HIV infection favor the accumulation of CD27+ cells, and a 
distinct situation (i.e., persistence of CD27– cells) could occur in a different type of 
infection, such as infection with human cytomegalovirus (CMV). Actually, 
downregulation of CD27 on CD8+ T-cells correlates with the acquisition of effector 
functions, such as the expression of perforin, granzyme B and FASL (Hamann et 
al., 1997). Interestingly, in the peripheral blood, the highest relative frequency of 
cells specific for CMV displays a CD27–CD8+ phenotype. Conversely, this 
population is markedly decreased in HIV infection (Appay et al., 2002; Kuijpers et 
al., 2003), which raised the possibility that the failure in the control of this viral 
infection might be due to the lack of CD27–CD8+ specific cells (Champagne et al., 
2001; van Baarle et al., 2002a; van Baarle et al., 2002b). Also in the mouse model 
one can observe the loss of CD27 expression; effector-memory LCMV-specific 
CD8+ T cells have a CD27low/int phenotype, whereas the central memory population 
is CD27+ (Wherry et al., 2003). In addition, CD27 downregulation is claimed to be 
an irreversible event on both CD4+ and CD8+ T cells (De Jong et al., 1992; Hintzen 
et al., 1993; Ochsenbein et al., 2004). Altogether, the prevailing data suggest 
CD27–CD8+ population seems to result from the continuous stimulation of CD27+ 
precursors and presumably represents a more differentiated antigen-experienced 
owing a more extensive replicative history and more complete effector functions 
that CD27+CD8+ cells. 
 
3.2 Immunological memory generation and lineage relationships 
 
Following primary immune responses, a small proportion of T cells escape 
survive the wide-scale elimination of effector T cells and become long-lived 
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memory cells. How these long-lasting memory cells generated and selected during 
the primary immune response is an issue difficult to address directly. However, 
several lines of evidence allowed the envisagement of a model to explain T-cell 
memory generation in humans (Sallusto et al., 2004; Sprent and Tough, 2001). 
According to this model, memory formation is a rather complex mechanism largely 
dependent upon multiple factors, such as the density of antigen, TCR affinity, local 
contact with particular cytokines and the nature of the APC. As discussed above, 
these factors establish the strength of stimulation that lymphocytes receive and 
determine their fate. Hierarchical activation thresholds are thought to progressively 
drive naïve T cells to proliferate, acquire fitness, differentiate and ultimately die by 
AICD (Figure 9a). As cytokine stimulation and encounter of T cells with APCs are 
probabilistic events that vary throughout the immune response, lymphocytes 
participating in the same response will receive different degrees of stimulation. 
This can lead to the arrest of primed T cells in different stages of the activation 
pathway, in addition to lymphocytes that have reached fully differentiation. In the 
early stages of the immune response, rapid replication of the pathogen ensures 
continuous entry of large numbers of activated APCs into the T-cell zones of the 
secondary lymphoid organs. Consequently, there is a huge density of APCs 
carrying high doses of antigen and co-stimulatory molecules, and secreting large 
amounts of cytokines. T cells can thus rapidly accumulate signals that enable 
them to become fit, proliferate and be converted into fully differentiated effector 
cells. At later stages of the response, elimination of the pathogen at the site of 
infection by effector cells reduces inflow of antigen-laden APC into the T-cell 
zones. Under these conditions, T-cell interaction with diminishing numbers of 
antigen-bearing APCs exhausts the capacity of APCs to produce stimulatory 
cytokines (Langenkamp et al., 2000). The exhausted APCs continue to elicit T-cell 
proliferation but cytokine production by T cells and formation of fully differentiated 
effector cells are reduced. Therefore, polarized cells would develop as the result of 
prolonged exposure to antigen, whereas non-polarized cells would arise by default 
when antigen is limiting (Iezzi et al., 2001; Langenkamp et al., 2002). This 
spectrum can be simply resolved into distinct subsets of TCM and TEM surviving 
after antigen clearance (Sallusto et al., 2004). Taken together, this model for T 
lymphocyte activation, generally known as «progressive differentiation model», 
proposes that generation of effector cells would be favored in early time points, 
whereas non-effector cells, that could constitute the precursors of fit, long lived-
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memory cells, would be preferentially generated at later stages of the immune 







This model is supported by several observations, including that only non-
polarized in vitro generated cells recirculate through secondary lymphoid tissues 
(Iezzi et al., 2001; Weninger et al., 2001) and that TEM have a lower proliferative 
potential and enhanced effector functions (Champagne et al., 2001; Hislop et al., 
2001; Masopust et al., 2001; Wherry et al., 2003). 
The previously described model implies that continuous exposure to antigen 
induces exhaustive differentiation (death) of virtually all of the effector cells, 
whereas a less-protracted contact with antigen, in addition to an extensive 
proliferative episode and an eventual effector stage, would induce in memory T-
cell precursors incomplete or reversible death pathways. This hypothesis is 
corroborated by several observations in which different doses of antigen elicited 
different cellular outcomes, such as live bacteria or antigen formulated with 
microbial products, which induce fully differentiated CTL and TH1 cells; killed 
Figure 9. Models of memory T-cell 
differentiation. (a) The progressive differentiation 
model assumes that T-cell differentiation 
depends on the strength of stimulation and it is 
the most consensual model for human T-cell 
differentiation. The duration and intensity of 
antigenic stimulation is depicted by the length 
and thickness of the solid arrows. (b) Deduced 
from the mouse model, the linear differentiation 
model proposes a pathway whereby memory T 
cells are direct descendants of effector cells and 
memory T-cell development occurs only after 
decline of antigen concentration. (c) A variation 
of the previous model, the lineage-independent 
model predicts that TCM cells can also be 
generated independently of the effector-cell 
lineage. Dashed arrows represent antigen-
independent events leading to T cell proliferation 
and differentiation. AICD, activation-induced cell 
death. 
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bacteria or antigen associated with the bacterial cell wall–derived Ribi adjuvant, 
which induce expansion of non effector CD8+ or CD4+ T cells; or antigens cross-
presented by immature DC, which induce abortive proliferation or expansion of 
non-effector cells depending on the level of antigen expression (for a review, see 
Sallusto et al., 2004). Therefore, the gradient of signal strength is associated with 
the fitness of T cells involved in the immune response: cells receiving signals of 
suboptimal strength would be unfit and die by neglect, whereas higher strengths of 
signal would drive memory precursors to up-regulate anti-apoptotic molecules and 
receptors for homeostatic cytokines, therefore becoming fit. At extreme conditions 
of high strength of signal T cells could eventually be deleted by activation induced 
cell death. 
In the mouse, the dynamics and relationship between TCM and TEM have 
been analyzed within the CD8+ T-cell compartment by adoptive transfer 
experiments and revealed surprising differences in relation to human memory cells 
(Bouneaud et al., 2005; Wherry et al., 2003). Interestingly, in the absence of 
antigen, TCM are extremely stable in vivo, whereas TEM are present only 
transiently. The data also indicates that TEM have a high propensity to undergo 
apoptosis and die in few weeks when antigen is not present, with the exception of 
a small subset that is able to convert into TCM by reacquiring CCR7 and CD62L 
expression (Bouneaud et al., 2005). A recent report has shown that the capacity of 
TEM to acquire a TCM phenotype strongly depends on the initial frequency of naïve 
T-cell precursors, the TEM cells generated at low precursor frequency conditions 
constituting a stable lineage with limited capacity of conversion into TCM (Marzo et 
al., 2005). In addition, the rate of conversion from TEM to TCM is inversely 
proportional to the strength of stimulation (Wherry et al., 2003). Finally, TCM 
convert into TEM upon antigenic re-stimulation, but not under steady-state 
conditions. These findings strongly suggest that in mice the level of antigen 
persistence shapes the composition of the memory CD8+ T-cell pool and that TCM 
and TEM do not necessarily represent distinct subsets, but rather belong to a 
continuum in a linear naïve  effector  TEM  TCM differentiation pathway 
(Wherry et al., 2003 and Figure 9b). By contrast, in humans both TCM and TEM 
subsets are rather stable, without evidence of TEM  TCM inter-conversion at 
steady-sate (Baron et al., 2003). Furthermore, human TEM also fail to reacquire 
stable CCR7 expression in vitro (Langenkamp et al., 2003). A repertoire study has 
also shown that there is a significant overlap of clones between TCM and TEM 
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repertoire in the H-Y mouse model, demonstrating that some TCM and TEM cells 
have arisen from a common naïve T cell-precursor (Bouneaud et al., 2005). This 
finding that TCM and TEM repertoires are partially distinct and therefore some TCM 
and TEM clones could arise independently, on a stochastic basis, based on pre-
commitment of the individual naive T cell or depending on its stimulation 
conditions, such as cytokine environment or access to CD4+ T-cell help (Figure 
9c). 
Collectively, these data strongly suggest that the mechanisms implicated in 
the generation and dynamics of memory T-cell populations are significantly 
different between mouse and man. 
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PART III. AIMS AND METHODOLOGICAL APPROCHES 
 
Sallusto and Lanzavecchia have shown for the first time that expression of 
the lymph node homing receptor CCR7 can be used to separate, both CD4+ and 
CD8+ human CD45R0+ T cells, into two functionally distinct subsets: CCR7+ 
CD45RA- (TCM) and CCR7
- CD45RA- (TEM). Unlike CD4
+ T cells, in the CD8+ 
compartment it can be found an additional CCR7- subset that expresses CD45RA 
(TEMRA). Confocal microscopy has revealed that this population harbor cells 
expressing the highest levels of perforin (Sallusto et al., 1999b). It was therefore 
suggested that the TEMRA subset should correspond to a population of terminally 
differentiated CD27- effector cells, previously described by Hamann et al. (1997). 
These cells display a Vβ repertoire significantly different from naïve cells, 
containing oligoclonal expansions of particular TCR Vβ elements, and also have 
shorter telomeres, suggesting that cells of the CD45RA+CD27- subset have been 
selected in vivo through antigen stimulation and evolved through extensive rounds 
of division (Hamann et al., 1999). The same authors had proposed that CD45RA 
and CD27 expression could be used to identify naïve (CD45RA+ CD27+), memory 
(CD45RA- CD27+) and effector (CD45RA+ CD27-) CD8+ T cells in humans 
(Hamann et al., 1997). This classification, however, underestimates the complexity 
of the memory CD8+ T-cell subset revealed by the expression of CCR7. For 
instance, memory cells defined by the CD45RA- CD27+ phenotype would therefore 
include both TCM and TEM, which were shown to enclose a distinct functional 
specialization (Champagne et al., 2001; Sallusto et al., 1999b). Whether memory 
CD27+ CD8+ T cells can additionally be harbored within the CD45RA+ subset has 
also been questioned.  CD27+ CD8+ T cells specific for several human viruses can 
be found within the CD45RA+ compartment during the chronic phase of infection 
(Appay et al., 2002). In addition, heterogeneity of the effector/memory 
compartments was shown to be further extended to CD28 expression in a study 
where CD8+ T cells specific for HIV, CMV, EBV and hepatitis C virus (HCV) were 
extensively characterized regarding their surface phenotype, intracellular 
functional molecules and ex vivo cytotoxic capacity. Based on these data, the 
authors showed that co-expression of CD27 and CD28 receptors could be used to 
distinguish three functionally different subsets of CD8+ T cells according to the 
expression of effector functions: early (CD27+ CD28+, DP), intermediate (CD27+ 
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CD28-, 27SP) and late (CD27- CD28-, DN)  differentiated cells (Appay et al., 
2002). This classification reflects, thus, the activation status of antigen-
experienced CD8+ T cells, rather than discriminating effector and memory cells. In 
particular, CD27 and CD28 expression does not allow distinguishing TCM from TEM, 
nor TEM from TEMRA.  
The prevailing data concerning the description of naïve, effector and 
memory CD8+ T-cell populations in humans remains, thus, rather fragmentary. 
Manifestly, analyses of CD8+ T cells including solely two or three parameters are 
not sufficient to reveal the whole heterogeneity of the antigen-experienced CD8+ 
lymphoid compartment. The compound subsets are not clearly established, 
especially within the TEM and TEMRA compartments, and the correspondent 
differential roles and lineage relationships remain undisclosed. However, 
understanding the distribution, function and relationship of the CD8+ T-cell 
subpopulations is of fundamental value for the monitoring of the immune system in 
several experimental and clinical situations. 
The present study aims to elucidate some still unclear aspects concerning 
the heterogeneity of the human CD8+ T-cell compartment. In particular, this study 
focuses on the distribution of circulating human CD8+ T cell populations based on 
the simultaneous association of CCR7, CD45RA, CD27 and CD28 cell-surface 
markers. The discrete populations that have been identified in the total CD8+ T-cell 
pool were further isolated by cell-sorting and gene expression of 18 genes was 
assessed, simultaneously, in single-cells by a novel multiplex RT-PCR method we 
developed. Our results indicate that the phenotype resulting from this combination 
of markers permits to discriminate seven types of functionally different populations: 
naïve, recently-activated cells, TCM, TEM-DP, TEM-27SP, TEM28SP and TEM-DN. 
CD45RA expression is required to define the naïve subset, but does not 
discriminate functionally different populations of primed cells. Although the 
methods used here did not allow the categorization of the nature of cells that 
mediate immunological memory versus effectors, our data provide important 
evidence that help to establish the stages of differentiation of CD8+ T cells from 
naïve cells to cytolytic effectors. In particular, our data suggest that the loss of 
surface receptors can occur asynchronously during the differentiation process and 
TEM and TEMRA subpopulations might play similar roles in the immune response in 
vivo. In summary, by crossing several markers that were independently used in 
previous studies, in association with single-cell multiplex gene expression 
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analysis, this work will help to clarify and consolidate some important features of 
the biology of CD8+ T cell populations. 
 
The results of this thesis are described in the following section by means of 
two scientific articles that approach, respectively, the development of a novel 
methodology of RT-PCR that allows the study of an extended number of functions 
expressed in single cells (published in Genome Research), and the 
characterization of the CD8+ T-cell subsets found in the human blood by gene 
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Quantitative gene expression analysis aims to define the gene expression patterns 
determining cell behavior. So far, these assessments can only be performed at the 
population level. Therefore, they determine the average gene expression within a 
population, overlooking possible cell-to-cell heterogeneity that could lead to different 
cell behaviors/cell fates. Understanding individual cell behavior requires multiple gene 
expression analyses of single cells, and may be fundamental for the understanding of 
all types of biological events and/or differentiation processes. We here describe a new 
reverse transcription-polymerase chain reaction (RT-PCR) approach allowing the 
simultaneous quantification of the expression of 20 genes in the same single cell. This 
method has broad application, in different species and any type of gene combination. 
RT efficiency is evaluated. Uniform and maximized amplification conditions for all genes 
are provided. Abundance relationships are maintained, allowing the precise 
quantification of the absolute number of mRNA molecules per cell, ranging from 2 to 
1,28×10
9
 for each individual gene. We evaluated the impact of this approach on 
functional genetic read-outs by studying an apparently homogeneous population 
(monoclonal T cells recovered 4 d after antigen stimulation), using either this method or 
conventional real-time RT-PCR. Single-cell studies revealed considerable cell-to-cell 
variation: All T cells did not express all individual genes. Gene coexpression patterns 
were very heterogeneous. mRNA copy numbers varied between different transcripts 
and in different cells. As a consequence, this single-cell assay introduces new and 
fundamental information regarding functional genomic read-outs. By comparison, we 
also show that conventional quantitative assays determining population averages 
supply insufficient information, and may even be highly misleading. 
Quantification of Multiple Gene Expression
in Individual Cells
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Quantitative gene expression analysis aims to define the gene expression patterns determining cell behavior. So far,
these assessments can only be performed at the population level. Therefore, they determine the average gene
expression within a population, overlooking possible cell-to-cell heterogeneity that could lead to different cell
behaviors/cell fates. Understanding individual cell behavior requires multiple gene expression analyses of single cells,
and may be fundamental for the understanding of all types of biological events and/or differentiation processes. We
here describe a new reverse transcription-polymerase chain reaction (RT-PCR) approach allowing the simultaneous
quantification of the expression of 20 genes in the same single cell. This method has broad application, in different
species and any type of gene combination. RT efficiency is evaluated. Uniform and maximized amplification
conditions for all genes are provided. Abundance relationships are maintained, allowing the precise quantification of
the absolute number of mRNA molecules per cell, ranging from 2 to 1.28×109 for each individual gene. We
evaluated the impact of this approach on functional genetic read-outs by studying an apparently homogeneous
population (monoclonal T cells recovered 4 d after antigen stimulation), using either this method or conventional
real-time RT-PCR. Single-cell studies revealed considerable cell-to-cell variation: All T cells did not express all
individual genes. Gene coexpression patterns were very heterogeneous. mRNA copy numbers varied between
different transcripts and in different cells. As a consequence, this single-cell assay introduces new and fundamental
information regarding functional genomic read-outs. By comparison, we also show that conventional quantitative
assays determining population averages supply insufficient information, and may even be highly misleading.
[Supplemental material is available online at www.genome.org.]
Functional genomic analysis is fundamental for understanding
how genomic expression profiles influence cell fate. Such studies
are usually performed by using either micro-arrays or a real-time
quantitative reverse transcription polymerase chain reaction (RT-
PCR). These methodologies can determine multiple gene expres-
sion, but have a major limitation. They only allow studies at the
population level and thus only determine average gene expres-
sion. They cannot evaluate variations of gene expression
between individual cells. However, in many types of biological
events, individual cells within apparently homogeneous popula-
tions have different fates. It is likely that these different fates are
conditioned by different patterns of gene expression. Because the
events occurring in each individual cell are unknown, current
methods may fail to identify the gene expression balance that
ultimately determines cell behavior. This latter information re-
quires multiple gene expression analysis of single cells, which
may be a fundamental step for the understanding of all types of
biological events and/or differentiation processes.
Multiple analysis of gene expression at the single-cell level
requires major technological advances. Most techniques are
qualitative and only allow studies of the expression of a few
genes (Phillips and Lipski 2000; Veiga-Fernandes et al. 2000; Wal-
ter et al. 2000; Lambolez et al. 2002). When more genes were to
be tested, these methods were reported to have inherent biases
(Phillips and Lipski 2000; Walter et al. 2000). Indeed, in more
extensive gene expression studies, the efficiency of detection was
simply not controlled (Ruano et al. 1995; Plant et al. 1997; Zawar
et al. 1999; Gallopin et al. 2000).
In principle, there are no sensitivity limitations for single-
cell gene expression analysis. Single-cell methods can detect ge-
nomic DNA, that is, two gene copies, when two successive PCR
amplifications of the same gene are performed (Loffert et al.
1996). However, the modification of such methodology to allow
multiple mRNA expression studies involves serious difficulties.
First, the amount of mRNA extracted from a single cell is so
minute that samples cannot be split. The expression of multiple
genes must be investigated in the same sample and in the same
RT-PCR round. This implies the presence of multiple primers and
the generation of multiple amplicons in a single PCR round,
which may induce serious competition between different ampli-
fications. It was claimed that analysis of the coexpression of more
than five genes in one cell simultaneously would necessarily lead
to nonspecific inhibitions of amplification (Walter et al. 2000).
These potential competition events may induce false-negative
results that are particularly difficult to control in single-cell as-
says. Indeed, as each individual cell is potentially different, it is
not possible to determine whether a negative result is due to the
absence of gene expression or to the absence of amplification due
to competition.
Further difficulties are involved in attempting to quantify
gene expression in single cells. Such quantification would require
the demonstration of the maintenance of abundance relation-
ships between multiple genes and throughout multiple reac-
tions: from mRNA to cDNA, and throughout two successive PCR
amplifications. The template switching required by two-step am-
plifications may introduce potential bias (Phillips and Lipski
2000). Moreover, it was postulated that abundance relationships
could not be maintained throughout exponential amplification,
as theoretical mathematic analysis showed that hybridization ki-
netics during thermal cycling could induce both sequence- and
copy number-dependent bias (Peccoud and Jacob 1996). How-
ever, certain techniques of enhanced reverse transcription faith-
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fully maintained relative abundance relationships using expo-
nential amplification (Iscove et al. 2002; Makrigiorgos et al.
2002). These new findings open the possibility that RT-PCR
methods could be modified in such a way that abundance rela-
tionships could still be maintained, allowing quantification of
gene expression in individual cells.
Here we describe a new method in which all previous limi-
tations have been overcome since the expression of 20 different
genes can be quantified simultaneously in each cell. We further
demonstrate that this powerful technique imparts fundamental
new information on cell behavior. In contrast, we also show that
gene expression studies performed at the population level do not
impart sufficient information and may even be highly mislead-
ing.
RESULTS
General Aspects of Quantitative Single-Cell
Multiplex RT-PCR
Sorted cells are lysed and the mRNA is retrotranscribed using
specific 3 primers. A first PCR follows, where both 3 and 5
primers for all 20 different genes are present in the same reaction
(Fig. 1). The products of this first amplification are next split into
individual wells where a second seminested real-time PCR am-
plifies each individual gene separately (Fig. 1). To quantify the
number of mRNA copies of different genes, the cycle threshold
(CT) value obtained for each different gene product is then com-
pared with a known quantified RNA standard that followed the
same rules of retrotranscription and amplification of the tested
samples. This comparison allows a precise determination of
mRNA copy numbers of different genes from a single individual
cell.
The feasibility of this method is strictly dependent on mul-
tiple parameters: a precise experimental strategy, which includes
the use of specific reverse transcription (see Discussion), the use
of precise rules for primer design, and particular amplification
conditions (see Methods).
Validation of Primer Design Strategy
Efficiency
To allow comparison of the expression of different genes, PCR
reactions amplifying different cDNA fragments must have the
same efficiency. We tested the efficiency of our PCR amplifica-
tions on the cDNA from gut intraepithelial T lymphocytes (IELs),
because this template contains all of the cDNAs coding for the 20
different genes we investigated. Aliquots of this template were
amplified separately for each gene product, using primer combi-
nations from either the first or the second PCR. The PCR accu-
mulation slope on the linear phase of all of these PCRs (Fig. 2A)
allowed us to evaluate PCR efficiency (Ramakers et al. 2003). We
show that all 40 types of PCR had equal efficiency (Fig. 2B).
Competition
A key feature of our method is the first PCR reaction, where all 40
primers amplifying different cDNAs are present and the 20 cDNA
types are amplified simultaneously. This is required for assess-
ment of multiple gene expressions in the same cell. However, this
multiple amplification may result in PCR inhibition and/or re-
duced PCR efficiency that may invalidate the data (Phillips and
Lipski 2000; Walter et al. 2000). To evaluate competition, the
same amount of IEL cDNA was amplified on the first PCR round:
either separately for each individual gene, or in combination
with all other genes. Next, the PCR products generated in these
two conditions were amplified on a second quantitative PCR. As
shown in Figure 2C,D, the relative levels of expression of each
gene were the same when the gene was amplified separately or in
combination.
We conclude that our method provides a variety of PCR
amplifications with similar efficiencies. Moreover, the 20 primer
combinations of the first PCR can be associated in the same
reaction, showing that our methodology prevents competition
between different amplifications, a major handicap of previous
methods for multiple simultaneous amplifications (Phillips and
Lipski 2000; Walter et al. 2000). Our strategy thus allows simul-
taneous multiple gene analysis in the same sample. Because all
PCRs have the same efficiency, this method also allows the com-
parison of relative levels of expression of different genes between
themselves.
Broad Spectra Application
We next investigated whether the strategy we used for this par-
ticular multiplex single-cell analysis could be applied for any
other type of gene combination, and in different species. For that
purpose we used the same rules described in the Methods section
to select primers and amplicons that study multiple T-cell func-
tions (including cytokine and chemokine expression) in human
cells. We tested the efficiency of our PCR amplifications on cDNA
from human small intestine, because this template also expresses
all of the cDNAs we investigated. Aliquots of this template were
amplified separately for each gene product, using primer combi-
nations from either the first or the second PCR (Fig. 3A). Evalu-
ation of PCR efficiency (Ramakers et al. 2003) revealed that all 40
of these individual PCR reactions had the same efficiency (Fig.
3B). To evaluate competition, the same amount of human small
intestine cDNA was amplified on the first PCR round, either sepa-
rately for each individual gene or in combination with all other
genes. Next, the PCR products generated in these two conditions
were amplified on a second quantitative PCR. As with the mouse
multiple gene analysis (Fig. 2B,C), we found no inhibition due to
primer/amplicon competition, as relative levels of expression
were identical whether each gene was amplified separately or in
combination (Fig. 3C,D).
We conclude that by using the primer/amplicon selection
strategy and the amplification conditions described in the Meth-
ods section, this methodology can be applied to the simulta-
neous quantification of any 20 mRNA combinations. This vali-
dates the basic principles of the method for multiparameter
analysis and provides proof of its broad spectrum of applications.
Figure 1 Outline of the quantitative multiplex single-cell RT-PCR.
Single-cell mRNA is retrotranscribed using a 3-specific primer for each
individual gene of interest (dark gray box). Next, single-cell cDNA is
amplified on a first multiplex PCR where both 3 (dark gray box) and 5
(white box) primers of all different genes are present (15 cycles). Products
of the first amplification are next split for a second seminested real-time
PCR where a nested 5 primer (light gray box) and the 3 primer (dark
gray box) are used to amplify each gene separately. This second round of
amplification allows a precise quantification because test samples are
compared with an RNA standard submitted to the same RT and amplifi-
cation protocol.
Multiple Gene Expression in Single Cells
Genome Research 1939
www.genome.org
From Population Studies to Single-Cell Studies
Template Switching
The quantification of the limited material recovered from single
cells as well as the study of multiple parameters in a single cell
requires the use of a two-step PCR amplification, and the conse-
quent template switching from the first to the second PCR round.
Such template switching may introduce potential bias (Phillips
and Lipski 2000). To prevent such bias, the first amplification
round should amplify rare templates in such a way that aliquot
switching should exclude tube-to-tube variability. The initial am-
plification should also guarantee that highly expressed genes do
not reach a saturation plateau that would exclude accurate quan-
titative assessments on the second PCR. In other words, to pre-
vent biased assessments, the first round of amplification must
preserve the initial representation of rare genes, simultaneously
excluding excessive amplification of highly abundant gene cop-
ies.
We tested for bias introduced by the template switching
between the first and second PCRs using several approaches.
First, we studied the amplification of a synthesized double-
stranded template, corresponding to the mouse Gzma sequence
we amplified in our PCRs (Fig. 4A). Because the molecular weight
of this template was known, we could calculate the abso-
lute number of DNA molecules that was present in each reac-
tion. In this way, we could study possible artifacts of two-step
Figure 2 Efficiency and competition of PCR amplifications. (A,B) Aliquots of cDNA from mouse IEL were amplified separately for each gene and each
type of PCR reaction to determine PCR efficiency. (A) Quadruplicate amplification slopes for Prf-1, Gzma. Set of primers from the first PCR (solid lines)
the second PCR (dashed lines).The same tests were performed for all genes, giving the same results (B) Slope values from the quadruplicates were
assessed on the exponential phase of the real-time amplification reaction, and PCR efficiencies were determined using LinRegPCR 7.0 software.
MeansSD of PCR efficiencies are shown for the first (upper panel) and second (bottom panel) PCRs. The significance of these differences was evaluated
by ANOVA. Within each PCR, all primer combinations had the same efficiency. We also found no significant difference in the variance between the
first and second PCR amplifications (ANOVA, P > 0.1). Data are from one of three independent experiments. (C,D) Competition: Aliquots of cDNA from
IELs were amplified separately for each gene, or in multiplex in the first PCR round. Quadruplicates of these reactions were further amplified in a second
real-time PCR. (C) Quadruplicates of amplification for Cd3-; IL15r, genes amplified in multiplex (solid line) or alone (dashed line). (D) Comparison of
threshold cycle mean values (CT) obtained for each different gene amplified in multiplex (black bars) or separately (gray bars). No significant differences




reactions at both high and low copy numbers of starting mate-
rial. Decreasing concentrations of this template, by a factor of 16,
from 1.28109 to four molecules, were amplified in single
or double-step amplification (Fig. 4A). Upon a single amplifica-
tion, the linear regression curve of this standard had a high cor-
relation coefficient (r2 = 0.999). These results show that we
can assess a vast range of template copy numbers while main-
taining linearity. Next, we studied the amplification of the same
double-stranded template using a two-step amplification. The
number of amplification cycles in the first PCR ranged from five
to 30. When the first PCR was 15 cycles, high correlation coeffi-
cients (r2 = 0.999) were maintained in the second PCR. Further-
more, using this 15-cycle preamplification, linearity was main-
tained at both high and low template concentrations (Fig. 4A).
We tested these same parameters for other synthesized cDNA
sequences, namely mouse Gzmb and Prf-1 and human CD3-,
and similar results were obtained (data not shown). We further
investigated tube-to-tube variability at very low copy numbers
directly. Triplicates of synthesized mouse Gzma sequence (four
molecules) were amplified in a first 15-cycle PCR, and then ali-
quots of these preamplified products were amplified, using a
quantitative PCR. We show that all samples had equal CT values
(Fig. 4B).
These results show that when a 15-cycle amplification is
used in the first PCR, we can exclude the existence of bias or
randomness introduced by template switching at template copy
numbers from 1.28  109 to 4 molecules. It must be noted that
at higher or lower amplification cycles on the first PCR, the sec-
ond PCR does not follow the same rules of linearity (data not
shown). When the first PCR has less than 15 cycles, low template
Figure 3 Broader applications for the quantitative single-cell multiplex RT-PCR. Aliquots of cDNA from human small intestine were tested as described
in Figure 2. (A,B) Efficiency of PCR amplification for different gene products. Aliquots were amplified separately for each gene and each type of PCR. (A)
Quadruplicate amplification slopes for Ccl-5, Gzma, first PCR (solid lines) and second PCR (dash lines). Amplification of all genes gave the same results
(B) Slope values from the quadruplicates were assessed on the exponential phase; efficiency and significance of variation were performed as described
in Figure 2. Results show meanSD of PCR efficiencies of the first (upper panel) and second (bottom panel) PCRs. All primer combinations had the same
efficiency. We also found no significant difference in the variance between the first and second PCR amplifications (ANOVA, P > 0.05). Data are from
one of three independent experiments. (C,D) Competition: Aliquots of cDNA from human small intestine were amplified separately for each gene, or
in multiplex in the first PCR round. Quadruplicates of these reactions were further amplified in a second real-time PCR. (C) Quadruplicates of
amplification for Ifn-, Gzmb genes amplified in multiplex (solid line) or alone (dashed line). Comparison of CT values obtained for each different gene
amplified in multiplex (black bars) or separately (gray bars). No significant differences were observed between the two amplification conditions for each
different gene (t-test, P > 0.1).
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concentrations were not amplified efficiently in the second PCR,
as tube-to-tube variability was observed. Conversely, when the
first PCR had more than 15 cycles we observed saturation when
high template concentrations were used.
We next investigated whether preamplification was biasing
quantitative estimates in cDNA extracted from normal cells.
We first analyzed bias on highly expressed genes by studying
mouse 28S (Mrp-S21) mRNA. We used serial dilutions of cDNA
that was amplified in a double-round PCR (the first PCR was 15
cycles). We show that the correlation coefficient was high even
when this highly expressed gene was tested, and high amounts of
total cDNA were used (Fig. 4C). These re-
sults demonstrate that our double-round
PCR conditions maintained linearity even
when high template amounts were ampli-
fied.
We next analyzed possible bias in the
amplification of rare messages. We studied
tube-to-tube variability in mouse Hprt-1 ex-
pression, considered a low-expressed gene
(Pannetier et al. 1993). We retrotranscribed
and amplified (15 cycles) Hprt-1 of indi-
vidual cells. Quadruplicates of the first PCR
round were amplified in a second PCR. As
shown in Figure 4D, quadruplicate aliquots
of this message gave the same results, show-
ing no tube-to-tube variability. We studied
15 individual cells using these conditions
(data not shown), and all had the same qua-
druplicate CT values, which also excluded
the possibility of template switching induc-
ing randomness and consequent tube-to-
tube variability.
We next investigated whether we
could reproducibly amplify two gene cop-
ies, by amplifying genomic DNA from indi-
vidual cells. For that purpose, single cells
were sorted, lysed, and processed for DNA
extraction. In these conditions, mRNA is
degraded and only DNA can be amplified.
We used primer combinations spanning a
small intron. In these conditions, ampli-
cons generated after DNA amplification
were only slightly longer than those gener-
ated when cDNA was amplified, ensuring
that DNA and cDNA amplification had
similar efficiency. We show that even with a
two-copy template in the first PCR round,
all samples amplified in the second PCR had
the same CT (Fig. 4E), excluding quantita-
tive randomness effects and demonstrating
the high sensitivity of our amplification
procedure.
Finally, we tested the relative contribu-
tion of nonspecific signaling to our PCR
read-outs. Indeed, SYBR Green incorpora-
tion in primers dimers could induce some
type of background amplification. To evalu-
ate this possibility, we studied several
expresser and nonexpresser single cells for a
particular gene product. As expected, some
SYBR Green accumulation was sometimes
detected in negative cells, but exponen-
tial accumulation (as found in positive
cells) was never observed (Fig. 5A). Because
CT values are evaluated in the linear phase
of SYBR Green accumulation, CT determination in negative
samples was not significantly different from samples where tem-
plate was not included (Fig. 5B). These results demonstrate that
negative cells did not originate significant background in our
analysis.
In summary, these results demonstrate that our method of
amplification preserves the initial representation of rare genes,
simultaneously excluding excessive amplification of highly
abundant gene copies and therefore allowing precise quantifica-
tion assessments of copy numbers ranging from 1.28109 to 2
molecules.
Figure 4 Linearity of double-round PCR amplification. (A) A double-stranded synthesized DNA
sequence from Gzma was amplified in quadruplicate by a single PCR (●) or by a two-step PCR of
15 preamplification cycles (). Decreasing template concentrations by a factor of 16 were used.
MeansSD of quadruplicates are included, although SDs frequently overlap with the symbols as
we found little or no variation. Linear regression curves of these amplified standards are indicated
and have similar high correlation coefficients (r2 = 0.999). Similar results were obtained with three
different types of synthesized cDNA. (B) Four molecules of a double-stranded synthesized Gzma
sequence were amplified in triplicate using 15 cycles on the first PCR amplification followed by a
second real-time PCR. PCR accumulation curves are shown. (C) A bulk cDNA population (7105
to 680 fg) was used to amplify 28S (Mrp-S21) gene in quadruplicate by a two-step PCR of 15
preamplification cycles. Decreasing template concentrations by a factor of 4 were used. Mean
values and standard deviations of quadruplicates are included, but SDs overlap with the symbols,
as we found little or no variation. The linear regression curve of this amplified standard is indicated
(r2 = 0.9978). (D) Single cells were retrotranscribed and preamplified (15 cycles) for Hprt-1. A
second quantitative PCR was used for the evaluation of the relative expression level (CT) of Hprt-1
on each individual cell. Quadruplicates of amplification are shown. (E) Single individual cells were
sorted, and treated for genomic DNA amplification (see Methods). The Gzma gene was next
amplified in a seminested PCR (15 cycles of preamplification). PCR accumulation curves are shown




Maintenance of Abundance Relationships
Exponential amplification has generally been considered to bias
abundance relationships, as cDNAs of differing lengths and com-
position would be amplified with differing efficiencies (Freeman
et al. 1999; Dixon et al. 2000; Phillips and Lipski 2000; Baugh et
al. 2001). Our primers were designed to amplify cDNAs of similar
length and composition, which should favor the maintenance of
abundance relationships. To test directly how abundance rela-
tionships were maintained, different synthesized cDNA se-
quences (from mouse Gzma, Gzmb, and Prf-1) were quantified
and mixed in known proportions (true ratios). These mixtures
were then amplified in our two-step PCR. The CT values obtained
in the second PCR were used to determine the corresponding
ratios after amplification (test ratios). To compare the mainte-
nance of abundance relationships at very different template con-
centrations, these three templates were mixed at 1/1, 1/64, and
1/4096 ratios.
When the three sequences were all mixed at the 1/1 ratio, all
PCRs had the same CT (Fig. 6, upper left). When the different
sequences were mixed at 1/1, 1/64, or 1/4096 ratios, differences
of CT values between different dilutions of different genes re-
flected initial dilutions, that is, six cycles for a 64-fold difference
and 12 cycles for a 4096-fold difference. This occurred for all
genes, tested in all types of ratio combinations (Fig. 6). Therefore,
despite very different initial template proportions, our PCR pro-
cedure provided a measure (test ratios) that was faithful to the
original template proportions. These data demonstrate that the
maintenance of abundance relationships is guaranteed even on a
large dilution range of the target template in a sample.
Reverse Transcription
To ensure maximal efficiency in capturing mRNA molecules pres-
ent in individual cells, we used specific reverse transcription (RT),
and the 5 extreme of the amplified gene fragments of the first
PCR was designed to be located between 300 and 400 bp from the
3 RT origin (see Discussion). To validate our approach, we as-
sessed the efficiency of the RT in these conditions. RNA frag-
ments from different genes and respective complement cDNA
sequences were produced and purified. We compared
the direct amplification of a precise number of cDNA molecules
with the amplification of the same number of synthesized RNA
copies after their reverse transcription. We found that both
cDNA and reverse-transcribed RNA template were amplified with
similar efficiency (Fig. 7). This occurred when RNA templates
coding for different genes were tested (Fig. 7A), and such efficient
RT was detected at all RNA concentrations studied (Fig. 7B).
These results demonstrate that we maintain copy numbers in the
RNA to cDNA transition, and that this RT approach is highly
efficient.
Population Versus Single-Cell Studies: The Impact
of Single-Cell Analysis in the Evaluation of Functional
Genetic Profiles
To compare the gene expression profiles obtained by single-cell
analysis to those evaluated in bulk populations, we studied the
same T-cell population using both methods. Mouse monoclonal
CD8 T cells, 4 d after in vivo antigen stimulation (Tanchot et al.
1998; Veiga-Fernandes et al. 2000) were sorted either as 20 cells/
well for population studies or as 20 single cells. All samples were
retrotranscribed and amplified as described above. For simplicity,
only four genes are shown.
Real-time PCR at a population level (Fig. 8A) showed a hi-
erarchy of gene expression: Gzmb > Tgf- = Ifn- > Prf-1. This
data would suggest that Gmzb is the most expressed gene, and
that this CD8 population differentiates similarly into Tgf-- and
Ifn--expressing cells. In addition, these data suggest that these
cells should be highly cytotoxic, due to the expression of high
levels of Gzmb (an enzyme important for cytotoxicity) and ex-
press Prf-1. Indeed, CD8 killer activity requires the coexpression
of both Gzmb and Prf-1 (Russell and Ley 2002).
Results of single-cell studies revealed a very different sce-
nario (Fig. 8B). First, most CD8 T cells differentiate into Tgf--
expressing cells (17/20), whereas Ifn- and Gzmb expression was
quite rare (4–6/20 cells). Moreover, Gzmb and Prf-1 were usually
expressed by different cells. These findings indicate that this CD8
population should be virtually devoid of killer activity, because
individual cells do not coexpress the two genes required to kill
target cells.
We conclude that single-cell multiparameter studies of gene
expression reveal fundamental new insights into cell behavior.
Conversely, the studies performed in bulk populations may be
highly misleading.
DISCUSSION
The analysis of heterogeneity within cellular populations has a
major impact on cell biology. The final aim of this approach is to
reveal the gene expression patterns that ultimately characterize
and define the fate of individual cells. Different cell fates likely
rely on both qualitative and quantitative differences of gene ex-
pression that affect multiple genes simultaneously, but tests al-
lowing the assessment of these features in individual cells are
lacking. Here we describe a single-cell multiplex RT-PCR that al-
lows simultaneous quantitative analysis and comparison of the
expression of 20 genes in each individual cell. We demonstrate
that this method substantially improves functional genomic
read-outs. Conversely, quantitative studies performed at the
population level may be very misleading.
It is not surprising that single-cell and population studies do
not overlap. Quantitative studies at the population level only
determine average rates of gene expression. They do not evaluate
the frequency of expressing cells. The same mRNA amount can
correspond to rare cells expressing high mRNA levels or to a
much higher cell number expressing lower mRNA levels. These
two situations may have very different biological meanings. The
Figure 5 Impact of nonspecific signal in PCR quantification read-outs.
Individual cells expressing or not Gzmb mRNA were amplified simulta-
neously. (A) SYBR Green signal in positive (solid lines) and negative (dot-
ted lines) cells. (B) CT evaluation, using the Sequence Detector 1.7 soft-
ware. The CT value of negative cells and wells not containing template
was not significantly different (t-test: P = 0.18). This program’s upper
limit of detection is 60 cycles; that is, samples without template score
with a CT of 60.
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impact of this potential bias has probably been underestimated,
as the range of identical mRNA molecules each cell could express
was not known. Here, for the first time, we were able to quantify
messages at the single-cell level and found that expression of a
single gene in individual cells could vary by 10,000 fold (data not
shown). This extensive variation seriously undermines the inter-
pretation of any quantitative studies that are not accompanied
by frequency determinations. Indeed, in studies performed at the
population level, very rare events (even at 104 frequencies) may
score similarly to frequent events. Therefore, in population read-
outs, events that are not representative of a global population
behavior may appear as very significant events. This bias is evi-
dent in the study we include, where Gzmb expression appears to
be a dominant function in the studied population, whereas stud-
ies at the single-cell level reveal that only a few cells expressed
this mRNA.
Another major potential impact of single-cell studies is the
possibility to determine gene coexpression. We were surprised to
verify that different genes (Prf-1 and Gzmb), which need to be
coexpressed for CD8 cytotoxicity, could segregate into different
individual cells. This finding emphasizes that studies at the
population level are not sufficient to identify cell properties.
Rather, coexpression studies at the single-cell level are funda-
mental for the interpretation of functional read-outs.
Concerning the present methodology,
quantification of multiple gene expression
in the same cell is only possible if several
rules are followed simultaneously: the same
efficiency of PCRs; the absence of primer
and amplicon competition during the first
PCR round, and an efficient RT to PCR tran-
sition requiring the use of specific RT. More-
over, all of these requirements are strictly
interdependent.
Comparison of the expression of differ-
ent genes between themselves requires that
all individual PCRs have the same effi-
ciency. This aim alone is not difficult to
achieve. Primer combinations claiming to
amplify multiple genes with similar effi-
ciency are beginning to be available com-
mercially. However, in these commercial
kits (where controls for many important
parameters are lacking), each individual
gene must be studied separately, using
one independent sample for each PCR. The
ability to compare the expression of differ-
ent genes between themselves and attribute
coexpression of 20 genes to the same
cell requires that all 20 different PCRs
reactions be performed in the same tube
and in the same PCR round. This imposes
the requirement that, besides similar effi-
ciency, the 40 primers and 20 amplicons of
the first PCR also do not compete with one
another.
It was claimed that analyses of more
than five genes in one cell would necessar-
ily lead to nonspecific inhibitions of ampli-
fication, which affect amplifications ran-
domly (Walter et al. 2000). When using pre-
vious methods of single-cell amplification,
we confirmed this claim, and all of our pre-
vious studies were restricted to four to five
gene amplifications (Veiga-Fernandes et al.
2000; Lambolez et al. 2002). We found later
that the modification of the PCR amplification conditions we
describe herein, associated with a careful study of primer/
amplicon competition, could prevent inhibition.
The constraints on primer selection impose another strat-
egy: the use of specific reverse transcription which targets the
mRNA sequence that is retrotranscribed and subsequently ampli-
fied. This is achieved by designing the 5 extreme of the ampli-
fied gene fragments to be located between 300 and 400 bp from
the 3 RT origin. This strategy is both necessary and optimal for
the maintenance of abundance relationships in the mRNA to
cDNA transition.
The use of specific RT rather than poly-AAA reverse tran-
scription is necessary to prevent 3 bias that would modify abun-
dance relationships in the transition from mRNA to cDNA. It is
well known that poly-AAA reverse transcription preferentially
transcribes mRNA fragments localized in the 3 termini. This bias
should be a major problem in our type of approach. Indeed, to
ensure similar efficiency of amplification and prevent competi-
tion (essential aspects of our methodology), primers must be se-
lected throughout the gene and not at the 3 end only. Our
strategy thus improves on previous methods used to achieve
readings of gene expression in small samples such as modified
poly-AAA reverse transcription methods (Dixon et al. 1998; Brail
et al. 1999) or poly-AAA reverse transcription, followed by cDNA
Figure 6 Maintenance of abundance relationships in double-step amplification. Different syn-
thesized DNA sequences (Prf-1, blue; Gzma, red; Gzmb, green) were mixed in known proportions
at different ratios indicated in each panel (true ratios). These mixtures were next amplified in
quadruplicate by a two-step PCR of 15 preamplification cycles. Triplicates of amplification curves
for each dilution are shown. CT values between different dilutions of different genes reflected initial
dilution conditions; that is, six cycles for a 64-fold difference and 12 cycles for a 4096-fold differ-




polyadenylation at the 3 and subsequent single-primer amplifi-
cation of the tailed cDNAs (Brail et al. 1999). In contrast to our
method, all of these other methods induce 3-biased abundance
relationships in the sample, which are difficult to control (Brail et
al. 1999). Another limitation of poly-AAA RT methods is that the
5 sequences of the retrotranscribed genes might be incomplete,
compromising any further precise assessment. We prevented this
limitation by designing the 5 extreme of the amplified gene
fragments to be located between 300 and 400 bp from the 3 RT
origin. We demonstrate that this strategy provides a maximized
and uniform amplification of retrotranscribed genes, because
RNA fragments are fully retrotranscribed and abundance rela-
tionships are maintained in the mRNA to cDNA transition. By
comparing to a standard of RNA that is simultaneously reverse-
transcribed and amplified, we can calculate the absolute number
of mRNA molecules expressed per cell. These additional controls
are lacking in all previous RT strategies that do not attempt to
determine RT efficiency. A methodology was recently described
that allows exponential amplification of cDNA yields, preserving
the relative gene expression patterns of the initial sample (Iscove
et al. 2002). However, this methodology also requires that gene-
specific primers and probes are restricted to 3 transcript termini
(Iscove et al. 2002). Therefore, this strategy is also totally incom-
patible with multigene comparative quantification in individual
cells that require primer and amplicon selection throughout the
gene and not only on the 3 end.
Because all efforts to achieve readings of gene expression in
small samples were directed to increase cDNA yields, and thus are
incompatible with gene coexpression studies, we used an alter-
native approach to measure the minute mRNAs recovered from
one cell. Instead of generating very high amounts of cDNA, we
exponentially amplified the low cDNA yields we obtained from
each individual cell, and used this exponential amplification to
quantify transcripts. It is usually assumed that this approach can
bias the information content of the sample, as theoretical math-
ematic analysis showed that hybridization kinetics during ther-
mal cycling could cause both sequence- and copy number-
dependent bias (Peccoud and Jacob 1996). We show here that if
adequate primer combinations are used, and optimized PCR con-
ditions are applied, double-strand exponential amplification
yields reproducible results from 1.28109 to 4 copies of mRNA,
which should cover all ranges of gene expression at the single-
cell level.
This technique brings new perspectives to the understand-
ing of biological processes. Most differentiation events have been
studied on the basis of a population phenotype which does not
necessarily reflect heterogeneity among the population. Con-
versely, single-cell analysis will allow further dissecting of cell
decisions that ultimately influence a population phenotype. This
technical approach also has a broader interest for diagnosis of
minute samples. Indeed, in several pathologies and infections,
only very small tissue samples can be obtained for diagnosis or
continuous follow-up of disease progression. This method over-
comes all restrictions in sample size by allowing the quantitative
assessment of multiple different parameters from just a few cells.
Indeed, we are presently using this method to characterize HIV-
specific CD8 T cells that were divided into eight subtypes by cell
surface markers, each subtype representing less than 0.1% of Pe-
ripheral Blood Lymphocyte (PBL). This approach allows the de-
termination of 20 cell functions simultaneously, even in such
small sample sizes. Preliminary evidence suggests that we will be
able to quantify the expression of up to 40 genes/cell.
In conclusion, we here describe a method of quantitative
multiplex PCR that can be applied to an extended number of
genes expressed in a single cell. We also show that the ability to
quantify multiple gene usage by individual cells provides funda-
mental insights into cell physiology and functional genomics.
METHODS
FACS Sorting
Cells were sorted using a FACS Vantage equipped with an auto-
matic cell deposition unit (Becton Dickinson). Cells were col-
lected in individual PCR tubes containing 5 µL of PBS-DEPC
0.1%, and stored at 80°C.
Reverse Transcription
Cells were lysed by cooling at 80°C followed by heating to 65°C
for 2 min. After cooling to 4°C, RNA was specifically retrotrans-
cribed for 1 h at 37°C by adding 10 µL of a mix containing 0.13
µM specific 3 primers (see Supplemental Material I and II), 50
mM KCl, and 10 mM Tris-HCl at pH 8.3 (Applied Biosystems), 3.3
mM MgCL2 (Applied Biosystems), 1 mM dNTPs (Pharmacia Bio-
tech), 39 units of RNAse block (Stratagene), and 11.5 units of
MuLV Reverse Transcriptase (Applied Biosystems), in a 15-µL re-
action. The reaction was stopped by 3-min incubation at 95°C.
Primer Design
Gene sequence data and exon/intron boundaries were obtained
from the Ensembl Project database (http://www.ensembl.org).
The primers we selected for these PCR reactions are listed in
Supplemental materials I and II.
Our primers were manually designed in order to avoid ge-
nomic amplification, by choosing 3 and 5 primers that hybrid-
ize with different exons. To achieve similar amplification effi-
ciencies, we designed primers of 20 bp size targeting nonrepeti-
tive sequences, with similar melting temperatures (Tm) calculated
according to the formula (Tm = 64.9°C + 41°C  (number of G’s
and C’s in the primer  16.4)/number of bp of the primer) and
amplifying fragments of a similar size. The composition of am-
plified fragments (50.61%  5.01% of GC content) was similar,
Figure 7 Efficiency of the reverse transcription. Gzma, Gzmb, and Prf-1
RNA and DNA molecules were synthesized and purified. RNA was first
retrotranscribed and subsequently amplified; DNA sequences were am-
plified directly following the same conditions as for cDNA. For each gene
the same number of DNA and RNA molecules was compared. Results
show triplicate amplifications of RNA (solid lines) and DNA (dashed lines).
(A) Comparison of RT efficiency of the same number of RNA molecules
coding for different genes. Gzmb (left) or Prf-1 (right). (B) RT efficiency at
different RNA concentrations. Different concentrations of Gzma RNA
(ranging from 7.5107 to 3105 molecules) and corresponding DNA
concentrations were compared. Results show RNA/ DNA amplifications at
two of the concentrations tested: 1.9107 and 4.7106 molecules. The
same results were obtained for all other concentrations.
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which is required to obtain uniform amplification efficiency for
all different mRNAs. To prevent nonspecific amplification, all
individual primer sequences were used in a BLAST search (http://
www.ncbi.nlm.nih.gov/genome/seq/MmBlast.html) of the
mouse genome in order to check potential nonspecific hybrid-
ization of primers against other genes besides the targeted gene of
interest. No significant hybridization was found with other
genes.
To prevent primer competition, we selected primers and po-
tential amplicons that did not cross-hybridize. Primer compat-
ibility and size of the amplified fragments were assessed using the
freely available software Amplify 1.2 (Engels 1993; http://
engels.genetics.wisc.edu/amplify). The formation of primer
dimers was also excluded, because the energies of primer asso-
ciations that could lead to primer dimerization were considerably
weaker than the 3 binding energies of primer to template asso-
ciations. Furthermore, the use of high annealing temperatures in
our PCR protocol also contributed to exclude nonspecific ampli-
fication or inhibition. These aspects are of major importance,
because during the first PCR round all genes are amplified simul-
taneously, and the disregard of such rules results in PCR inhibi-
tion.
First PCR Amplification
The cDNAs resulting from the reverse transcription reaction were
next amplified. The first round of PCR consisted of one step of
denaturation at 95°C for 10 min and 15 cycles of amplification
(45 sec at 95°C, 1 min at 60°C, and 1 min 30 sec at 72°C) with 50
mM KCl, and 10 mM Tris-HCl at pH 8.3 (Applied Biosystems), 2
mM MgCl2 (Applied Biosystems), 0.2 mM GeneAmp dNTPs (Ap-
plied Biosystems), 3 units of AmpliTaq Gold DNA Polymerase
(Applied Biosystems), and 0.015 µM of specific primers (see
Supplemental materials I and II) in an 85-µL reaction volume.
When PCR was performed from single-cell genomic DNA, cells
were previously treated for 45 min at 55°C and 10 min at 95°C
with 7.5 µg of proteinase K (Merck) and 50 mM KCl, and 10 mM
Tris-HCl at pH 8.3 (Applied Biosystems) in a final volume of
15 µL.
Real-Time Quantitative PCR
Real-time quantitative PCR was performed by adding 10 µL of
2 SYBR Green PCR Master Mix (Applied Biosystems) to each
well containing 4 µL of template and 6 µL of a primer mix with
0.25 µM of each specific primer (see Supplemental materials I and
II) in a 20-µL reaction volume using the ABI PRISM 7700 Se-
quence Detection System (Applied Biosystems). After a denatur-
ation step at 95°C for 10 min, the cycle profile used was 30 sec at
95°C, 30 sec at 60°C, and 45 sec at 72°C for 60 cycles of ampli-
fication. An aliquot of 4 µL from the first PCR of positive cells was
used to quantify the expression level of each different gene.
Threshold cycle (CT) was determined on the linear phase of PCRs
using the software Sequence Detector version 1.7 (Applied Bio-
systems). PCR products were resolved on a 1.5% agarose
ethidium bromide gel, and were all sequenced to confirm speci-
ficity (ABI PRISM 3100, Applied Biosystems). The PCR efficiency
of each individual sample was assessed in the linear phase of a
real-time PCR reaction using LinRegPCR version 7.0 software.
This program uses the raw real-time PCR data of each individual
sample and performs an assumption-free analysis (Ramakers et
al. 2003).
Synthesis of Double-Strand DNA Sequences
cDNAs from Prf-1, Gzma, and Gzmb mouse genes were amplified
u s i n g 5  - T C A C A C T G C C A G C G T A A T G T - 3  a n d 5  -
CTGTGGTAAGCATGCTCTGT-3, 5-TCAAATACCATCTGTGC
TGG-3 and 5-AGAGGGAGCTGACTTATTGC-3, and 5-
GTCAATGTGAAGCCAGGAGA-3 and 5-AGGATCCGATGTT
GCTTCTG-3, respectively. Amplified fragments were resolved
on a 1.5% agarose ethidium bromide gel and purified using Wiz-
ard SV Gel and PCR clean-up System (Promega). DNA was quan-
tified by incorporation of Picogreen (Molecular Probes) accord-
ing to the manufacturer’s instructions.
Figure 8 Impact of quantitative single-cell analysis on gene expression profiles. Monoclonal CD8 T cells, 4 d after in vivo antigen stimulation were
sorted (A) at 20 cells/well for population studies, and (B) as 20 single cells at one cell/well. RT and PCR conditions were the same in both A,B. Results
show: (A) Real-time PCR amplification of Gzmb (solid line), Tgf- (dashed line), Inf- (dash-dotted line), Prf-1 (dotted line). (B) Quantification of gene
expression in individual cells, using quantitative single-cell multiplex PCR. Expression levels of each gene in each cell are shown as shades of gray,
compared to the log scale in the left. The absolute number of mRNA molecules was obtained by comparing amplifications with a standard of a known




Molecular Cloning and In Vitro Transcription
cDNA was obtained from RNA extracted from gut intraepithelial
T lymphocytes (IELs) of C57Bl/6 mice and human small intestine
using the RNeasy mini-kit (QIAGEN). We used these cells because
they express all of the genes we studied. The cDNA was synthe-
sized by incubating for 1 h at 37° C using 2.2 mM poly-(T) (Ap-
plied Biosytems) in a 45-µL volume reaction containing 50 mM
KCl, 10 mM Tris-HCl at pH 8.3 (Applied Biosystems), 3.3 mM
MgCl2 (Applied Biosystems), 2.5 mM dNTPs (Pharmacia Biotech),
39 units RNAse block (Stratagene), and 3 units MuLV Reverse
Transcriptase (Applied Biosystems). The reaction was stopped by
10-min incubation at 95°C. cDNAs from Prf-1, Gzma, and Gzmb
mouse genes were first amplified using 5-TCACACTGCCAGCG
TAATGT-3 and 5-CTGTGGTAAGCATGCTCTGT-3, 5-
TCAAATACCATCTGTGCTGG-3 and 5-AGAGGGAGCTGACT
TATTGC-3, and 5-GTCAATGTGAAGCCAGGAGA-3 and
5-AGGATCCGATGTTGCTTCTG-3, respectively. Amplified frag-
ments were resolved on a 1.5% agarose ethidium bromide gel and
purified using the Wizard SV Gel and PCR clean-up system. Se-
quences were next cloned as described (Poirel et al. 1997). Cloned
fragments of Prf-1, Gzma, and Gzmb were used as templates for
the in vitro transcription reaction. This reaction was performed
using the MEGAscript T7 transcription kit (Ambion) using 1.5 µg
of previously Hind III-linearized plasmid in a reaction volume of
80 µL. After transcription, the samples were treated with 4 units
of DNase I for 15 min at 37°C and purified using the MEGAclear
purification kit (Ambion). The purified RNA was eluted in 50 µL
of Tris-EDTA, and an aliquot was run on a native gel (TBE1, 2%
agarose) and controlled for the presence of contaminating plas-
mid DNA and unfinished products of the in vitro transcription
reaction using an Agilent 2100 bioanalyzer (Agilent Technolo-
gies) according to the manufacturer’s instructions. In vitro tran-
scriptions were >70% pure, and no DNA contaminations were
detected. RNA and DNA were quantified by incorporation of Ri-
bogreen and Picogreen (Molecular Probes) respectively, accord-
ing to the manufacturer’s instructions and using the ABI PRISM
7700 Sequence Detection System.
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Understanding the distribution, function and lineage relationship of CD8+ T-cell 
subpopulations is of fundamental value for the monitoring of the immune 
system in several experimental and clinical situations. However, the available 
data concerning the description of effector and memory CD8+ subsets in 
humans remains rather fragmentary since different studies favored the usage of 
distinct and restricted sets cell surface markers and functional parameters. We 
associated multiple markers to subdivide CD8+ T cells into fourteen different 
cell types several of which were not described previously, and evaluated the co-
expression of eighteen genes simultaneously in individual cells from each 
subset. Our results show that each subset has a defined pattern of gene 
expression. Moreover, effector gene expression of CCR7– cells correlated only 
to CD27 expression levels and CD27/CD28 co-expression, but not with 
CD45RA/R0 phenotypes. Our findings thus describe new CD8+ cell subsets, 
allow the identification of relatively homogeneous CD8+ subpopulations, provide 
a predictable and precise correlation between particular cell-surface markers 
and CD8+ T-cell functional properties and identify effector cells present in both 
the CCR7-CD45RA+ and CCR7-CD45R0+ compartments. The results also 
indicate that activated cells might modulate the expression of CD45RA/R0 
asynchronously, rather than CCR7–CD45RA+ cells always issuing from 
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Abstract 
Understanding the distribution, function and lineage relationship of CD8
+
 T-cell 
subpopulations is of fundamental value for the monitoring of the immune system in several 
experimental and clinical situations. However, the available data concerning the 
description of effector and memory CD8
+
 subsets in humans remains rather fragmentary 
since different studies favored the usage of distinct and restricted sets cell surface markers 
and functional parameters. We associated multiple markers to subdivide CD8
+
 T cells into 
fourteen different cell types several of which were not described previously, and evaluated 
the co-expression of eighteen genes simultaneously in individual cells from each subset. 
Our results show that each subset has a defined pattern of gene expression. Moreover, 
effector gene expression of CCR7
–
 cells correlated only to CD27 expression levels and 
CD27/CD28 co-expression, but not with CD45RA/R0 phenotypes. Our findings thus 
describe new CD8
+
 cell subsets, allow the identification of relatively homogeneous CD8
+
 
subpopulations, provide a predictable and precise correlation between particular cell-
surface markers and CD8
+









 compartments. The results also indicate 





 cells always issuing from CD45RA
–






 T lymphocytes play a key role in defense against cytosolic pathogens and 
tumors. Understanding the mechanisms through which the immune system controls such 
pathological situations to avoid disease depends upon the thorough characterization of all 
CD8
+
 T subpopulations and differentiation stages, from naïve precursors to fully mature 
effectors. For that purpose, the CD8
+
 T-cell compartment was subdivided into several 
different subsets with distinct properties. In humans, it has been established that expression 















, named “central memory” (TCM) and “effector memory” (TEM), respectively. 
Unlike CD4
+
 T cells, an additional CCR7
–
 subset that expresses CD45RA (TEMRA) can also 
be found in the CD8
+
 compartment. Since this population harbors cells expressing high 
perforin levels, it was suggested that the TEMRA subset should correspond to a population of 
terminally differentiated CD27
-
 effector cells, previously described by Hamann and 
collaborators 
1
. These cells display a Vβ repertoire significantly different from naïve cells, 
containing oligoclonal expansions of particular TCR Vβ elements, and also have shorter 




 cells have been selected in vivo through 
antigen stimulation and evolved through extensive rounds of division 
2
. The same authors 
had proposed an alternative classification for CD8
+
 T lymphocytes in which CD45RA and 














 T cells in humans 
1
. This classification, 
however, underestimates the complexity of the memory CD8
+
 T-cell subset revealed by the 





phenotype would include both TCM and TEM, which were shown to enclose distinct 
functional specializations 
3,4




 cells may also 
express CD45RA 
5
. Heterogeneity of the effector/memory compartments was shown to be 
further extended to CD28 differential expression. CD8
+
 T cells specific for several 
persistent human viruses were extensively characterized regarding their surface phenotype, 
perforin and granzyme A expression and ex vivo cytotoxic capacity. Based on these data, it 
has been shown that co-expression of CD27 and CD28 could be used to distinguish three 
functionally different subsets of CD8
+
 T cells according to the progressive expression of 












) differentiated cells 
5
. This classification thus reflects the activation status of 
antigen-experienced CD8
+
 T cells, rather than discriminating effector and memory cells. 
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Moreover, CD27 and CD28 expression does not allow distinguishing TCM from TEM, nor 
TEM from TEMRA. 
The prevailing data concerning the description of naïve, effector and memory CD8
+
 
T-cell populations in humans remains, thus, rather fragmentary. Manifestly, analysis of 
CD8
+
 T cells including solely two or three parameters are not sufficient to reveal the whole 
heterogeneity of the antigen-experienced CD8
+
 lymphoid compartment. The compound 
subsets are not clearly established, especially within the TEM and TEMRA compartments, and 
the correspondent differential roles and lineage relationships remain undisclosed. 
Interestingly, in different human chronic viral infections, as EBV, CMV, hepatitis C virus 
(HCV) and HIV-1, viral specific CD8
+
 T cells display distinct predominant phenotypes 
5-9
. 
However, it is not clear whether the lack of certain CD8
+
 T subpopulations results from a 
specific virus-induced blockage in differentiation or, instead, is a consequence of different 
clinical settings
4,10
. Thus, understanding the distribution, function and relationship of the 
CD8
+
 T-cell subpopulations is of fundamental value for the monitoring of the immune 
system in several experimental and clinical situations. 
The present study aims to describe thoroughly the heterogeneity of the human CD8
+
 T-cell 
compartment by establishing an accurate correlation between cell-surface phenotype and 
functional properties of each subset. In particular, this study characterizes the circulating 
human CD8
+
 T cell populations based on the simultaneous association of CCR7, CD45RA, 
CD27, CD28, CD11a and CD62L cell-surface markers. The association of these particular 
markers allowed the identification of 14 different CD8
+
 T-cell subsets, some of which 
never previously described. We isolated individual cells of each subset and studied in each 
cell the expression of 18 different mRNAs coding for cytokines, chemokines, cytotoxic 
molecules and several receptors. This work describes new CD8
+
 T-cell subsets, identifies 
homogeneous CD8
+
 T cell sub-populations and allows a predictable correlation between 
cell-surface phenotype and in vivo function. Moreover, it reports the presence of effector 
cells both in TEM and TEMRA subsets and suggests an asynchronous modulation of 










Isolation of peripheral blood cells 
PBMCs were obtained from healthy volunteers of both sexes with ages ranging from 22 to 
56 years old after informed consent. Heparinized venous blood was centrifuged on J Prep 
density gradient (Adgenix) and CD8
+
 T lymphocytes were purified from freshly isolated 
PBMC using the Dynal® CD8 Negative Isolation Kit (Dynal), according to the 
manufacturer’s instructions. CCR7 depletion was performed by negative selection of cells 





 T cells were >98% pure. 
 
Antibodies and reagents 
 
Purified and FITC-labeled anti-human CCR7 were purchased from R&D Systems. PE-
labeled anti-CD27 and APC-Cy7-labeled anti-CD8 were purchased from Ebiosciences. 
FITC-labeled anti-CD3 was purchased from Caltag. Streptavidin and other antibodies 
(CD62L anti-CD28, CD45RA, anti-CD4) were obtained from Pharmingen. They were 
directly coupled to FITC, allophycocyanin (APC), PE, PE-cyanine 7 (Cy7), APC-Cy7 or 
biotinilated, revealed by PE-Cy7- Streptavidin or APC-Cy7- streptavidin. 
 
Cell sorting and flow cytometry 
 
Cells were sorted using a FACS Vantage upgraded to DiVa configuration and equipped 
with an automatic cell deposition unit (Becton Dickinson). For single-cell sortings, cells 
were collected directly in 0,2 mL PCR tubes containing 5 µL of PBS 0,1% 
diethylpyrocarbonate (DEPC) and stored at -80ºC. Cells were analyzed in a BD-LSR I 
flow cytometer with CellQuest software (Becton Dickinson). 
 
Primers and quantitative multiplex RT-PCR 
 
Primer design was performed as described previously. Efficiency of amplifications for 
each gene and for each set of primers was calculated and proven to be maximal and 
uniform for all the genes in both first and second round of amplification. Competition was 
assessed and no interference was detected between the different primers and/or amplicons 
during multiplex amplification 
11






GATCAGCACAGACTTGCTTG-3’; granzyme A: 5’-CTCCTCATTCAAGACCCTAC-
3’, (sm)-5’-CTGCAGCTCACTGTAACTTG-3’, rev-5’-
CACATGGTTCCTGGTTTCACA-3’; granzyme B: 5’-CTTCCTGATACGAGACGACT-
3’, (sm)-5’-CCAGCAGTTTATCCCTGTGA-3’, rev-5’-CTTGTTGCTAGGTAGCCTGA-
3’; perforin: 5’-CCCTCTGTGAAAATGCCCTA-3’, (sm)-5’-
ACCAGCAATGTGCATGTGTC-3’, rev-5’-GGAGTGTGTACCACATGGAA-3’; CD3: 
5’-GGTTATTATGTCTGCTACCC-3’, (sm)-5’-TGGAGATGGATGTGATGTCG-3’, rev-
5’-GGTCAGATGCGTCTCTGATT-3’; IL-2: 5’-CTCACCAGGATGCTCACATT-3’, 
(sm)-5’-AACCTCTGGAGGAAGTGCTA-3’, rev-5’-ACAATGGTTGCTGTCTCATC-3’; 
IL-10Rα: 5’-CCTAGAGATCCACAATGGCT-3’, (sm)-5’-









GGTATCAGCGATGTCAAAGG-3’; TNF: 5’-CTCTTCTCCTTCCTGATCGT-3’, (sm)-
5’-CTCTCTCTAATCAGCCCTCT-3’, rev-5’-CTGGGAGTAGATGAGGTACA-3’; 
LTA/TNF-β: 5’-ACACCACCTGAACGTCTCTT-3’, (sm)-5’-




CACAACTCCGGTGACATCAAA-3’; Fas-L: 5’-CTGGTTGCCTTGGTAGGATT-3’, 
(sm)-5’-CAGCTCTTCCACCTACAGAA-3’, rev-5’-GGCAGGTTGTTGCAAGATTG-3’, 
(sm, semi-nested). Procedures for specific RT and multiplex semi-nested PCR are 
described in detail by 
11
. PCR products were resolved on a 1.5% agarose ethidium bromide 
gel. An aliquot of 4 µL from the first PCR of positive cells was used to quantify the 
expression level of each different gene. Real-time quantitative PCR was performed by 
adding 12 µL of SYBR Green PCR Master Mix (Applied Biosystems) to each well 
containing 4 µL of template and 8 µL of a primer mix with 0,25 µM of each specific 
primer in a 24-µL reaction volume using the ABI PRISM 7700 Sequence Detection 
System (Applied Biosystems). After a denaturation step at 95°C for 10 min, the cycle 
profile used was 30 sec at 95°C, 30 sec at 60°C, and 45 sec at 72°C for 60 cycles of 
amplification. Threshold cycle was determined on the linear phase of PCRs using the 
software Sequence Detector version 1.7 (Applied Biosystems). Absolute quantification 
was extrapolated from a standard curve obtained following the amplification of triplicate 
serial dilutions containing known amounts of cDNA molecules and run in parallel with test 








Cell-surface phenotypic characterization of the CD8
+
 T-cell subsets from the human 




 T-cell populations into four major subpopulations based on the 
expression of CCR7 and CD45RA, as previously reported
3,12
 (Figure 1A). The co-
expression of CD27, CD28 and CD11a (the alpha chain of LAF-1) was further evaluated 









quite homogeneous. Most co-expressed all these additional markers (Figure 1B, Table1). 
Furthermore, the intensity of expression of CD27, CD28 and CD11a did not vary within 
each cell subset (Table 2). In contrast, CCR7
-









) compartments contained T 
cells co-expressing CD28 and CD27 (double-positive, DP); expressing either one of these 
markers (single-positive, SP); or expressing none (double-negative, DN). Although the 
percentages of each T-cell subset varied between donors (Table 1), all these populations 
could always be found and presented the same characteristics in each individual donor (see 
bellow).  




 T-cell subsets expressing high levels of 
CD27 (CD27
high
) (Figure 1B, Table1). These subsets were present in both TEM and TEMRA 
sets and were mainly composed by CD27-SP cells, but could also harbor DP cells (Figure 
1B). In striking contrast to the other CD8
+
 T cell subpopulations, the presence of CD27
high
 
cells in blood appeared to be rather transitory, as the representation of these subsets in the 
same donor varied significantly with time.  
It was previously reported that in vitro activation of CD8
+
 T cells induces down-regulation 
of CD27 and CCR7 
3,13,14
 and up-regulation of CD28 and CD11a 
15,16
. Accordingly, TN 
cells had the highest levels of CD27 and CCR7 (Figure 1A, 2A), as compared to TCM, 
while TEM- and TEMRA-27SP expressed even lower levels of CD27 than TCM. CD28 and 
CD11a followed the opposite trend: CD28 expression was lower in TN than in all subsets 
of primed cells and CD11a was upregulated from TN to TCM < TEM < TEMRA (Figure 2B,C 
and Table 2). However, within the TEM and TEMRA subsets, cells expressing CD27 and/or 
CD28 (DP or SP) displayed similar expression levels of these markers, as well as identical 
high levels of CD11a (Figure 2). Interestingly, independently of their additional phenotype, 
CD27
high
 cells expressed relative low levels of CD11a when compared to any other subset 
of primed cells (Figure 2C and Table 2).  It was previously reported that CD27 could be 
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transiently up-regulated shortly after in vitro activation. The relatively low CD11a 
expression of CD27
high
 cells and their transitory presence in the blood suggest they may be 
recently activated CD8
+
 T cells. Therefore, CD27, CD28 and CD11a expression levels 




 T cells, but do not allow 




 cells behave as a 
distinctive sub-population, with CD11a levels approaching those of naïve cells. 
 
Expression of CD62L within the CCR7
–
 compartment is highly restricted to CD27
high
, DP 
and CD28-SP subsets 
 
CD62L plays a fundamental role on the migration of lymphocytes to secondary lymphoid 
organs. While TN and TCM CD8
+
 T cells are consistently CD62L
+
, only a fraction of 
CCR7
–
 cells expresses this adhesion molecule 
3
.We have further investigated if CD62L 




 T-cell subtypes (Figure 2D). We found a 
correlation to CD27/CD28 expression, but no differences between TEM/TEMRA subsets. 
Thus, independently of their CD45RA phenotype, either CD27
high
, DP or CD28SP cells 
contained abundant CD62L
+
 cells. Only a minor fraction of CD27SP cells expressed low 
levels CD62L. CD62L expression in DN cells was even lower. It is unlikely that such low 
expression might be sufficient to ensure migration to the lymph nodes, since we could 
never detect DN CD8
+
 T populations in lymph node cells (unpublished data). 
Altogether, these observations revealed that TN and TCM are homogeneous populations 
with respect to all additional markers, whereas TEM and TEMRA are significantly 
heterogeneous, containing multiple subpopulations that likely cross a large spectrum of 




 T-cell subpopulations heterogeneity evaluated at a single-cell level  
 
The further addition of CD27 and CD28 to previous established CD45RA and CCR7 cell 
surface markers subdivided the CD8
+
 T-cell compartment into fourteen phenotypically 
different cell subsets (Figure 1). Whether this subdivision is sufficient to fully describe the 
functional properties of CD8
+ 
T cells, or each of the individual CD8
+
 T-cell subsets can be 
yet heterogeneous, harboring cells with multiple functional potentialities is not known. To 
evaluate the homogeneity of CD8
+
 T-cell populations, we envisaged to isolate individual 
cells from each CD8
+
 T-cell subset by cell sorting and analyze multiple gene expression in 
each individual cell by a method of multiplex RT-PCR we developed. This method allows 
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to assess in each individual cell the simultaneous expression of genes coding for 
inflammatory chemokines, cytokines, cytotoxic molecules and several receptors described 
to be involved in CD8
+
 T-cell responses. To minimize the chances of include cellular 
contaminants in our study, we have purified CD8
+
 T lymphocytes by magnetic negative 
selection prior to sorting, and we have further assessed in each sorted cell the presence of 
the mRNA coding for CD3. Thus, these data correspond exclusively to CD8
+
 T cells 
expressing the CD3 mRNA. 
We found that some genes (IL-2, IL-10 or MIP-1α/CCL3) were expressed in such low 
frequencies (less than 5%) that their impact on functional profiles could not be analyzed at 
single-cell-level. Also some of these sub-populations were so rare (less than 0.05% of CD8 
cell sets) that could not be sorted reliably. For this reason, we failed to characterize 
CD27
high
-DP cells, and could only collect CD28-SP from one single donor. For all 
remaining 11 populations we have characterized fifteen different parameters in each 
individual cell. To evaluate if cell-surface phenotypes always correlated to peculiar 
functional profiles, we compared the gene expression profiles of three different 
individuals. We found that within each phenotype gene expression profiles were 
remarkably similar between all donors. When some variation was found, the ranges of 
expression are mentioned in the text.  
 
TN cells lack effector functions, but express several receptors types 
 
As expected, the less activated CD8
+
 T-cell set was TN (Figure 3A). These cells did not 
express mRNAs coding for chemokines, cytotoxic molecules or effector cytokines, such as 
TNF-α or IFN-γ. However, a small fraction of cells (<15%) generally expressed TNF-β 
(coded by the lta gene). In addition, about 40-50% of the cells expressed TGF-β1 and most 
expressed TGF-β receptor 2 (TGF-βR2). In addition to TGF-βR2, TGF-βR1 expression is 
also required for TGF-β1-induced signaling to occur. Co-expression of TGF-βR1 and 
TGF-βR2 was detected in more than 30% of the naïve cells. TN population also contained 
the highest frequency of cells expressing IFN-γR2, which determines the responsiveness to 
exogenous IFN-γ, and approximately one half of the cells expressed interleukin IL-10Rα. 
Interestingly, these results are coincident with the expression patterns found in mouse 
naïve CD8
+
 T cells, although TGF-β1 is then expressed in much lower frequencies 















subsets (Figure 3B). These populations expressed TGF-β1 at 
the same frequency as naïve cells and TNF-β was expressed in a slightly lesser extent. In 





 T-cell subsets. IL-10Rα frequencies increased up to 75% and 
perforin and granzymes were expressed in average by 20% and 10% of the cells, 
respectively. However, expression of perforin and either granzyme A or B was detected in 
separate cells, suggesting that cells expressing CD27
high
 are not cytotoxic.  Remarkably, 
the mRNA coding for the inflammatory chemokine RANTES (also known as CCL5) was 
detected in 45-70% of CD27
high
 cells. Importantly, TEM and TEMRA CD27
high
 subsets had 
undistinguishable gene expression profiles, suggesting they might play similar functional 
roles in vivo. 
 
TCM: the memory subset expressing fewer effector functions 
 





 subpopulations (Figure 3C). Three evident differences were noticed. First, 
the mRNA coding for granzyme A (GZMA) was up-regulated, since it was expressed in up 
to 40% of the cells. However, only a very modest percentage of TCM cells (<15%) co-
expressed this molecule along with perforin, indicating that only a small fraction of these 
cells can be cytotoxic. Secondly, expression of RANTES was also up-regulated and could 
be detected in more than 70% of the cells. Finally, expression frequency of the IFN-γR2 
was down-regulated being detected but in a small fraction of cells. It must be noted that 
only TN and TCM subsets do express IFN-γR2 mRNA, all other sets of activated T cells 
lacking this molecule. 
 
TEM and TEMRA harbor three hierarchically differentiated subsets 
 
The gene expression pattern of all CCR7
–
 subpopulations, with the exception of the 
previously described CD27
high
 subsets, shows a degree of functional differentiation 
significantly higher than the TCM subset (Figure 4). This was revealed by increased 
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expression of RANTES, which is consistently expressed my more than 90% of the cells, 
perforin, GZMA and IL-10Rα, together with further expression of additional molecules.  
Within CCR7
–
 cells, the DP cellular subsets were those more closely resembling the TCM 
subset. As compared to TCM cells, virtually all TEM and TEMRA-DP now expressed 
RANTES, GZMA and IL-10Rα, and perforin was expressed in much higher frequencies 
ranging from 50 to 80% (Figure 4A). In a fraction of these cells, we detected for the first 
time expression of Fas-L (6-20%) and macrophage inflammatory protein (MIP)-1β, also 
named CCL4 (14-40%).  Only very rare cells could score positive for IFN-γ or granzyme B 
(GZMB). Strikingly, the patterns of gene expression of TEM and TEMRA-DP populations 
were nearly overlapping, the sole difference concerning a slight increase on the frequencies 
of perforin and FAS-L expression in TEM-DPs. We were able to isolate CD28SP cells from 
a single donor and solely of the TEM compartment. Interestingly, this subset displayed a 
pattern of gene expression very similar to the DP subpopulations (Figure 4B), suggesting a 
close relationship.  
The TEM and TEMRA CD27-SP subsets were more activated than the DP subsets (Figure 
4C). Indeed, in addition to the genes already expressed at high frequency by DP cells, 
GZMB expression was up-regulated (10-50%), while the frequency of Fas-L expression 
shows a less striking increase (15-25%). Once again, we were surprised to notice an 
evident overlap between the expression patterns of TEM and TEMRA-CD27-SP subsets that 
was extended to all the molecules we have studied.  
TEM and TEMRA-DN CD8
+
 T cells displayed the most activated gene expression profile 
(Figure 4D). Now, near all cells expressed perforin and GZMA, GZMB was expressed by 
most cells and Fas-L expression frequencies increased. In some donors, IFN-γ expression 
was also up-regulated, being detected in up to 30% of the cells. Again, we found no 
difference in gene expression profiles between TEM and TEMRA-DN CD8
+
 T cell sets. 
Thus, the results obtained by single-cell multiplex RT-PCR clearly depict a hierarchy of T-
cell differentiation status in antigen-experienced cells. Importantly, this hierarchy is 
defined by CCR7 expression, CD27 expression levels and CD27/CD28 co-expression, but 
does not correlate with expression of CD45RA. 
 
Gene expression of TEM and TEMRA compounding subsets is similar at quantitative level 
 
Since the gene expression profiles of all CCR7
–
 T-cell subsets correlated to CD27/CD28 




 phenotype, we next investigated if we could 
distinguish TEM and TEMRA cell sets by a different amount of effector mRNA gene 
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expression. This approach was possible because in the methodology used here the 
efficiency of reverse transcription was evaluated 
11
. Therefore, we were able to directly 
quantify the number of mRNA molecules coding for distinct genes in each individual cell. 
Moreover, our methodology also uses PCR reactions of identical efficiency for all genes, 
allowing the comparison of different relative gene expression levels. We have thus 
quantified the expression of all genes in all gene expressing cells from different 
populations in the same donor. As expected, not all the genes were expressed at the same 
level. Perforin and MIP-1β had the lowest number of mRNA molecules per cell, while 
RANTES and the receptors for TGF-β and IL-10R displayed the highest level of 
expression levels (not shown). Nevertheless, the expression level of each gene was 
relatively constant between the different cell subsets (Figure 5). Moreover, TEM and TEMRA 
showed overlapping gene expression levels in all individual cells we tested, as exemplified 











 T-cell compartment encloses several subpopulations with multiple 
functionalities, including naïve, effector and memory subsets. The prevailing data 
describing these subsets in the peripheral blood is unclear in several aspects, mainly due to 
multiple analyses of CD8
+
 T cell subpopulations using different and limited sets of surface 
markers and functional properties. The present study aims to elucidate the ambiguous and 
missing data concerning the heterogeneity of the human CD8
+
 T-cell compartment. For 
this purpose, we used two approaches. Firstly, we performed a detailed characterization of 
the cell-surface phenotype of the circulating CD8
+
 T cell populations ex vivo, based on the 
simultaneous association of the most common and relevant cell-surface markers described 
in the literature, namely CCR7, CD45RA, CD27, CD28, CD62L and CD11a. These 
molecules are widely used to identify CD8
+
 T-cell subsets, but they are usually only 
partially associated 
1,3-5,12
. The concurrent association of all these cell-surface markers 
allowed the identification of multiple CD8
+
 T cell subsets, several of which were never 





 compartments, whose precise differential functions remained 
unclear thus far. The second strategy concerned an approach to evaluate the heterogeneity 
of each one of these cellular subsets. We studied individual cells in each population and 
each cell was characterized for the expression of 18 different mRNAs involved in T-cell 
functions. Single-cell gene expression analysis allowed the assessment of functional 
heterogeneity inside each cell subset and gave important insight concerning the differential 
function of the various subpopulations. Furthermore, we also found that each one of these 
particular phenotypes corresponded to specific patterns of gene expression, since each 
displayed reproducible gene expression patterns in all the donors studied. Thus, the 
phenotypes we here describe apparently can be used to predict defined characteristics in 
CD8
+
 subpopulations in normal healthy individuals. 
Our results show that the combination of CCR7, CD45RA, CD27 expression levels and 
CD28 permits to discriminate 14 CD8
+
 T-cell subsets. With the exception of CD27
high
 
cells, which display characteristics of recently activated populations, all remaining subsets 
could be found in all donors, albeit with different representations. When isolated and 
studied at single cell level, each subset displayed a characteristic pattern of gene 
expression. In CCR7
–
 cells, this pattern strongly correlated to expression of both CD27 and 
CD28, following a hierarchy of cell activation CD27
high 
< DP < CD28-SP < CD27-SP < 
DN. Surprisingly within each of these subsets, CD45RA
–
 TEM cells showed the same gene 
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expression patterns, at both qualitative and quantitative level, as their counterparts 
expressing CD45RA. These findings contradict the paradigm that T-cell activation 
necessarily leads to CD45RA loss, and that further maturation induces CD45RA re-
expression in such way that effector cells should be present only in the TEMRA 
compartment. They rather suggest that CD8
+
 T cells may modulate or not CD45R0/RA 
expression after activation, rather than TEMRA cells forcedly differentiate from TEM 
precursors.  





 populations. Our results on the study of CD27
high
 
subpopulations also support that CD45RA isoform can be maintained after T cell 
activation. It has been reported CD27 is transiently up-regulated after T-cell activation in 
vitro, the peak expression level occurring by 24 hours 
17,18
. Our results strongly support 
that CD27 is also up-regulated following in vivo activation, since CD27
high
 cells have all 
the characteristics of recently activated cells: they were not detected in all donors and their 
frequency in the same donor was not stable, suggesting that they may disappear with time. 
Furthermore, the gene expression profile of these CD27
high
 subpopulations was very close 
to that of naïve cells. As major difference, a fraction of CD27
high
 cells expressed RANTES, 
which has been reported as being one of the first genes to be induced after in vitro 
activation. It was described to be already up-regulated 3 to 5 days after T cell activation 
19-
21
. However, “recently activated” CD27
high
 cells with the same characteristics can be found 
in both TEM and TEMRA populations, indicating that primed populations can maintain 
CD45RA after activation. Other independent evidence suggests TEMRA populations can 
derive directly from naïve cells, since their replicative history may approach that of naïve 
T cells 
12
.  It is possible that besides CD45R0/RA, activated T cells may alternatively 
maintain or loose CD28/CD27. We could detect recently activated CD27
high
 cells that co-
expressed both molecules, as well as primed cells that were CD28-SP cells. 
Since our results argue against the model of a mandatory TEMRA origin from TEM cells, it is 
adequate to review the experimental evidences leading to this notion. The CD45R0 





 cells with all characteristics of effector cells forced to review this issue. In vivo 
analysis of antigen specific cells for persistent human viruses, commonly HCMV and 
EBV, showed that at early time points of acute infections epitope-specific CD8
+
 T cells 
were prevalent in the CD45R0
+







 T-cell subsets contain significant frequencies of cells with the same 
specificity 
22,23









. Nevertheless, this hypothesis was never fully confirmed. In the primary 
immune response to EBV infection, a frequency of 5-14% of EBV-specific cells yet 
expresses the CD45RA isoform early after infection and the CD45RA/R0 distribution of 
individual clones was not investigated 
22
. Wills and collaborators analyzed the distribution 
of a single CMV-specific clone in only two donors and always found the same clone in 
both CD45RA/R0
+
 subsets, albeit at different frequencies. However a more extensive 
study investigating CD45 isotype expression and the TCR Vβ usage showed that the 
dominance of the CD45 phenotype was extremely variable between individuals, as in some 
cases the immunodominant clone was predominantly CD45RA
+









 T-cell subpopulations supports the 
idea that those cells can differentiate directly from the naïve pool and, thus, a CD45R0
+
 
stage is not necessary 
12
. Furthermore, recent in vitro studies failed to induce CD45RA re-
expression in TEM cells, while TCM cells re-expressed CD45RA exclusively under cytokine 
influence, but never after T cell triggering. It is therefore clear that more thoroughly ex 
vivo studies are required to determine the lineage relationships between these cell types, 
possibly through the evaluation of the distribution of multiple clones in several 
independent donors. 






 T lymphocytes can issue directly from naïve 
cells 
12
 is in apparent contradiction with other data suggesting that TEMRA corresponds to a 
terminal differentiation stage, in contrast to TEM, given the highest perforin content and 
reduced division capacity 
3,4





 cells were not subdivided based on CD27 and CD28 expression. Our results 
clarify these apparent contradictory data. We show that TEM and TEMRA have different 
distribution of the compounding subsets DP, CD27-SP, CD-28SP and DN. DN cells, the 
most activated CD8
+
 T-cell subset, are enriched in the CD45RA
+
 compartment, explaining 
why this subset appeared to harbor more differentiated cells in previous studies. These 
results emphasize the importance of the additional characterization of CCR7
–
 cells through 
assessment of CD27 and CD28 co-expression. 
We also show that each subset within TEM and TEMRA CD8
+
 T-cell subpopulations is 
characterized by the acquisition of a particular effector function. Interestingly, this 
phenomenon appears to occur sequentially, in such a way that along the hierarchy of 
activation, the expression of each gene once induced is never lost in the subsequent 
activation stages. Hence, the DP subsets had high frequencies of cells expressing RANTES 
and GZMA, and a low perforin expression, whereas CD27SP cells maintained high 
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frequencies of RANTES and GZMA, but now up-regulated perforin, rare cells expressing 
GZMB. Subsequently, DN cells co-expressed high frequencies of RANTES, GRANZA 
and perforin but now also up-regulated GZMB, and Fas-L expression. These results 
demonstrate that differential cellular activation leads to the progressive co-expression of 
multiple “killer” mRNAs by the same cell. Since each of these molecules mediates killing 
by a different mechanism, their co-expression may occur to improve killer efficiency of 
individual cells. Indeed, association of granzymes and perforin is fundamental for perforin-
mediated cytotoxicity 
25
 and FasL cytolysis alone is not very efficient 
26
. In humans, it was 
shown that different viral infections selectively induce a preferential differentiation of cells 
to distinct phenotypes 
5
. EBV induces DP cells, HIV CD27-SPs and CMV generates DN 
types. These differential phenotypes were attributed to a different capacity of lymphocytes 
to become fully activated. Nevertheless, all these infections induce major expansions of 
CD8
+
 T lymphocytes in the acute phase and infection by EBV is well controlled by DP 
cells. Thus, an alternative possibility is that the immune response to each virus requires the 
generation of particular effector subsets. Actually, since all TEM and TEMRA populations 
(with the exception of CD27
high
 subsets) co-express perforin and granzymes and are able to 
mediate cytotoxicity, it is possible that the panel of molecules expressed by each one CD8
+
 
T-cell subpopulation confers particular advantages for the control of each type of 
infections. Therefore, the predominance of a given phenotype amongst viral-specific CD8
+
 
T cells can result from the selection of the most advantageous CD8
+
 T-cell subset in the 
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47 16 8 22 1,5 5,5 
CD45RA– 
(30-65) (2-27) (2-15) (7-46) (0,6-2) (1-13) 
21 19 6 47 2 5 
CD45RA+ 
(10-44) (7-28) (2-12) (19-72) (0,9-3) (2-15) 
 
Results are from 8 healthy donors. They depict the average distribution of different CCR7
–
 
TEM or TEMRA subpopulations expressing CD27 and/or CD28 and, in brackets, the 















Table 2. Expression levels of different markers in CD8
+
 T cells 
 CD27 CD28 CD11a 
N 445 30 164 
TCM 270 74 513 
TEM 153 66 608 
TEMRA 119 51 628 
CD27
high
 542 37 181 
 
Results show mean fluorescence intensity (MFI) of stainings for different cell surface 
markers gated on positive populations in PBMCs of one donor. Similar relationships were 









Figure 1. CD27/CD28 expression in CD8
+
 T peripheral blood lymphocytes. PBMCs 
were subdivided using CCR7 and CD45RA expression in naïve (TN) central memory (TCM) 
effector memory (TEM) and effector memory CD45RA
+
 (TEMRA) cell subpopulations (A) 
and CD27/CD28 co-expression evaluated in each of these cell sets (B).  
Figure 2. Expression levels of different markers in different CD8
+
 T-cell subsets. 
Upper panels: comparison of CD27 (A) or CD28 (B) and CD11a (C) expression levels on 
TN cells (shadowed histograms) with:  TCM (left); TEM: (thick line) TEMRA (dotted line). On 
(C) left graph includes CD11a expression on CD27
high 
cells (dashed line). Lower panels 
(D): TEM and TEMRA subpopulations were subdivided accordingly to their expression of 


















 (DN) cell sets.  Results show CD62L expression in 
each of these sets in one representative donor.  














(C) TCM were single-cell sorted and the expression multiple genes was determined 
simultaneously in each individual cell. Each horizontal line depicts the same cell individual 
cell that is numbered. Each vertical line shows a different gene.  All cells tested were 
positive for the expression of CD3ε mRNA. Results depict representative profiles of three 
donors studied, with overlapping results. The following genes ccl5, ccl4, tgfb1, tnf, lta, 
ifng, prf1, gzma, gzmb, faslg, tgfbr1, tgfbr2, ifngr2 and il10ra code, respectively, for 
RANTES, MIP-1β, TGF-β1, TNF-α, TNF-β, IFN-γ, perforin, granzyme A, granzyme B, 
FasL, TGF-β receptor 1, TGF-β receptor 2, IFN-γ receptor 2 and IL-10 receptor α. 
Figure 4. Single-cell expression profiles of the most differentiated CD8
+
 T-cell 
subpopulations. Single cells of each CD8
+
 T-cells subset were sorted individually and a 
multiplex RT-PCR was performed as for Fig. 3. Each single cell corresponds to one line, 
whereas the expression of the several genes studied is depicted vertically. The 
representative gene expression patterns presented correspond to (A) the DP, (B) CD28-SP, 




 T subsets. Results depict representative profiles of 
three donors studied, with overlapping results, with the exception of CD28-SP for which 
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one single donor was studied. The following genes ccl5, ccl4, tgfb1, tnf, lta, ifng, prf1, 
gzma, gzmb, faslg, tgfbr1, tgfbr2, ifngr2 and il10ra code, respectively, for RANTES, MIP-
1β, TGF-β1, TNF-α, TNF-β, IFN-γ, perforin, granzyme A, granzyme B, FasL, TGF-β 
receptor 1, TGF-β receptor 2, IFN-γ receptor 2 and IL-10 receptor α. 
Figure 5. Quantitative assessment of mRNA expression in single cells. Single cells of 
each CD8
+
 T-cell subsets were sorted and cells expressing each gene identified, as shown 
in Fig.3, 4.  In all the positive cells shown in these figures, the mRNA expression levels 
were further quantified. Each graph shows three representative cells from each population. 
We show GZMA and RANTES amplification since these genes can be found in all cell 
sets, and thus their expression levels can be directly compared. We found that different 
genes were expressed at different levels, but expression of each gene was similar in cells 

































































Part I. Single-cell multiplex RT-PCR 
 
 
The heterogeneity of lymphocyte populations defines the spectrum of 
potential fates and roles that the individual compound cells might have. Cell fate 
and function are actually deeply conditioned by different patterns of gene 
expression. Hence, the study of the cellular gene expression balance is crucial to 
understand several types of biological events and differentiation processes, and 
has a major impact on the comprehension of the behavior of cellular populations. 
Different cell fates likely rely on both qualitative and quantitative differences 
of gene expression affecting multiple genes. For example, in the mouse it has 
been demonstrated that resting memory T cells maintain certain functions after 
antigen elimination, which suggests that differences between memory and effector 
cells may be more quantitative than qualitative (Opferman et al., 1999; Selin and 
Welsh, 1997; Veiga-Fernandes et al., 2000). Additionally, acquisition of effector 
functions may require the co-expression of several effector molecules by the same 
cell (e.g., co-expression of perforin and granzymes for effective cytotoxic activity) 
and this information is fundamental on the evaluation of vaccination protocols that 
may rely on the induction of such differentiation programs. However, 
methodologies available for studying gene expression present several limitations. 
Micro-arrays and RT-PCR, which allow the detection of multiple gene expression, 
only enable assessments at a population level. In turn, techniques that permit the 
study of multiple gene expression on single-cells are just qualitative and allow 
studies of only few genes. Furthermore, in vitro studies were shown to induce 
modifications in the cellular behavior. In particular, the capacity of T cells to 
proliferate in vitro does not correlate with their capacity do proliferate in vivo 
(Bachmann et al., 1999a; Tanchot et al., 1998; Veiga-Fernandes et al., 2000), and 
the production of cytokines by individual cells, upon short-term in vitro reactivation, 
is extended to a higher frequency of cytokine secreting cells (Panus et al., 2000; 
Veiga-Fernandes et al., 2000). New approaches allowing the study of the gene 
expression of individual cells directly ex vivo and in a quantitative fashion were 
therefore lacking. 
We developed a new technique of quantitative single-cell multiplex RT-PCR 
that overcomes all the previous limitations. This method allows the study of 
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individual cells directly ex vivo and the simultaneous quantification of a vast array 
of cellular transcripts (up to 20) at a single-cell level. Since it can be performed 
with very small numbers of cells up to one cell, it has a significant interest for the 
analysis of minute samples, which commonly are the only source of diagnosis in 
several pathologies in humans. Furthermore, it is a very sensitive technique 
allowing the detection of 2 molecules per cell. As several genes are amplified 
simultaneously, competition between different primers or for limiting resources 
were common limitations for the simultaneous study of multiple cell functions. We 
show that in our method, despite the simultaneous amplification of several 
molecules, all PCRs have the same efficiency. In addition, this method also 
enables the progress from quantitative assays performed at population level to 
quantitative assays at single-cell level. This allows discriminating if a raise or 
diminution on the expression of a given function, such as cytokine production, is 
due to a variable frequency of cells expressing that function or, instead, results 
from an increased or lower amount of function produced per cell. 
An additional advantage of this method is the possibility to quantify the 
absolute number of transcripts present in a cell, in contrast to the classical real-
time PCRs that in reality only provide a relative estimation of the number of 
messages. We used two approaches to achieve this goal. First, by using different 
numbers of cells, we established control curves correspondent to different copy 
numbers based on the amplification of the genomic DNA. Since each cell has two 
copies of DNA coding for each gene, we could run a scale based on a range of 
cells in parallel with our RT-PCRs and from these curves of amplification estimate 
copy numbers. Secondly, both the analysis and the precise quantification of the 
absolute copy number of messages present in a cell depend not only on the PCR 
efficiency, but also on the efficiency of the reverse transcription reaction. We 
addressed the later point by comparing the amplification of a known number of 
mRNA molecules of a given sequence (where the RT reaction precedes the 
amplification), with the amplification of an identical number of double-stranded 
molecules of the same sequence (where the RT reaction is not required for the 
amplification). This strategy enabled us to precisely determine the efficiency of the 
reverse transcription step in our method. In addition, the synthesized double-
stranded molecules allowed us to establish a standard scale for PCR 
quantification that avoids the inconvenient manipulations needed for sorting 
different cell numbers required for the DNA calibration. 
 137 
This method brings new perspectives for the study of lymphocyte 
populations ex vivo. Hereafter, it is possible to accurately determine the kinetics of 
expression of distinct cellular functions in multiple immunological events, such as 
primary and secondary immune responses or hematopoiesis. Although these 
issues can be partially addressed by techniques using a population approach, the 
exact evaluation of both frequency of cells expressing given functions and the 
amount of each function produced in a per cell basis, can only by achieved by 
means of a quantitative single cell method. Furthermore, this method can be 
applied in the study of different species, in particular mice and men. Finally, it can 
also be adapted to study the expression of a flexible set of genes. Indeed, this 
approach is currently being used in the study of different aspects of the murine 
and human hematopoiesis, in the study of the immune response to the challenge 
of different pathogens in the mouse system, and in the characterization of the 
lymphocyte populations isolated from human secondary lymphoid organs, such as 
lymph nodes and spleen. The main conclusions attained in the study of the human 
CD8+ T lymphoid populations isolated from the blood described on the next pages 
illustrate well the advantages conferred by this approach. 
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Part II. Characterization of human CD8+ T-cell subpopulations 
 
The CD8+ T-cell compartment harbors several subpopulations with multiple 
functionalities, including naïve, effector and memory subsets. As previously 
detailed in the last section of the introduction chapter, the prevailing data 
concerning the description of these subsets in the human peripheral blood is 
rather fragmentary, since a multitude of studies used a different and limited set of 
surface markers to identify each subset. A comprehensive analysis of the global 
cell-surface pattern of co-expression of the most commonly used markers in 
human CD8+ T cells was, thus, lacking. 
The central goal of this thesis was to fulfill the gaps resulting from the 
multiple disconnected studies concerning the characterization of human CD8+ T-
cell subsets and unify the overall knowledge relating to this issue. For that purpose 
we analyzed the CD8+ T-cell compartment by simultaneously crossing the most 
common and relevant cell-surface markers described in the literature, namely 
CCR7, CD45RA, CD27 and CD28. This approach led to the discrimination of 
fourteen subsets of CD8+ T cells, including the minor and uncharacterized 
CD27high subpopulations. In addition, we could directly compare the primed 
subsets present within the CD45RA+ and CD45RA- compartments. This 
comparison is extremely relevant, since up to now the precise differential functions 
between CD45RA+ and CD45RA- subpopulations remained unclear and are thus 
vaguely referred. Finally, we choose a novel strategy to study the CD8+ T-
lymphocyte subpopulations: the single-cell multiplex RT-PCR. We found this 
approach would be very informative regarding the global gene expression of each 
T-cell subset and, at the same time, would be a helpful tool to assess the 
heterogeneity of subpopulations. In addition, despite information being restricted to 
the mRNA level, we found this method gives valuable and discriminating insight 
concerning the functional potential of each cellular subset. 
 
Rarely detected genes: IL-10, IL-2 and MIP-1α 
 
IL-10 is a multifunctional cytokine that regulates a variety of functions of 
hematopoietic cells. Its main role seems to be containment and eventual 
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termination of inflammatory responses, enabling elimination of infectious 
organisms with minimal damage to host tissues (Moore et al., 2001). 
Transcription of the IL-10 gene is regulated by Sp1 and Sp3, two 
transcription factors expressed constitutively by many different cell types, including 
T cells (Tone et al., 2000). It was reported that comparable promoter activity could 
be measured in resting and stimulated T cell lines, but the levels of IL-10 mRNA 
varied after activation. Such control is achieved by degradation of IL-10 mRNA, 
which contains several instability elements, and thus act at the posttranscriptional 
level (Powell et al., 2000). This strategy may perhaps facilitate a more rapid 
control of IL-10 expression than can be achieved by activation of transcription 
(Moore et al., 2001). 
In our study of gene expression by single-cell RT-PCR, expression of IL-10 
was rarely detected in all of the sorted CD8+ T-cell populations. If regulation of IL-
10 expression in physiological conditions occurs as described for T-cell lines, 
CD8+ T lymphocytes in the blood failed to receive the appropriate stimuli that 
induce posttranscriptional stabilization of IL-10 mRNA and ultimately lead to the 
expression of this cytokine. CD8+ T lymphocytes expressing IL-10 should therefore 
be encountered elsewhere in the body. We have isolated CD8+ T lymphocytes 
from human lymph nodes and we have begun the study of CD8+ T-cell 
subpopulations by multiplex RT-PCR at the single-cell level. Our preliminary 
results indicate that in some CD8+ T-cell subsets we could detect significant 
frequencies of IL-10 producing cells, up to 20% (unpublished results). These 
evidences strongly suggest that IL-10 is produced by CD8+ T cells following 
activation in the peripheral lymphoid tissue. The production of IL-10 could possibly 
result from the high levels of co-stimulation and/or helper signals that CD8+ T cells 
receive in these sites. Our observations do not exclude the possibility that CD8+ T 
cells can also receive, in the sites of injury, similar stimuli that allow IL-10 
secretion, which might be fundamental for the termination of some inflammatory 
responses occurring in those sites. 
Similarly to IL-10, we failed to detect expression of IL-2 in CD8+ T cells 
circulating in the peripheral blood. However, in some cell subsets of the lymph 
nodes, a modest (~15%) frequency of cells expressed the mRNA coding for IL-2. 
This cytokine was reported to be early expressed gene following T-cell activation 
(Ullman et al., 1990). Its expression is induced within hours after TCR 
engagement. Furthermore, the mRNA coding for IL-2 is extremely instable and 
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rapidly degraded in the absence additional stabilization factors, such as co-
stimulation through CD28. These reasons might explain why IL-2 expressing cells 
could be detected exclusively in the lymph node CD8+ T-cell populations. 
 
Macrophage inflammatory protein 1-α (MIP-1α, or CCL3), similarly to 
RANTES and MIP-1β, is a chemokine that attracts immunocompetent cells to the 
sites of infection. Its production and secretion generally requires cell activation. 
MIP-1α shares with RANTES and MIP-1β the same receptor, CCR5, whose 
expression is modulated upon chemokine binding (Rossi and Zlotnik, 2000). By 
single-cell RT-PCR, in striking contrast to MIP-1β and especially RANTES, we 
detected expression of the mRNA coding for MIP-1α only sporadically. This result 
indicates that circulating CD8+ T lymphocytes producing MIP-1α are very rare 
(<5%). In the mouse, MIP-1α production by T lymphocytes following activation 
was shown to be induced in vitro by co-stimulation through CD28 (Herold et al., 
1997). Together with our results, this data raises the possibility that T cells 
expressing the transcript for this chemokine should more probably be found in the 
secondary lymphoid organs. Surprisingly, in our preliminary analysis of the lymph 
node CD8+ T-cell subpopulations, we were unable to detect expression of MIP-1α 
as well. However, in single-cell analyses we performed on splenic CD8+ T-cell 
subpopulations, we found within some CCR7- subsets cells expressing MIP-1α 
that could reach a frequency of 20% (unpublished results). These observations 
indicate that CD8+ T lymphocytes receive the appropriate signals that induce MIP-
1α expression mostly in the spleen. The nature of these signals is uncertain and 
our data suggest that they might be delivered by cells that are excluded from the 
lymph nodes, but not the spleen. In the literature, production of MIP-1α (and MIP-
1β) is described to be induced by several proinflammatory stimuli, including LPS, 
viral infection, TNFα, IFNγ and others (Maurer and von Stebut, 2004). 
Interestingly, we found high frequencies (>50%) of cells expressing TNF-α and 
IFN-γ in the spleen, but not in the peripheral blood or lymph nodes. Thus, induction 
of MIP-1α expression by CD8+ T cells may require TNF-α and/or IFN-γ signals, 
whereas, in contrast, these signals are apparently not essential for expression of 
the highly related chemokines MIP-1α and especially RANTES (discussed later). 
Another possibility is that MIP-1α synthesis by human CD8+ T lymphocytes occurs 
preferentially in the site of infection, in response to signals delivered by other cells 
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that were also recruited. The two hypotheses are not mutually exclusive. 
Alternatively, MIP-1α mRNA might be more unstable than MIP-1β and RANTES 
mRNAs, and TNF-α and/or IFN-γ signals are continuously required for stabilization 
of MIP-1α transcript. This hypothesis seems unlikely since MIP-1α and MIP-1β are 
highly related chemokines sharing 57% of the gene sequence, and up to now no 
differential regulation of gene expression was reported. 
Our observation that MIP-1α is expressed by CD8+ T lymphocytes in the 
spleen is in line with previous reports ascribing to MIP-1α an important role on the 
differentiation of CD4+ T lymphocytes into TH1 polarized cells. It has been 
described that MIP-1 proteins can regulate immune responses by modulating TH 
differentiation (Rossi and Zlotnik, 2000). Consistent with this possibility is the fact 
that CCR5-deficient mice display TH2-skewed cytokine profiles (Andres et al., 
2000). 
The fact that MIP-1α, but not MIP-1β, expression is virtually absent from the 
human peripheral blood, together with the observation the incidence of cells 
expressing MIP-1β is always superior to the frequency of MIP-1α-expressing cells 
in the spleen (unpublished results), strongly suggests a functional specialization. 
As mentioned above, MIP-1α, similarly to RANTES and MIP-1β, bind CCR5, a 
chemokine receptor expressed mostly by macrophages and to lesser extent by 
activated T cells and DCs. In addition, MIP-1α and RANTES, but not MIP-1β, can 
also bind CCR1, which is mostly expressed by macrophages and T cells, and less 
significantly by neutrophils and eosinophils (Maurer and von Stebut, 2004). 
Interaction of MIP-1 proteins (and RANTES) with their cognate receptors is known 
to be crucial in the orchestration of acute and chronic inflammatory responses, 
mainly by recruiting cells for the sites of infection, including T cells. The fact that 
MIP-1β can not bind CCR1 implies that only MIP-1α and RANTES can act on cells 
expressing CCR1. Collectively, these data together with our results suggest that 
both MIP-1α and MIP-1β are very efficient in attracting macrophages, which 
express high levels of CCR1 and CCR5. Nevertheless, since a higher proportion 
of cells expressed MIP-1β, this chemokine should play a major role in the 
recruitment of macrophages by CD8+ T lymphocytes in relation to MIP-1α. 
Conversely, since CCR1 is expressed in higher levels than CCR5 in T 
lymphocytes (Maurer and von Stebut, 2004), MIP-1α might be playing a prominent 
 142 
role in inducing chemotaxis on T cells. Nevertheless, a significant role for RANTES 
can not be excluded. 
 
 




 As discussed previously, TGF-β1 is a multifunctional cytokine whose 
spectrum of action depends of several external factors, such as co-stimulation, 
cytokine context, etc. Expression of TGF-β1 in an important fraction of cells was 
detected in all the CD8+ T-cell subpopulations studied by single-cell RT-PCR. 
Nevertheless, no drastic differences of TGF-β1 expression were observed 
between CD8+ T-cell subpopulations, apart perhaps a modest tendency of slightly 
higher frequencies by more differentiated CCR7- subsets (DP, 28SP, 27SP and 
DN), as compared to CCR7+ and CD27high cells. CCR7- CD8+ T-cell populations 
with distinct degrees of differentiation, defined by differential expression of CD27 
and CD28 molecules, contain comparable frequencies of cells expressing the 
mRNA coding for this cytokine. Furthermore, no pattern of segregation with other 
particular functions, such as its own receptors, could be ascribed. For these 
reasons, it is difficult to attribute a specific significance or specify a particular 





 TNF-β, also named lymphotoxin α (LTA), is a cytokine expressed 
prominently in the lymphocyte compartment. When produced as homotrimers 
TNF-β is secreted, but it can also be found in a membrane bound form when 
complexed with monomers of another related protein, lymphotoxin β. Signaling 
initiated upon ligation of TNF-β to its receptor is thought to be crucial for the 
induction of key cytokines, chemokines and other factors that organize and 
maintain the complex microenvironment within lymphoid tissues (Fu and Chaplin, 
 143 
1999; Ware et al., 1995). A role in lymphoid organ development was also reported. 
TNF-β can also act in the periphery, presumably as a modulator in the immune 
response. In particular, it is considered to be a key element in promoting 
inflammatory processes (Ware, 2005). 
Recent studies in the mouse system revealed that TNF-β has a constitutive 
expression on naïve lymphocytes within lymphoid organs, perhaps contributing to 
the homeostasis of the tissue. Antigen-specific and nonspecific activation of T 
lymphocytes from peripheral blood can also induce transcription and protein 
expression of TNF-β. Cytokines, like IL-2, seem to play an important role in the 
regulation of TNF-β expression by human T lymphocytes (review by Ware, 2005). 
The expression of TNF-β on single-cells studied by RT-PCR was extremely 
inconsistent between populations and donors. For instance, it is consistently 
expressed by 15% of the naïve CD8+ T cells in two donors, but absent from a third 
one; or, in one donor only CD27high and TCM contain some cells expressing TNF-β, 
while in another cells expressing the mRNA coding for this cytokine were found in 
nearly all populations. Moreover, quantitative assess of the number of TNF-β 
mRNA molecules produced per cell showed that cells from all the subsets express 
comparable amounts of this transcript. Collectively, these results are quite 
puzzling and do not indicate a clear pattern of expression that correlates with 
surface phenotype. It might be possible that is not associated to a genetic 
programming in CD8+ T cells inherent to the general state of “naïve”, “TCM”, “TEM-
DP”, etc. If this is the case, expression of TNF-β may possibly be influenced by 
external factors, such as the cytokine environment, independently of the 
differentiation stage of the cell. Further investigation on the factors that influence 
TNF-β gene expression is required to confirm this hypothesis. 
 
 
Expression of several types of receptors by CD8+ T-cell subsets 
 
Single-cell analysis of mRNA expression of the CD8+ T-cell subsets 
revealed that the great majority of the cells of all the populations express the 
mRNA coding for several receptors, like the receptors 1 and 2 for TGF-β (TGF-
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βR1 and TGF-βR2), the signaling chain of the IFN-γ receptor (IFNγ-R2) and the 
binding chain of the receptor for the IL-10 (IL10Rα). 
 
TGF-βR1 & TGF-βR2 
 
In all the studied CD8+ T-cell subsets, we found a considerable expression 
of the receptors for the TGF-β, but no substantial differences on their expression 
pattern between the distinct CD8+ T cell populations. Since TGF-β is a cytokine 
that regulates multiple cellular processes in T lymphocytes, including proliferation, 
differentiation and survival, such a comparable responsiveness to TGF-β by the 
CD8+ T-cell subpopulations does not necessarily mean that this cytokine will 
trigger the same outcome on each one them. In particular, target cells at distinct 
differentiation states may receive different additional regulatory signals, including 
co-stimulation and cytokine signals, which can influence TGF-β regulation of T cell 
activity (Li et al., 2006). Therefore, the true meaning of these results is rather 
difficult to infer at this stage.  
In the naïve compartment, our results show that, in general, TGF-βR1 was 
expressed simultaneously to TGF-βR2 in more than 30% of the cells. These 
evidences indicate that only one third of the naïve CD8+ T cells can potentially be 
regulated by the action of TGFβ. Importantly, in naïve T cells, TGF-β was reported 
to inhibit antigen-driven expansion in vitro, in the absence of co-stimulation (Kehrl 
et al., 1986). The anti-proliferative effect of TGF-β is, however, decreased by 
CD28 co-stimulation. Furthermore, anti-proliferative effect of TGF-β apparently 
depends on the strength of stimulation. Hence, at weak stimulatory conditions 
TGF-β prevents naïve T-cell expansion at a greater extent than when stronger 
stimuli are provided (Gunnlaugsdottir et al., 2005). Cottrez and co-workers have 
proposed a model for regulation of TGF-β responsiveness by T cells during 
activation (Cottrez and Groux, 2001). This model predicts that naïve T 
lymphocytes generally express TGF-βR2, which would render them susceptible to 
negative regulation by TGF-β, thus preventing inappropriate activation by antigens 
presented by nonprofessional APCs. Upon stimulation by DCs in lymph nodes, T 
cells would down-regulate TGF-βR expression and migrate to sites of infection 
without being negatively regulated by TGF-β, which is widely expressed in 
different tissues. Our results are in disagreement with this hypothesis. Despite 
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circulating naïve CD8+ T lymphocytes widely express TGF-βR2, co-expression of 
TGF-βR1 and TGF-βR2, which determines responsiveness to TGF-β, is limited to 
a minor subset of cells. Alternatively, our results suggest that, in vivo, naïve T cells 
from the human peripheral blood display different susceptibilities to TGF-β 
regulation. The absence of TGF-β receptor co-expression on a significant subset 
of naïve CD8+ T cells might be an indicator that these cells escape the control by 
TGF-β and, thus, can be activated by weaker stimuli. Only a smaller subset would 
require higher signal strength conditions (in terms of TCR activation and co-
stimulation) in order to initiate a productive immune response. Because incubation 
with TGF-β prevents the expression of molecules required for execution of effector 
functions, but, at least in the mouse system, does not inhibit the up-regulation of 
molecules that usually report the activation status of the cell, Gorelik and Flavell 
suggested that activation of naïve T cells in the presence of TGF-β might favor the 
differentiation of TCM (Gorelik and Flavell, 2002). Although this T-cell subset 
displays several typical features that fit into the classical definition of memory cell, 
such as long-living and enhanced proliferative capacity as compared to naïve 
cells, it can not exert effecter functions immediately on activation. In addition, TCM 
were reported to be able to differentiate into TEM or TEMRA (Geginat et al., 2003; 
Lanzavecchia and Sallusto, 2000; Wherry et al., 2003). Interestingly, T 
lymphocytes activated in the presence of TGF-β (in the absence of IL-2) remain in 
a similar undifferentiated state, expressing no effector functions, and also retain a 
pluripotent differentiation capacity (Gorelik and Flavell, 2002). A differential 
responsiveness to TGF-β within the naïve CD8+ T-cell compartment could, thus, 
reveal a division on the possible outcomes following activation: the lymphocytes 
co-expressing TGF-β receptors would preferentially differentiate into TCM, while 
those lacking co-expression of both TGF-β receptors would directly differentiate 
into TEM or TEMRA. Further investigation is required to confirm this hypothesis. 
A slight trend for an increased responsiveness to TGF-β, given by the co-
expression of TGF-βR1 and TGF-βR2, could be ascribed to the CCR7- CD8+ T-cell 
subsets, with a modest tendency to augment from DP and CD28SP  CD27SP  
DN subsets. This might be related with the ability of TGF-β of inhibiting T-cell 
proliferation. However, TN and TCM, which were described to have a strong 
proliferative potential, are also responsive to TGF-β at a significant extent. It 
seems therefore unlikely that the loss of proliferative capacity might result 
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exclusively from the action of TGF-β. Rather, signaling through the co-stimulatory 
receptors, which are differentially loss in distinct activation stages, probably play a 





IFN-γR2 is a fundamental component of the IFN-γ R complex that plays only 
a minor role in ligand binding, but is required for signaling (for a review, see Stark 
et al., 1998). Unlike IFN-γR1, which is moderately expressed at the surface in 
nearly all cells, IFN-γR2 is constitutively expressed at extremely low levels. 
Expression of IFN-γR2 is controlled by external stimuli and its regulation is a 
critical factor in determining IFN-γ responsiveness (Bach et al., 1997). The best 
defined effects of IFN-γ on CD8+ T lymphocytes are indirect and related to the 
increase of antigen presentation, by induction of expression of the 
immunoproteasome, the TAP transporter proteins and MHC class I molecules 
(Stark et al., 1998). More recently, it has been reported that IFN-γ can also have a 
direct action on CD8+ T cell activity. In the mouse models of infection with Listeria 
monocytogenes and LCMV, IFN-γ was reported to regulate immunodominance of 
the responding cells (Badovinac et al., 2000; Tewari et al., 2004). In addition, 
comparison of simultaneous wild-type and IFN-γR1-deficient cell-responses to 
LCMV in experiments of dual adoptive transfer have demonstrated that IFN-γ acts 
directly upon CD8+ T cells to increase their abundance during acute viral infection 
(Whitmire et al., 2005b). 
Single-cell RT-PCR results show that expression of the mRNA coding for 
IFN-γR2 was observed in only two CD8+ T-cell populations, naïve and TCM, and 
the highest expression frequency resides in the former. A recent study in which 
human naïve, effector and memory CD8+ T cells were separated according to the 
CD45RA/CD27 classification and the correspondent gene expression analyzed by 
microarrays reports that INF-γR2 expression was exclusive of naïve cells (Holmes 
et al., 2005). Our results disagree with this conclusion, since we have consistently 
detected the presence of transcripts coding for IFN-γR2 in a fraction of TCM cells in 
all donors.  
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Remarkably, the maximal frequency of IFN-γR2-expressing cells found 
within the naïve CD8+ T-cell subset did not exceed 25%. Since expression of IFN-
γR2 dictates the capacity to respond to IFN-γ and, thus, identifies cells that likely  
play a pivotal role in an anti-viral response, it is surprising to conceive that IFN-γ 
responding cells might be present at such reduced frequencies. In the splenic 
CD8+ T-cell subsets, we have found higher frequencies of IFN-γR2 expression. 
This finding suggests that signals required for the up-regulation of this receptor are 
probably provided preferentially in the sites where antigen presentation occurs. 
Moreover, the fact that expression of IFN-γR2 is reduced when CD8+ T 
lymphocytes leave these sites may be an indicator that it is crucial for IFN-γ 
responsiveness to be avoided when the infectious agent is not present. 
In the mouse system, it was described that expression of IFN-γR2 in CD8+ T 
cells is transiently down-regulated at the mRNA level shortly after activation, being 
progressively regained by a smaller subset of memory cells after the expansion 
phase. The ability to phosphorylate STAT1, a molecule involved in the signaling 
pathway initiated by binding of IFN-γ to its receptor, was 
coincident with re-expression of IFN-γR2, indicating that 
responsiveness to IFN-γ correlates with mRNA expression 
of IFN-γR2 (Haring et al., 2005). CD8+ T cells are known to 
produce themselves high amounts IFN-γ after antigen 
activation (Slifka et al., 1999). The authors have therefore 
proposed that loss of responsiveness to IFN-γ during the 
expansion phase might be necessary to evade the 
potentially apoptotic effects of IFN-γ during that phase of 
the immune response, in which it is important for activated 
cells not only survive, but also expand to sufficient 
numbers to clear rapidly growing pathogens. Our findings 
that INF-γR2 expression is absent from all the antigen-experienced subsets, but 
TCM, suggest that IFN-γ stimulation might be deleterious for cells with poor 
proliferative potential, such as effector and memory cells of the TEM/TEMRA subsets. 
Alternatively, and since TN and TCM are two mostly undifferentiated populations 
that, following stimulation, will proliferate and further differentiate into effector 
and/or memory cells, signaling through the IFN-γR2 might be required to initiate 
the differentiation program that ultimately can lead to up-regulation of effector 
Figure 10. Number of 
mRNA molecules per 
cell coding for IFN-γR2 
in naïve and central 
memory cells in one 
donor. 
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functions. Characterization of the putative common downstream molecules that 
mediate IFN-γ signaling and differentiation of effector functions would be helpful to 
elucidate this issue. 
 In the same aforementioned study, it was further reported that memory 
cells express IFN-γR2 mRNA at lower levels than naïve cells. We have evaluated 
quantitatively the expression of IFN-γR2 at the mRNA level in one donor and found 
precisely the opposite result (Figure 10). This difference can be explained 
considering the fact that the measurement of the number of IFN-γR2 mRNA 
molecules in the referred study was performed on total RNA extracted from the 
isolated populations. Our results in single cells show that the naïve T-cell pool 
contains a higher number of cells expressing the IFN-γR2 mRNA as compared to 
the TCM pool, which probably accounts for the higher level of IFN-γR2 mRNA 




The IL-10 receptor is composed of two subunits, a ligand-binding subunit 
(IL-10Rα) and an accessory subunit for signaling (IL-10Rβ). IL-10Rα expression 
on T cells was reported to be down-regulated by activation at both the mRNA and 
protein levels. In contrast, IL-10Rβ is constitutively expressed in most cells and, in 
cells of the immune system, no evidence was found for significant activation-
associated regulation of IL-10Rβ expression. Therefore, any stimulus activating IL-
10Rα expression should suffice to render most cells responsive to IL-10 (reviewed 
by Moore et al., 2001). 
IL-10 is generally considered a suppressive cytokine due to its inhibitory 
effects on macrophages and CD4+ T cells. For instance, (1) IL-10 strongly inhibits 
cytokine production and proliferation of CD4+ T cells via its down-regulatory effects 
on APC function; (2) IL-10 can also directly inhibit IL-2, TNF and IL-5 production; 
(3) IL-10 can further affect chemotaxis by modulating the expression of CXCR4. 
Nonetheless, on CD8+ T cells IL-10 exerts stimulatory effects and induces their 
recruitment, cytotoxic activity, and proliferation. This fact suggests significant 
differences in the responses of CD4+ and CD8+ T cells to IL-10 (reviewed by 
Moore et al., 2001). 
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 Expression of IL-10Rα at the mRNA level was detected in all CD8+ T-cell 
populations studied. Furthermore, IL-10Rα expression is present in a considerable 
frequency of cells. The naïve population had consistently the lowest frequency of 
IL-10Rα-expressing cells (51%±14), followed by the primed-subsets with a lesser 
differentiation status (TCM, 80%±17; TEM-SP27high, 80%; TEMRA-SP27high, 76%; 
and TEM-SP28, 70%). The populations with higher frequencies of cells expressing 
IL-10Rα (>85%) were those with a more differentiated profile of gene expression 
(TEM-27SP; TEMRA-27SP; TEM-DN; and TEMRA-DN). These findings indicate a very 
clear tendency of cells to become progressively responsive to IL-10 during effector 
differentiation. The fact that IL-10Rα is generally expressed at least in up to 50% 
of the cells suggests an important role for IL-10-induced signaling. However, the 
induction of different outcomes by IL-10 on populations with a distinct degree of 
differentiation (for instance, naïve versus TEM-DN) can not be excluded. 
 
 
Gene expression profiles within the CD8+ T-cell subsets  
 
Naïve T cells 
 
In terms of gene expression the TN subset exhibits the least differentiated 
profile: absence of cytotoxic function and of the effector cytokines IFN-γ and TNF-
α. Furthermore, the mRNA coding for RANTES, found in a significant fraction of all 
the other CD8+ T-cell subsets, was detected only rarely amongst TN cells. The 
hallmark of these cells was a preeminent gene expression concerning the genes 
coding for multiple receptors, just as if these cells were waiting for receiving 
external signals. 
Our results show that naïve CD8+ T cells, defined here by the co-expression 
of CCR7 and CD45RA, also co-express the co-stimulatory receptors CD27 and 
CD28, which is in line with observations made by others (Rufer et al., 2003; 
Tomiyama et al., 2004). However, CD27 and CD28 co-expression is not exclusive 
to the naïve pool, being observed in the TCM, TEM and TEMRA CD8
+ T cell subsets. 
Therefore, cell surface co-expression of CD27 and CD28 alone do not discriminate 
any particular functional subset within the CD8+ T-cell compartment. 
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The naïve CD8+ T cells express uniformly CD28, however at a substantial 
lower level as compared with all the other populations. Up-regulation of the 
expression level of CD28 at the cell surface of CD4+ and CD8+ T cells after in vitro 
activation has been reported (Salazar-Fontana et al., 2001; Turka et al., 1990). In 
vivo, modulation of cell-surface expression of CD28 has been observed in CD4+ T 
cells (Minguela et al., 1997; Salazar-Fontana et al., 2001). Our results are clear in 
showing that in vivo up-regulation of CD28 expression also occurs in CD8+ T cells. 
Our results clearly show that the naïve subset exhibits the lowest levels of CD28 
expression, as mean fluorescence intensity of the CD28 staining on naïve cells 
was consistently lower than in CD8+ T cells from any other subset in all donors 
(average MFI difference of 12,5±4,7). We observed the same phenomenon in the 
mouse (data not shown). These results indicate that up-regulation of CD28 
expression at the cell-surface occurs in consequence of T-cell activation. In 
accordance, the single-cell RT-PCR results show that expression of activation-
related genes, such as the genes coding for cytolytic molecules and inflammatory 
chemokines, is virtually absent from naïve cells, but is up-regulated in populations 
expressing high levels of CD28. The frequency of expression of such genes is 
drastically increased on the CD28- CD8+ T-cell subsets. These results indicate that 
acquisition of effector functions primarily relates to up-regulation of CD28 
expression and, at later points, with loss of this receptor from the cell surface. 
Conversely, density of expression of CD27 was higher in TN cells than in 
TCM, TEM-DP, TEMRA-DP, TEM-CD27SP and TEMRA-CD27SP subpopulations. This 
finding suggests that high levels of co-stimulation through CD27 may be crucial in 
the initial phases of the immune response. In accordance, we have shown that the 
CD8+ T-cell subsets that display the closest gene expression profile to TN cells 
and, thus, have the lowest activation status observed amongst antigen-
experienced subpopulations, were subpopulations where the intensity of CD27 
expression was up-regulated at the maximal levels observed. 
 
 
Naïve T cells up-regulate CD27 following activation 
 
In some donors, a subset of cells expressing a clear high level of CD27 was 
present and stood out from the TEM and TEMRA populations. This subset was mainly 
composed, albeit not exclusively, by CD28- cells. In some donors we were able to 
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isolate these cells to further analyze its profile of gene expression by RT-PCR. 
Surprisingly, despite their CCR7- phenotype, the profile of gene expression of TEM-
CD27high and TEMRA-CD27
high populations suggests that these cells are functionally 
not very different from naïve cells. The most striking difference from unprimed cells 
was a significant expression of RANTES, consistently detected in more than 50% 
of the cells. Importantly, in all the other CD8+ T-cell subsets, for which the gene 
expression profiles indicated a higher activation status, expression of RANTES 
concerned nearly 100% of the cells. These findings indicate that TEM-CD27
high and 
TEMRA-CD27
high populations are in a subsequent stage of differentiation in relation 
to the TN subset, but are less differentiated than all the remaining primed 
populations. This hypothesis was further supported by the staining of TEM-CD27
high 
and TEMRA-CD27
high populations for the α chain of the integrin LFA-1, CD11a. 
Staining for CD11a is widely used to distinguish naïve T lymphocytes, which 
express low levels of this molecule, from antigen-experienced CD11ahigh-
expressing T cells. The mean fluorescence intensity of CD11a staining in CD27high 
cells was significantly higher as compared to the TN subset, corroborating the idea 
that CD27high lymphocytes have already encountered antigen. Interestingly, when 
compared to the other subsets of antigen-experienced cells, CD27high cells 
expressed lower levels of CD11a, suggesting that cells expressing high levels of 
CD27 correspond to a very early stage of differentiation. 
Collectively, these findings suggest that CD27high cells have been recently 
activated and have just initiated a program of differentiation that can lead 
ultimately to fully maturation into cytotoxic effectors. RANTES expression is, 
therefore, one of the earliest effector molecules to be up-regulated, preceding the 
expression of cytolytic molecules. In accordance, it was previously reported that 
expression of RANTES mRNA is up-regulated between days 3 and 5 following 
stimulation with mitogen or alloantigen, a temporal window that precedes the up-
regulation of perforin, granzymes A and B and granulisin in vitro (Ortiz et al., 1997; 
Song et al., 2000; Ullman et al., 1990) (Figure 11). The gene expression profile of 
CD27high populations strongly corresponds to the one described for cells on the 
late proliferation phase. Furthermore, all the primed CD8+ T-cell subsets described 
below in this manuscript present a more differentiated gene-expression profile. 
Finally, it is noteworthy that the representation of TEM-CD27
high and TEMRA-CD27
high 
populations was significantly variable in the same individual over time (1,7 to 2,1 
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fold difference), suggesting that these populations might be transitory and 
differentiate into other subsets quite rapidly. 
 
 
Figure 11. Sequence of gene expression events after T-cell activation 
by antigen. Commitment refers to the time after which withdrawal of the 
initial stimulus does not significantly interfere with proliferation. RANTES 
mRNA undergoes up-regulation on day 3-5 post-activation and its 
expression is maintained in terminally differentiated CTLs. Expression of 
the transcripts coding for proteins of the cytolytic granules was reported to 





Central memory CD8+ T cells 
 
 TCM cells are described as a T-cell population with high proliferative 
potential, but reduced immediate effector function (Champagne et al., 2001; 
Sallusto et al., 1999a). Accordingly, the pattern of gene expression revealed by 
our results corroborates a low level of differentiation for this subset. Expression of 
granzyme B is absent, Fas-L expression is detected rarely and despite the mRNA 
coding for granzyme A could be detected in up to 40% of the cells, only a very 
modest percentage of TCM cells (<15%) co-expresses this molecule along with 
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perforin. IFN-γ and TNF-α expression is consistently absent. Expression of 
RANTES, however, was very important and could reach more than 70% of the 
cells. Collectively, these findings indicate that TCM possess a more activated status 
as compared with the CD27high subsets. 
Interestingly, it has been described that expression of the chemokine 
receptor CCR4 subdivides TCM cells into two distinct subsets (Geginat et al., 
2003). In vitro stimulation of freshly isolated TCM lymphocytes showed that CCR4
+ 
cells produce high levels of IL-4 and IL-13, while CCR4- cells produce mainly IFN-γ 
and, after one week of culture, down-regulate CCR7 and acquire perforin 
expression. These evidences led to the notion that TCM cells expressing CCR4 are 
specialized in producing type 2 cytokines, whereas TCM cells lacking CCR4 
expression apparently correspond to CTL precursors. Confronting our results with 
these data, a reasonable hypothesis is that TCM cells in which we detected the 
expression of cytolytic molecules might correspond to CCR4- cells or, in other 
words, to CTL precursors. However, since expression of type 2 cytokines was not 
assessed in this study, it is uncertain if the TCM cells that lack cytolytic molecules 
correspond or not to a homogeneous CCR4+ subpopulation. Further experiments 
would be required to confirm this possibility. 
 
 
CCR7– CD8+ T-cell subsets 
 
 Cells from the CCR7- CD8+ T-cell subset express CD45RA in a continuum, 
from negative to high expression. In agreement to which is described in the 
literature, we divided this population into CD45RA+ (TEMRA) and CD45RA
- (TEM) 
and studied the surface expression of several molecules within each subset, as 
well as the gene expression patterns of the resulting populations. Unexpectedly, 
we found that the TEM and TEMRA subsets harbor very similar subpopulations. 
Expression of CD27 and CD28 subdivides both TEM and TEMRA subsets in a similar 
way, revealing the following subpopulations: CD27+CD28+ (DP), CD27highCD28+/- 
(CD27high), CD27-CD28+ (28-SP), CD27+CD28- (27-SP) and CD27-CD28- (DN). 
Some of these subsets, with the exception of CD27high, were already detected, at 
least partially, by others (Appay et al., 2002; Rufer et al., 2003; Tomiyama et al., 
2004). However, a direct comparison between the CD45RA+ and CD45RA- was 
never performed, in part due to the sole partial association of the cell-surface 
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markers. Consequently, whether the subsets defined by CD27/CD28 expression 
display similar or different properties in the TEM versus TEMRA compartments 
remained illusive. The most significant difference we could find between TEM and 
TEMRA cells was on the representation of the distinct CD27/CD28 sub-populations. 
Hence, the DP subpopulation is usually larger on TEM as compared to TEMRA, the 
CD27high, 27SP and CD28SP populations have comparable representations in 
both subsets and the DN population shows a higher frequency of cells within the 
TEMRA subset as compared to TEM.  
 Since the analysis of gene expression on single-cells revealed no 
differences between TEM and TEMRA populations, for simplicity I’ll next simply 
describe the results referring to the subpopulations DP, 28-SP, 27-SP and DN. 
 
CD27 and CD28 expression defines a hierarchy of activation 
 
 The gene expression pattern of all CCR7- subpopulations, with the 
exception of the previously described CD27high subset, reveals a degree of 
differentiation significantly higher than the TCM subset. First, all the populations 
integrally expressed RANTES (>90%) and expression of an additional 
inflammatory chemokine, MIP-1β, was present in all populations at variable 
frequencies (ranging from 5 to 50%). Second, all the populations express perforin, 
granzyme A and Fas-L. The frequency of expression of these molecules strongly 
correlates with the cell-surface phenotype. Lastly, molecules like granzyme B, IFN-
γ and TNF-α could also be detected, albeit only in some cell subsets. 
 
 DP subsets 
 
 The gene expression patterns of CCR7- populations revealed that the less 
differentiated cells were those co-expressing CD27 and CD28. Granzyme A was 
virtually expressed by all cells and perforin was expressed in frequencies ranging 
from 50 to 80%. In contrast, granzyme B expression is detected in only very few 
cells (<10%). In addition, expression of Fas-L is detected in up to 20% of the cells. 
These results indicate that (1) more than half the cells from the DP subset have 
cytotoxic potential, (2) both perforin/granzymes and Fas-L cytotoxic pathways can 
potentially be used kill, and (3) cytotoxicity exerted by the perforin/granzymes 
pathway can use perforin and granzyme A, but not granzyme B. The effector 
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cytokines IFN-γ and TNF-α were expressed only rarely by cells from the DP 
subset, indicating that these cells are potentially poor cytokine producers. 
Therefore, DP CCR7- CD8+ T cells constitute a population of cytotoxic cells that 
exerts its function mainly, but not exclusively, through the perforin/granzyme A 
pathway. 
 
 CD28SP subsets 
 
The population with the profile of gene expression more related to the DP 
subset was the CD28SP. These populations are quite rare and, thus, we were 
able to recover cells from this subset in only one donor. Further analysis of cells 
with the same surface phenotype would thus be required to confirm results 
described in this study. 
The frequency of cells co-expressing perforin and granzyme A is superior to 
the DP subset, as well as cells expressing the mRNA coding for FasL. However, 
we could not detect expression of granzyme B and frequency of MIP-1β 
expression is significantly lower in this subset as compared to DP cells. The 
reasons that might explain these results are uncertain and are may be related to 
the origin of the CD28SP cell subset. These cells remain poorly characterized 
since they constitute minor subsets of TEM and TEMRA, which imposes a limitation 
for the most common assays that usually require a significant number of cells. In 
studies where CD8+ T cells specific for human viruses were stained for CD27 and 
CD28, this subset comprised always less than 5% of the tetramer specific cells, 
and most of the times were completely absent (Appay et al., 2002; Rufer et al., 
2003). This raises the question whether the differentiation of these cells are 
preferentially induced by agents other than viruses. Nevertheless, whatever the 
stimuli that leads to their differentiation, an important fact is that CD28SP cells 
have lost CD27 expression, but seem to still require co-stimulation through CD28. 
This evidence indicates that this subset might keep the potential to proliferate, a 
fact that would be relevant to confirm. The loss of CD27 expression might also 
mean that this cell subset has a higher propensity to undergo apoptosis, since co-
stimulation through CD27 is described to deliver survival signals that allow the 
accumulation of proliferating cells (Hendriks et al., 2003). In addition, in the mouse 
system, CD28 was reported to have a preponderant role in secondary challenge in 
the peripheral tissues, as compared to the primary immune response (Hendriks et 
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al., 2003). Unlike the primary response, the absence of CD28 can not be 
compensated by CD27 in these sites. In line with these evidences, a very likely 
possibility is that the CD28SP subpopulation in humans differentiates from the TCM 
pool. The CD28SP subset would therefore harbor cells that are responding to a 
secondary challenge. If this is true and TCM contain the precursors of CD28SP 
cells, differentiation might be direct from TCM to CD28SP if both CCR7 and CD27 
are down-regulated in concert or, alternatively, might involve intermediate stages, 
such as loss of CCR7, passing throughout a DP stage, followed by down-
modulation of CD27 from the surface. It seems unlikely that up-regulation of CD27 
might happen during differentiation from the TCM pool, since this memory subset 
expresses RANTES at nearly 100% and display some cytotoxic potential, and up-
regulation of CD27 would therefore imply a partial loss of these functions and a 
reversion into a less activated stage. If this scenario is confirmed, then CD28SP 
cells might constitute a subset with simultaneous proliferative and effector 
capacity. Such circumstances fit into the picture of a transitory subset that appears 
during the expansion phase of a secondary immune response, which could explain 
the rarity of cells with these phenotype. As memory cells are highly effective in 
eliminating antigen, it is thus probable that CD28SP will further differentiate into a 
more mature state, in which a large panel of effector functions is up-regulated. As 
described further in this manuscript, this situation correlates with loss of CD28 and 
acquisition of a DN phenotype. Confirmation of this hypothesis would require an 
evaluation of the cycling state of CD28SP cells, as well as the assessment of their 
differentiation potential. 
The evidences presented in this work, however, do not permit to exclude 
that CD28SP can also arise during the primary immune response, corresponding 
to a transitory intermediate stage on the differentiation pathway from a naïve to a 
fully mature effector, DN phenotype. The CD28SP stage would be therefore an 
alternative pathway to CD27SP, for some cells to differentiate into DN cells. It 
seems, however, unlikely that CD28SP cells might arise from CD27SPs. 
Another possibility is that CD28SP cells are still expressing CD27, but the 
extracellular domain of this receptor was cleaved and can no longer be recognized 
by the antibody. In this way, they could display a cell-surface “CD28SP” 
phenotype, but in reality being a modified DP population. Remarkably, DP and 
CD28SP subsets do not have very distant gene expression profiles. Nevertheless, 
this possibility remains to be confirmed. 
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 CD27SP subsets 
 
 Loss of cell surface expression of CD28 correlates with a gene expression 
pattern that evidences a further differentiation stage than the DP or CD28SP 
subset. Indeed, in the CD27SP subsets there is a generalized expression of 
perforin and granzyme A. Furthermore, expression of granzyme B is up-regulated 
into important levels (ranging from 10 to 50% of the cells, depending of the donor), 
while the frequency of Fas-L expression shows a less striking increase (15 to 25% 
of the cells). IFN-γ and TNF-α, however, are still expressed by only few cells 
(<10%). The hallmark of the gene expression of CD27SP cells is therefore the 
acquisition of granzyme B expression, concurrently with a high level of perforin 
and granzyme A co-expression. Similarly to DP cells, CD27SP can potentially 
exert cytotoxicity by both perforin/granzymes and Fas-L pathways, but in addition 
to granzyme A, CD27SP also express granzyme B, which should account for a 
better capacity to efficiently respond to a broader spectrum of challenges. 
Therefore, DP, CD28SP and CD27SP CCR7- CD8+ T-cell subsets are effector 




 DN subsets 
 
The pattern of gene expression reflecting the highest stage of differentiation 
corresponds to the DN CCR7- subset. These data are in agreement with other 
reports in which intracellular perforin staining was assessed and the cytolytic 
potential of DN was compared to CD27SP ex vivo, indicating that the DN subset 
possessed the highest perforin content and induced the highest target cell lysis 
(Appay et al., 2002; Rufer et al., 2003; Tomiyama et al., 2004). Furthermore, our 
results show that the highest frequency of expression of granzyme B and Fas-L 
also resides within the DN subset, an observation that is in line with a high content 
of these molecules in DN cells revealed by intracellular and surface stainings for 
granzyme B and Fas-L, respectively, reported by others (Rufer et al., 2003). 
Collectively, these data indicates that DN cells dispose of multiple alternative 
strategies to kill, which can explain the higher efficiency of target-cell lysis as 
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compared with other subpopulations. In addition, we found the highest frequency 
of cells expressing IFN-γ in the DN subsets, the TEM showing a subtle propensity to 
contain more IFN-γ-expressing cells than the TEMRA. Importantly, the capacity of 
express IFN-γ was restricted to a limited fraction of DN cells (up to 30%), a far 
reduced frequency as compared to the fraction capable of exerting cytotoxicity. 
For TNF-α the situation was even more extreme, as we were able to detect TNF-α 
expression only in a very restricted fraction of cells (<10%). These results indicate 
that the potential of secreting IFN-γ and TNF-α is limited to a reduced subset of 
circulating cells, but does not preclude that this situation might be inverted on the 
sites of infection and/or in the secondary lymphoid tissues. Actually, in CD8+ T-cell 
lymphocytes we have isolated from the human spleen, IFN-γ and TNF-α 
expression could be extended, respectively, to up to 70% and 50% of the cells 
(unpublished data). It seems therefore possible that not only some particular 
subsets might be excluded from some organs, as we found in lymph nodes for 
some CCR7- subsets (unpublished data), but also the representation of cells with 
particular specializations (e.g. IFN-γ secretion) within each subset might vary 
between the blood, lymphoid tissues and/or sites of infection. A higher frequency 
of cytokine-producing cells in the lymphoid tissue might be explained by the fact 
that antigen presentation and lymphocyte activation occur in those sites. 
Therefore, the probability to find cells in advanced stages of functional maturation 
is higher in the secondary lymphoid organs, when compared to the blood. 
Moreover, since highly differentiated effector cells are endowed with receptors that 
enable them to follow multiple chemokine gradients that guide them to the 
peripheral tissues where infection is taking place, these sites will probably be also 
enriched in cells highly specialized for cytokine secretion. If this is true, may be the 
expression of chemokine receptors, such as CCR4, CCR5 or CXCR4, responsible 
for the recruitment of effector cells to the inflamed tissues, in addition to CCR7, 
CD27 and CD28 would allow to identify with exactitude the cells in charge of 
cytokine secretion. 
Our results of single-cell gene expression thus clearly demonstrate that the 
cell-surface phenotype defined by CCR7, CD27 and CD28 correlates with gene 
expression profiles reflecting different degrees of activation of antigen-experienced 
CD8+ T-cell populations. The hierarchy of activation status is the following: CCR7-
CD27highCD28+/- < CCR7+CD27+CD28+ < CCR7-CD27+CD28+ < CCR7-CD27-
CD28+ < CCR7-CD27+CD28- < CCR7-CD27-CD28-. These conclusions are in line 
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with a previous report, where the differentiation phenotype of viral specific CD8+ T 
cells were shown to be ascribed to three subsets, CD27+CD28+, CD27+CD28- and 
CD27-CD28-, which sequentially exhibited higher degree of activation given by the 
expression of cytolytic molecules  (Appay et al., 2002). In contrast, our results 
disagree with the hypothesis proposed by Champagne and coworkers, which 
ascribes to TEMRA the end stage of differentiation (Champagne et al., 2001). These 
authors suggest a linage differentiation pathway based on the expression of CCR7 
and CD45RA, in which TN  TCM  TEM  TEMRA. This hypothesis was proposed 
following the analysis of proliferation capacity in vitro, through stimulation of each 
one of the four subsets with anti-CD3 and anti-CD28 antibodies, and ex vivo, 
through intracellular staining for the Ki67 nuclear antigen, which revealed that cell 
division was mostly restricted to the CCR7+ subsets. The authors therefore 
suggested that the TN and TCM populations function as precursors that seed the 
CCR7-CD8+ T-cell compartment. To confirm this hypothesis, the authors further 
assessed the differentiation potential of the TEM and TEMRA CD8
+ T-cell subsets 
upon in vitro antigen-specific stimulation. Neither population could divide, and the 
TEM subset, but not TEMRA, kept the potential of reverting to phenotypes of 
precursor cells. The authors suggested that TEMRA cells constitute a terminally 
differentiated effector subpopulation that intervenes readily in case of antigen re-
encounter, while precursor cells expand and replenish continuously the effector-
cell pool. Our results argue against this hypothesis, demonstrating that TEM and 
TEMRA subpopulation display similar effector potentials. Indeed, we could find cells 
with characteristics of fully differentiated effectors within both TEM and TEMRA 
subsets and CD45RA expression did not correlate with any particular 
differentiation stage amongst antigen-experienced cells. The difference between 
TEM and TEMRA subsets must therefore rely on other parameters not related with 
effector function. For instance, intracellular staining of CD8+ T-cell subsets for Bcl-
2 ex vivo showed a decrease expression of this antiapoptotic molecule from which 
TN  TCM  TEM  TEMRA (Geginat et al., 2003). These data indicate that TEMRA 
subpopulations might have a higher propensity to undergo cell death by apoptosis 
that their counterparts TEM. It must be noted, however, that TEM and TEMRA 
populations were not subdivided into CD27/CD28 subsets. The lower Bcl-2 
expression of TEMRA cells, as compared to TEM, could be due to a difference on the 
relative distribution of CD27/CD28 subsets within TEM and TEMRA compartments. It 
would be therefore interesting to evaluate Bcl-2 expression within the distinct TEM 
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and TEMRA CD27/CD28 subsets, along with other anti-apoptotic molecules. 
Alternatively, TEM and TEMRA subsets might follow distinct migration routes, an 
issue that could be addressed through the extensive analysis of expression for 
chemokine receptors in the two subsets. 
Interestingly, CD27 expression is lost in concert with CD28 expression 
when human CD8+ T cells mature into the last stage of effector differentiation. This 
evidence might be a sign that perhaps it is crucial for co-stimulation to be avoided 
at the end stages of CD8+ cell maturation or, alternatively, that it is not required at 
this stage. 
The gene expression profiles are very distinct between CCR7- populations 
defined by CD27 and CD28 expression. In addition, the pattern of expression of 
each of these phenotypes was extremely reproducible between all the donors 
studied. Remarkably, the expression of functions positively correlates with 
activation status of the different cellular subsets. In other words, when a particular 
molecule is expressed in a subpopulation, e.g., RANTES, its expression is always 
found, and usually at higher frequency, in all the subsets displaying higher 
degrees of activation. The inverse situation was observed for molecules whose 
expression is lost throughout progressive activation, namely IFN-γR2 and CCR7. 
The finding that CD45RA+ subpopulations have a gene expression profile 
identical to CD45RA- subsets indicates that CD45RA can not be used to 
distinguish subpopulations at different differentiation stages. It is currently 
considered that fully differentiated “effector cells” reside within the CD45RA+CD27- 
compartment and “memory cells” are located in the CD45RA-CD27+ subset. 
Nevertheless, we found strong evidence that fully differentiated effectors can be 
likely found within both CD45RA+CD27- and CD45RA-CD27- subsets since these 
populations exhibit identical expression patterns. In the same way, we found that 
CD45RA-CD27+ and CD45RA+CD27+ subsets display similar functionalities, as 
well as CD45RA-CD28+/- and CD45RA+CD28+/-. 
 
 
Expression of CD62L within the CCR7– CD8+ T-cell subsets 
 
 Unlike TCM cells, which integrally express CD62L, TEM and TEMRA cells are 
reported to be heterogeneous concerning the expression of this molecule (Sallusto 
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et al., 1999b). Since analysis of the gene expression patterns of CCR7– CD8+ T-
cell subpopulations unexpectedly revealed no apparent functional differences 
between the TEM and TEMRA subsets, we have further investigated if there would be 
differences in the expression of CD62L that might indicate possible distinct 
migratory potentials.  Expression of CD62L enables cells to interact with the 
peripheral node addressin (PNAd), which is one of the requirements for trafficking 
to the lymph nodes. Hence, cells expressing CD62L home preferentially to 
lymphoid organs, whereas cells that lack CD62L accumulate in the peripheral 
inflamed tissues, but are excluded from most lymphoid organs (Weninger et al., 
2001). 
 Staining for CD62L of TEM and TEMRA subpopulations revealed that CD27
high, 
CD28SP and DP populations were biphasic in relation to CD62L expression and 
loss of CD28 expression from the surface was associated to an important 
decrease on the expression of CD62L. In accordance to the previously described 
evidences that CD27high populations include recently activated cells, TEM-CD27
high 
and TEMRA-CD27
high both contain in average 50% of cells expressing CD62L, the 
highest frequency observed amongst CCR7- subsets. Considering the natural 
variability observed between donors, CD27high, 28SP and DP presented 
comparable biphasic CD62L patterns of expression fluctuating between 25 and 
50% of positive cells. Conversely, TEM and TEMRA-SP27 show a considerable 
reduction of CD62L+ cells, with frequencies generally bellow 25%. Expression of 
CD62L+ cells on TEM and TEMRA-DN populations was even lower, registered 
consistently in less than 10% of the cells. Moreover, the intensity of expression of 
CD62L on DN cells was noticeably low, as compared with the other subsets. This 
evidence suggested that these cells are largely excluded from the lymph nodes, 
which we could confirm by surface phenotyping of cells extracted from human 
lymph nodes. A slight tendency of CD45RA+ subsets to contain higher frequencies 
of CD62L+ cells, in relation to their CD45RA- counterpart subsets was observed, 
but sometimes an inversion could also occur. Therefore, CD62L expression can 
not objectively discriminate CD45RA+ from CD45RA- subpopulations, although it is 
differently expressed amongst the CD27/CD28 subsets. Expression for other 
chemokine receptors should further be assessed in order to conclude if these 
subsets effectively own completely overlapping migratory properties. 
 Interestingly, down-regulation of CD62L was largely associated with loss of 
CD28 expression. In accordance to the previously described single-cell RT-PCR 
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results, loss of CD28 marks a cellular differentiation state characterized by the co-
expression of multiple effector functions. CD28- CD8+ T cells are, thus, pluripotent 
effector-like cells, that achieve the highest differentiation stage after concurrent 
loss of CD27. The expression pattern of CD62L clearly indicates that 27SP and 
DN CCR7- CD8+ T cells should be largely excluded from the lymph nodes and that 
exclusion, such as acquisition of effector functions, is a progressive phenomenon 
that emerges throughout differentiation and is accompanied by sequential loss of 
multiple surface molecules and concomitant acquisition of others. 
 
 
Reversion of phenotype from CD45R0+ to CD45RA+  
 
In addition to the similarities between CD45RA+ and CD45RA- 
subpopulations, the co-existence of so many sub-populations within the CCR7- 
compartment suggests that differentiation towards a fully mature, DN stage might 
occur throughout multiple alternative ways. In other words, down-regulation of the 
various cell-surface markers might be asynchronous. In this case, naïve T cells 
receiving a given stimulus would preferentially acquire a CCR7-CD45RA+ 
phenotype, while in other circumstances, such as different strength of TCR 
stimulation, extent of co-stimulation and helper signals and/or cytokine context, 
would rather differentiate into a CCR7-CD45RA- phenotype. This hypothesis 
questions, however, the paradigm of loss of CD45RA expression following 
activation, and further re-expression upon maturation into a terminally 
differentiation stage. 
 The notion that T cells down-regulate CD45RA following activation and 
comes from in vitro studies, in which activation of CD45RA+CD8+ T cells induced 
up-regulation of CD45R0 and loss of CD45RA. In turn, when stimulated, 
CD45R0+CD8+ T cells maintained their phenotype (Akbar et al., 1988). This led to 
the idea that CD45R0 does not only identify previously activated cells, but is also 
expressed in cells that have been recently stimulated. Other studies, using 
polyclonal T cells and T cell lines stimulated with PHA or anti-CD3 antibody, 
further reported that reversion from CD45R0 to CD45RA might be possible (Fujii et 
al., 1992; Michie et al., 1992). This issue has also been addressed in vivo through 
analysis of antigen specific cells for persistent human viruses, commonly HCMV 
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and EBV. Both belong to the family of herpesvirus that can establish both lytic and 
latent infections and affect the great majority of the population. Briefly, following 
primary infection, both HCMV and EBV persist life long in a latent state in the 
myeloid or B-cell reservoir, respectively. The chronic infections are asymptomatic, 
except in cases of immunosuppression. How exactly the immune system controls 
the infection by these viruses at long term is not clear, but CD8+ T lymphocytes 
seem to play a central role in this setting to prevent disease. In the early time 
points of acute HCMV and EBV infections, there is a prevalence of epitope-
specific CD8+ T cells in the CD45R0+ subset on the peripheral blood. In the 
chronic, asymptomatic phase of both infections, however, both CD45RA+ and 
CD45R0+ CD8+ T-cell subsets contain significant frequencies of cells with the 
same specificity (Callan et al., 1998; Wills et al., 1999). It was therefore assumed 
that, after the primary response, some of the clonally expanded CD45R0+ viral-
specific CTLs revert into a memory CD45RA+ phenotype (Wills et al., 1999). 
Although this hypothesis became generally accepted, it should however be 
critically considered. 
First, although the majority of the CTLs from the clone analyzed by Wills 
and collaborators through clonotype probing have a CD45R0+ phenotype at 3 and 
4 weeks, ~15-30% of the CD8+ T cells from the same clone express CD45RA+, 
which is not negligible. In the primary immune response to EBV infection, CD8+ T 
cells also mainly express CD45R0, for both EBV lytic and latent cycle epitope-
specific cells (Callan et al., 1998). Still, a frequency of 5-14% of EBV-specific cells 
expresses the CD45RA isoform. It is therefore possible that these CD45RA+ CTLs 
found in early time points of the acute phase of CMV and EBV infections have 
differentiated directly from the naïve T-cell pool. Sequencing the clones found 
within CD45RA+ and CD45R0+ compartments would be extremely informative. 
Secondly, although the matrix protein pp65 of HCMV is reported as being 
immunodominant, no other clones were analyzed. The CTLs harbored within the 
CD45RA+ compartment are probably subdominant clones that may be exclusive of 
this subset. Confirmation of this hypothesis implies that other specificities must be 
analyzed. In another study, the relationship between the expression of CD45 
isoforms and the TCR Vβ usage of CMV-specific CD8
+ T lymphocytes on several 
donors was addressed (Vargas et al., 2001). Although only the chronic infection 
phase was studied, it is clear that major expansions of cells expressing the same 
Vβ elements can express CD45RA or CD45R0. More importantly, the dominance 
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of the CD45 phenotype is extremely variable between individuals, as in some 
cases the immunodominant clone is predominantly CD45RA+ and in others 
CD45R0+. In addition, the dominance of the same CD45 isoforms for the same Vβ 
specificity was constant over time in each individual. 
Taken together, these studies clearly demonstrate that in acute viral 
infection memory CD8+ T cells are preferentially located within the CD45R0 
compartment and, over time, progressively become distributed between CD45RA+ 
and CD45R0+ populations. Moreover, the extent of CD45RA or CD45R0 
phenotype dominance within virus-specific CD8+ T cells was shown to be highly 
variable between individuals. At present, there is still no direct proof that antigen-
specific CD45RA+ cells are actual “revertants”. Hence, it can not be excluded that 
these cells have been activated later and/or under different conditions and arise 
directly from the naïve CD8+ T-cell pool. The replicative history of the CD45RA+ 
CD8+ T-cell subpopulations, assessed by the measurement of TRECs (T-cell 
receptor excision circles), supports the idea that those cells can differentiate 
directly from the naïve pool and, thus, a CD45R0+ stage is not necessary (Rufer et 
al., 2003). In contrast, in vitro evaluation of the differentiation potential of human 
CD8+ T cells argues that only precursors present in the TCM population, but not TN 
or TEM, can generate CD45RA
+ cells (Geginat et al., 2003). However, according to 
this study, CD45RA+ cell-differentiation from TCM occurs exclusively upon cytokine 
stimulation, in the absence of antigen stimulation. Such situation seems quite 
unphysiological, since differentiation of potent effector cells, as the ones found 
within the CD45RA+ compartment, without the tight control of antigen stimulation, 
as well as a selection of the antigen specificity, would represent a threaten for the 
organism. Nevertheless, a role for cytokines in the differentiation of CD45RA cells 
can not be excluded. Further ex-vivo evidences would be required to clarify this 
point. 
Since HCMV and EBV are life long persistent viruses, it is likely that viral 
latent peptides are continuously presented to CD8+ T cells that, in this way, remain 
in incessant activity, thus keeping infection under control. The set of viral peptides 
presented to CTLs, differing between acute and chronic EBV and HCMV 
infections, could also possibly elicit different types of CD8+ T-cell responses 
(Goodrum et al., 2002; Tierney et al., 1994). One hypothesis in line with this idea 
is that highly expressed peptides of the viral lytic cycle, presented on the acute 
phase of the infection might preferentially induce the generation of CD45R0+ CD8+ 
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T cells, while peptides expressed during the latent phase might induce the 
differentiation of CD45RA-expressing CD8+ T cells. This could explain the 
generation of a subdominant CD45RA+ CTL response during primary infection, 
resulting from the activation with latency early expressed peptides or, alternatively, 
peptides that might be common to lytic and latent cycles and are expressed at a 
lesser extent during acute infection. At present, there are no evidences supporting 
this idea. However, an exhaustive examination of the phenotype of a panel of 
clones including subdominant viral-specificities present in acute and chronic 
infection would be helpful to confirm this hypothesis. In addition, full understanding 
of the lineage relationships between the CD45R0+ and CD45R0+ CD27/CD28 
compounding subsets would require immunoscope analysis of the correspondent 
repertoire. 
Finally, it has been described that human CD45R0+ cells turn over more 
rapidly than CD45RA+ in vivo and have a higher proliferative potential in vitro 
(Champagne et al., 2001). As discussed earlier in this manuscript, the in vitro cell-
division capacity of the four canonical CD8+ T-cell subsets defined by CCR7 and 
CD45RA expression was determined as follows: TN > TCM > TEM > TEMRA, being 
extremely reduced in TEM and virtually absent in TEMRA. This led to the assumption 
that the precursors of TEMRA must be harbored within the CCR7
+ subsets. Although 
this theory does not exclude the possibility that TN can directly differentiate into 
TEMRA, in a secondary immune response, the responding, proliferating cells that 
could differentiate into TEMRA would forcedly be TCM, or eventually TEM. In either 
case, this scenario implies that cells expressing CD45R0 (TCM or TEM) in the 
beginning of the immune response down-regulate that molecule and revert into a 
CD45RA+ state (as TEMRA). Tracking of the cells responding to antigen would be 
required to solve this question. 
In summary, the reversion phenomenon by which CD8+ memory cells re-
express CD45RA+ with concomitant downregulation of CD45R0+ expression has 
not yet been objectively demonstrated in vivo. This notion should be taken into 
account while establishing linear relationships between the different CD8+ T cell 
subsets. 
CD45 as a major role on the regulation of the signaling induced by following 
TCR stimulation. In particular, it regulates the extent of phosphorylation of key 
signaling molecules and the distinct isoforms appear to be related with a 
differential activity of CD45 and with the responsiveness of T cells to diverse 
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stimuli. In particular, the CD45R0 isoform is considered to adopt at a great extent 
an inhibitory conformation, thus corresponding to a less active isoform than 
CD45RA. Accordingly, CD45RA+ cells should be more responsive to TCR stimuli 
than CD45R0+ T cells. Thus, differentiation of CD8+ T cells into TEMRA could 
represent an advantage in terms of sensitivity to antigen stimulation in relation to 
TEM cells, meaning that TEMRA would be able to respond to lower strengths of 
antigenic stimulation. Clarification of this issue would be extremely relevant in 




Loss of expression of CCR7, CD27 and CD28 – the way to differentiation 
 
 Altogether, our results concerning antibody staining of cell-surface 
receptors and single-cell expression analysis of CD8+ T cell subpopulations of the 
human blood highlighted a panel of factors relevant in the differentiation of naïve 
CD8+ T cells into different stages of antigen-experienced effectors and/or memory. 
We could therefore envisage a picture of the possible lineage relationships 
between the different CD8+ T-cell subsets (Figure 12). 
Firstly, activation of naïve CD8+ T cells correlates with up-regulation of both 
CD28 and CD27. As CD27high were found exclusively within the CCR7- 
compartment, loss of CCR7 expression should occur early after antigen 
encounter, preceding up-regulation of these molecules. High density of CD28 
molecules at the cell surface would enable activated lymphocytes to receive 
stronger levels of co-stimulation than naïve cells. Since CD28+ cells display a high 
proliferative potential, likely due to high levels of co-stimulation, this differentiation 
process is likely accompanied by an important clonal expansion episode, in which 
high numbers of antigen-specific cells are generated. 
At the CD27high stage CD8+ T cells up-regulate some molecules, especially 
RANTES. As few CD27high different cells expressed single cytolytic molecules, this 
stage likely precedes the up-regulations of such functions. High expression of high 
levels CD27 at the surface might be crucial for these cells to receive survival 
signals that will allow them to escape apoptosis, a phenomenon to which 
proliferating cells became especially susceptible. Therefore, the CD8+ T 
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lymphocytes that achieve to be co-stimulated through CD27 receptor might have 





Figure 12. Hierarchy of activation stages and putative lineage relationships between 
CD8+ T-cell subpopulations. The distinct CD8+ T-cell subsets defined by the simultaneous 
expression of CCR7, CD45RA, CD27 and CD28 of the human peripheral blood are depicted and 
ordered according to the activation status. Downregulation of CD45RA expression from the surface 
may not be a mandatory step occurring after stimulation of naïve CD8
+
 T cells (TN), being 
influenced by factors yet undefined. Shadowed surface represents the strength of stimulation that 
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hypothetically is associated to the differentiation of each cellular phenotype. Excessively weak or 
strong stimuli induce cell death of cells. A minimal level of stimulation is believed to be needed for 
TN CD8
+
 T cells to upregulate functional genetic programs and survival factors that enable them to 
avoid death. Central memory (TCM) cells are thought to differentiate upon low levels of stimulation 
that induce their fitness, but are insufficient for them to completely upregulate genetic programs 
associated to effector functions. Stronger stimulation is believed to generate effector memory cells 
(TEM) and hierarchical thresholds of activation might induce distinctly differentiated subsets. The 
less activated TEM subset expresses high levels of CD27 (CD27
high
) and apparently it is transitory, 
giving rise to cells double positive (DP) for the expression of CD27 and CD28, single positive (SP) 
for one of these molecules (28SP or 27SP) or double negative (DN). Although CD27
high
 cells are 
less activated than TCM, it is unlikely that TCM could be generated through a CD27
high
 stage. Also, 
re-stimulation of TCM cells likely generates DN, 27SP, 28SP or DN cells directly, without reverting to 
a CD27
high
, less activated state (dashed arrows). The presence of CD27
high
 subsets, with 
characteristics of recent activation, in both TEM and TEMRA is a strong argument for the maintenance 
of CD45RA expression after priming of naïve cells. Since all primed subsets but CD27
high
 cells are 
stable populations, all of them can potentially re-encounter antigen (Ag) and elicit a secondary 
immune response, eventually differentiating into other more activated cell subsets. 
 
Once the cells have received enough signals that enable them to escape 
apoptosis, CD27 expression probably lowers into intermediate levels, inferior as 
compared to naïve cells. At this phase, expression of CD28 might have, or not, 
been down-regulated, an event that might depend on several factors. For instance, 
if cells receive a very strong stimulus via the TCR, co-stimulation through CD28 is 
less required and, thus, expression of this receptor may be down-regulated faster. 
Alternatively, an extensive and productive contact with CD4+ T helper cells might 
also relieve CD8+ T cells from the need of prolonged CD28-mediated stimulation. 
Hence, at this stage CD8+ T lymphocytes display a DP or CD27SP condition. This 
means that several functions are already being expressed by the majority of the 
cells, such as perforin, granzyme A, IL-10Rα and RANTES. Other functions, such 
as MIP-β or Fas-L were induced only in a limited fraction of cells. Granzyme B, 
depending if the cells are DP or CD27SP, can be expressed at different extents. 
If CD8+ T lymphocytes received a weak stimulus, or lacked appropriate CD4 
help, or were in disadvantage with other lymphocytes for the contact with APC and 
failed to receive enough levels of co-stimulation, CD28 might possibly be kept at 
the surface for longer periods than in conditions of optimal co-stimulation. In this 
situation, co-stimulation through CD27, which also requires cell-to-cell contact, 
might compensate for a sub-optimal co-stimulation through CD28 and allow these 
cells to survive the contraction phase of the immune response. Since stimulation 
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of CD27 induces its down regulation, some cells might thus acquire a CD28SP 
phenotype. These cells eventually accumulate enough signals that allow them to 
finally down-regulate CD28 expression from the surface and differentiate into DN 
cells. 
Another possibility is that CD8+ T cells achieve the highest stage of 
differentiation through the CD27SP pathway, when conditions favor CD27 
expression to be lost after CD28’s. At present, there it is not known if these cells 
may reacquire expression of CD27 and/or CD28. Such possibility implies that DN 
cells should be able to revert not only the cell-surface phenotype, but also the 
profile of gene expression into less differentiated stages and ascribes to the 
immune system a high degree of flexibility and adaptation to different settings of 
the same infection. Conversely, reversion not being possible, loss of CD27 and 
CD28 would lead to an end stage. DN lymphocytes display the highest activation 
status and are the major subset of CD8+ T cells responding to CMV chronic 
infection. Thus, they probably play a crucial role on the control of this, and possibly 
also other infections. Since these cells can not receive survival signals through 
CD27 and can not proliferate in response to CD28 stimulation, they should receive 
other signals through distinct receptors in order to survive.  
Whether CD8+ T lymphocytes progress sequentially through these stages 
following antigen encounter directly to a terminally differentiated DN stage, or 
become rather arrested in intermediate stages, is still undisclosed. It seems logical 
that the progressive loss of expression of CCR7, together with the co-stimulatory 
receptors, depends on the strength of stimulation that these cells receive and, 
interestingly, is accompanied by a progressive functional maturation. The action of 
other external factors can not be excluded. For instance, priming of naïve CD8+ T 
cells in the presence of cytokines such as IL-7 and IL-15 might favor differentiation 
of lymphocytes with retention of CD45RA expression. Alternatively, as this isotype 
form confers high responsiveness of lymphocytes to TCR stimulation, loss of 
CD45RA might be induced in situations of extremely efficient antigen presentation, 
such as when high density of APCs is available. In sum, the progression 
throughout a particular differentiation pathway versus another, as well as cells 
moving forward versus being arrested in a particular differentiation stage, are fate 
decisions that probably rely on a complex spectrum of stimuli for which 
lymphocytes will compete and, plus, are likely characteristic of each type of 
infection. 
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In some situations, activation of naïve lymphocytes upon antigen priming 
might be incomplete, as suggested by the model of progressive differentiation 
(Lanzavecchia and Sallusto, 2000). This might be case, for example, of 
lymphocytes that encounter antigen in the last phases of the immune response, 
when the number of APCs and the density of antigen they present, as well as 
other factors, become more limited. In such a scenario, naïve CD8+ T cells receive 
some level of stimulation, which enable them to up-regulate CD28 and enter cell 
cycle. In addition, they can eventually receive survival signals through CD27 that 
allow the induction of anti-apoptotic molecules which account for an enhanced 
resistance to apoptosis. However, further signaling that would permit to finish the 
remodeling of genes coding for effector functions, which ultimately leads to the 
activation of differentiation programs, fail to occur. These expanded cells become 
long-lived, but undifferentiated and since they have undergone the initial activation 
events that have rescued them from the G0 phase of the cell-cycle, they proliferate 
slowly in response to homeostatic cytokines produced by other cells. Therefore, 
upon a further challenge, these cells can rapidly start to proliferate and also 
progress in the differentiation program they have initiated upon previous antigen 
encounter. These cells likely correspond to TCM cells, but the possibility that a 
continuum of several degrees of undifferentiated cells might exist across the DP 
subset can not be excluded. 
When TCM cells re-encounter antigen and receive the appropriate 
stimulation that will allow them to proceed differentiation, they may follow the same 
pathways described above. However, up-regulation of high levels of CD27 seems 
unlikely, as it would imply a regression concerning the expression of effector 
functions that TCM were already expressing. Since in secondary immune 
responses CD28 appears to have a paramount role that can not be compensated 
by CD27, in differentiation of TCM CD27 expression might preferentially be lost 
before CD28. In this case, TCM would progress into DN through a possible, but not 
necessary, DP stage from which CD28SP cells would arise. Nevertheless, the 
differentiation of TCM throughout the alternative pathway DP  CD27SP  DN can 
not be excluded. A particular cytokine environment and/or differential priming 
conditions might eventually favor the re-expression of CD45RA. 
In the context of several chronic viral infections, the establishment of 
lifelong protection, where viral replication is thought to be controlled by specific 
CD8+ T cells, is conferred by different CD8+ T cells subsets according to the type 
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of infection. As an example, in chronic infections by EBV, HIV and CMV, the CD8+ 
T cells specific for each virus are enriched, respectively, on DP, CD27SP and DN 
cells. This strongly suggests that the distinct CD8+ T cell subpopulations provide 
selective advantages for the control of each type of infection. Whether all, or only 
some particular subsets amongst TCM, DP, CD27SP, CD28SP or DN are endowed 
with the gift of longevity, or rather they are selectively replenished with cells from 
one pool to the other, is uncertain. If expression of CD27 could provide significant 
survival advantage, expression of CD28 would assure that memory cells retain the 
capacity of interacting productively with professional antigen cells in order to 
receive co-stimulation in a further challenge, which might contribute significantly 























Although heterogeneity of human CD8+ T cells has been extensively 
analyzed in bi- and tri-dimensional studies using the CCR7, CD45RA, CD27 and 
CD28 molecules, the partial use of these markers renders the characterization of 
naïve, effector and memory CD8+ T-cell subsets rather fragmentary. A 
comprehensive analysis of the global cell-surface pattern of co-expression was 
thus lacking. 
The aim of this thesis was to overcome the prevailing ambiguity concerning 
the functional properties of memory and effector CD8+ T cell-subpopulations found 
on the human peripheral blood. We found that an innovative approach for such 
study could bring important insight onto the functional characterization of CD8+ T-
cell subsets, as well as concerning their lineage relationships. We have therefore 
developed a novel method of multiplex RT-PCR at single-cell level. This strategy 
allowed us to: (1) study the expression of a considerable number of molecules at 
the quantitative level in single cells; (2) assess the heterogeneity of each cellular 
subset; (3) associate cell-surface phenotype to gene expression profiles; and (4) 
characterize and understand minor populations that are not possible to study by 
other methods.  
We have shown that CD8+ T-cell subsets display distinct patterns of gene 
expression. A hierarchy of activation stages correlated to CD27 and CD28 co-
expression, but surprisingly is independent of CD45 isotype expression. This 
finding strongly suggests that the loss of surface receptors might occur 
asynchronously following antigen stimulation, indicating that TEM and TEMRA 
subpopulations might play similar roles in the immune response in vivo. This 
possibility challenges the prevailing notion that CD45RA expression is necessarily 
downregulated after activation. The identification of populations with 
characteristics of recently activation within both TEM and TEMRA subsets provided 
strong evidence supporting that hypothesis. However, only a thorough repertoire 
analysis of TEM and TEMRA populations can help to confirm if CD45RA expression 
can be maintained after CD8+ T-cell activation. We are presently establishing a 
project for the study of TEM and TEMRA CD8
+ T-cell subsets repertoire by 
immunoscope analysis. 
We were also surprised to found that several genes reported to be 
significantly expressed by CD8+ T cells had a very low or absent expression. This 
was the case, for example, of TNF-α and MIP-1α, and others. This finding 
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indicates that it may be extremely relevant to study the CD8+ T-cell populations 
recovered on the secondary lymphoid tissues. Although the access to these types 
of biological samples is very limited, we were able to perform preliminary studies in 
lymph nodes and one spleen sample that have shown that indeed, in these sites, 
cellular subsets with the same phenotype as in the blood were enriched in cells 
expressing further functions, namely, cytokines and chemokines. This observation 
suggests that the degree of functional heterogeneity of the cellular subsets can 
vary between the blood and the sites where antigen presentation can occur. In 
particular, this work shows that heterogeneity concerning cytokine production by 
CD8+ T lymphocytes can not be assessed in the blood, since circulating 
lymphocytes are poor cytokine producers. It will be therefore interesting to 
investigate if patterns of cytokine co-expression can be found in CD8+ T cells 
isolated from secondary lymphoid organs. It will be further exciting to confirm 
which patterns of cytotoxic gene expression segregate with particular cytokines, 
and if differences at the quantitative level can be detected between functions 
expressed by cells in the blood or in the secondary lymphoid tissue. 
Since differences between TEM and TEMRA could not be detected in what 
concerns effector functions, we wonder if cells present on these compartments 
would not drastically differ in other settings, including proliferation, survival or 
production of other cytokines and/or chemokines. We consider therefore the 
possibility of designing a relevant panel of genes, or several independent gene 
sets, that would allow studying these functions quantitatively and at the mRNA 
level, in order to investigate the extent of which the expression of these functions 
differs from subset to subset. Moreover, it may be pertinent to compare these 
results with functional experiments aiming to answer the same questions. This 
would provide a direct comparison between the outcomes observed at in vitro 
studies and the ex vivo potentialities of the cells. 
Finally, the fact specific CD8+ T-cells for EBV, CMV, HCV and HIV-1 show 
distinct predominant phenotypes is intriguing. This might result from a viral-
induced blockage in CTL differentiation or, alternatively, the distinct CD8+ T-cell 
subsets might provide selective advantages to respond and control to each 
specific viral infection. For this reason, we envisage a comprehensive study of the 
gene expression profiles of CD8+ T-cell subsets specific for multiple epitopes of 
different virus. With this, we intend to clarify if a pattern of gene expression 
correlates only with cell surface phenotype or might also depend on antigen 
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specificity, in particular, for epitopes of the lytic and chronic phases of infection. 
Moreover, it will be interesting to address whether the gene expression profiles we 
found in this study are altered in the context of viral infection. We hope to provide 
significant progress on the understanding of the mechanism of disease, which 
might bring fundamental insight for the assessment of therapeutic strategies 
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Table Supplemental Materials. Specific primers used for the first and second PCR. 
Primers on the top: 5’ primers; Primers on the bottom: 3’ primers. Reverse transcription 
reactions were carried out using the 3’ primer indicated for each individual gene. Acession 
numbers correspond to gene sequences obtained at the Ensembl Project Homepge 
(http://www.ensembl.org). 
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